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I. Abstract 
Intracellular protein and RNA localization is one of the mayor players in the 
formation of cell shape, enabling cell agility, cellular differentiation and cell 
signaling. Various diseases are associated with malfunctions of intracellular 
molecule transport. There are many known pathways of how and why proteins and 
RNAs are transported within the cell and where they are located, though there is 
not much known about the global distribution of proteins and RNAs within the cell. 
In this study I apply a subcellular fractionation method coupled to multiple omics 
approaches to investigate the global distribution of mRNAs, noncoding RNAs and 
proteins in neuronal cells. Neurites and soma from mouse neuroblastoma cells 
(N1E-115) as well as from Ascl1 induced neurons (Ascl1-iNs) were isolated and 
the composition of the spatial proteome and transcriptome was examined.  
The localization of mRNAs correlates significantly with the localization of their 
corresponding protein products in Ascl1-iNs whereas it does not in the mouse 
neuroblastoma cell line N1E-115. Comparing these datasets with recently 
published data of other cell lines and methods it is clear, that the local proteome, 
transcriptome and translatome of neuronal cells is highly cell type specific. 
To investigate how spatial protein pools are established I analyzed local pools of 
newly synthesized proteins revealing that many proteins are synthesized on the 
spot. RNA localization therefore plays a crucial role in generating local protein 
pools in these highly polarized cell systems.  
Additionally, I propose a method to identify on a global scale de novo “zip codes” 
in these cell systems which would be a great step towards understanding 
malfunctions in molecule transport. 
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I. Zusammenfassung 
Intrazelluläre Protein- und RNA-Lokalisation ist ein lebenswichtiger molekularer 
Mechanismus. Ihm unterliegen sowohl die äußere Gestaltung der Zellform, 
Zellagilität, zelluläre Differenzierung sowie die intra- sowie interzelluläre 
Kommunikation. Diverse Krankheiten werden mit Fehlfunktionen des 
intrazellulären Molekültransportes assoziiert und es existieren unzählige Beispiele 
für bekannte Wege des intrazellulären Protein- und RNA-Transportes. Allerdings 
ist die globale Komposition lokaler Protein- und RNA-Reservoirs bisher kaum 
wissenschaftlich erforscht worden. 
In dieser Studie beschreibe ich die Protein- sowie RNA-Kompositionen 
subzellulärer Fraktionen zweier neuronaler Zelltypen. Die Neuriten und Somata 
von Neuroblastoma-Zellen (N1E-115) und Ascl1 induzierten Neuronen (beides 
Mauszellen) wurden mechanisch voneinander separiert und mittels RNA-
Sequenzierung und Massenspektrometrie auf ihre Bestandteile untersucht.  
Die Verteilung von mRNAs korreliert signifikant mit der Verteilung der 
entsprechenden Proteine in Ascl1-iNs während in der Neuroblastoma Zelllinie 
N1E-115 kein solcher Trend nachgewiesen werden konnte. Der Vergleich zu 
Datensätzen von anderen Zellsystemen und Methoden zeigt, dass das lokale 
Proteom sowie das lokale Transkriptome und Translatome stark Zelltyp spezifisch 
ist. 
Um den Einfluss lokaler Proteinbiosynthese auf die Komposition subzellulärer 
Proteinpools zu erheben, habe ich die Lokalisation neu synthetisierter Proteine 
untersucht. Es scheint, als sei die RNA-Lokalisation und lokale Translation von 
hoher Relevanz für die Protein-Lokalisation in diesen stark polarisierten 
Zellsystemen. 
Des Weiteren stelle ich eine Methode vor, um de novo „zip codes“ in diesen 
neuronalen Zellsystemen zu identifizieren. Diese könnte ein elementar wichtiger 
Schritt sein, um Fehlfunktionen im interzellulären Molekültransport zu verstehen. 
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1. Introduction 
1.1. Development of multicellular organisms and the importance of molecular 
trafficking 
Most animals and plants start as single cells, but they do have very different and distinct ways 
to form multicellular organisms. This process is depicted broadly as a self–assembly process 
with four fundamental forces: cell proliferation, cell-cell interactions, cellular differentiation 
and cell movement. All these conserved mechanisms shape the animal body plan starting from 
a single fertilized zygote. This unique cell carries a lot of maternal information and resources 
and cleaves rapidly without growing. It is by definition omnipotent, since it carries the potential 
to form each cell of the organism. During maternal to zygotic transition the blastula is formed 
and embryonic development can be observed as we know it from textbooks [1]. External cells 
form the ectoderm, invaginated cells form the endoderm and cells moving in between these 
two layers form the mesoderm [2]. At this point most cells are pluripotent. During further 
development the cells become increasingly restricted in their potential for differentiation. This 
process reaches its limits when cells undergo terminal differentiation. The fate of a cell relies 
not only on its genetic material but also on a combination of endogenous genetic information, 
external factors and historical burdens – the cell memory [3], [4]. Cell-cell contacts, even if 
they are transient and weak, greatly impact the future of both cells [5] and genes involved in 
cell-cell communication, transcription, while chromatin structure and regulatory DNA are of 
crucial importance during all steps of embryonic development [6]. Through combinatorial 
control and cell memory even simple plans can form complex patterns [7]. The first steps of 
this developmental patterning can be observed within the first seconds of embryonic life: 
polarization of the embryo before gastrulation and asymmetric cell divisions generate cell 
diversity within the very first moments of all of our lives [8], [9]. Throughout this process three 
major axes are generally formed: the animal-vegetal axis, which defines whether parts of the 
body are ex- or internal; the anterior-posterior axis, which defines the future head-tail 
orientation of the organism; and the dorso-ventral axis, which specifies the future back and 
belly orientation. At one extreme – the insect egg – these axes are already defined by the outer 
appearance of the zygote. At another extreme – the mammalian development – the egg is 
spherical, and the axis must be formed from inside. A combination of signaling proteins 
patterns the vertebrate embryo and forms the organism as we know it [10]. 
1.1.1. Cell proliferation: The cell cycle 
The only way to from a new cell is to duplicate an existing cell. In unicellular species the 
division results in two new organisms, whereas multicellular species are a result of a cascade 
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of cell divisions. Continuous cell divisions are crucial for the sustainability of higher 
organisms. The two main tasks are (1) dividing the cell body and meanwhile (2) passing on the 
genetic code to the two new daughter cells. This process is called the cell-cycle and can be 
divided into four phases: G1, S, G2 and M-phase. The event is controlled by a number of 
feedback loops and irreversible ON/OFF switches and results in a duplication of the genetic 
material (mitosis), cell organelles and cytoplasmic division (cytokinesis) [11]. The control 
system of the cell cycle operates like a timer and is remarkably robust and highly adjustable. It 
consists of a cascade of cyclically expressed and activated cyclin-dependent protein kinases 
(Cdks) and blocks progression if, at any step, a mistake is detected. The activities of these 
kinases rise and fall as the cell progresses through the cycle and with them, the phosphorylation 
of intracellular protein groups that initiate or regulate the process changes. Cyclins, which are 
proteins that are expressed and degraded in a cyclic dependent manner, bind these kinases and 
inhibit their activity [12]. There are four classes of cyclins, three of which are required for all 
eukaryotic cells: G1/S-cyclin, which activate Cdks in late G1 phase an initiate the cycle; S-
cyclins, which bind Cdks soon after progression and help to stimulate chromosome duplication; 
and M-cyclins, which activate Cdks that stimulate mitosis and G1-cyclins that help in most 
cells to govern the G1/S cyclin work [13]. In vertebrate cells there are additionally four classes 
of Cdks: two of these classes interact with G1-cyclins, one with G1/S-cyclins and one with S- 
and M-cyclins. Cyclins do not only activate the kinase activity of Cdks but also help to 
recognize their targets. As a result, each cyclin-Cdk pair phosphorylates a different set of 
proteins. Additionally, Cdks can be suppressed by phosphorylation by the kinase Wee1, 
activated by the phosphatase Cdc25 or inhibited by several inhibitory proteins (CKIs) [14]. The 
cell cycle control system also depends on transcriptional regulation, where not only cyclins but 
up to 10% of the whole genome is expressed in a cyclic dependent manner [15]. 
The first step of the cycle is in late G1 phase (G for gap), which can account for up to 90% of 
the length of the cycle. G1 phase is a stable state of Cdk-inactivity. This is the preparation 
phase for mitosis and cytokinesis and if conditions demand it, it can go to G0, which is a steady 
state. G1 phase ends and S-phase starts with the activation of Cdks via G1/S-cyclins. Now the 
DNA replication begins at the origin of replication. Helicases unwind the double helix and 
replication can start. The pre-replicative complex (preRC) is formed by the origin recognition 
complex (ORC), Cdc6, Ctd1 and a pair of helicases already in G1 phase. It is activated in S-
phase via phosphorylation by S-Cdks. At this point, the origin can no longer be used until the 
preRC forms again during another G1 phase. S-Cdks also phosphorylate the ORC and Cdc6 
and thereby inhibit new preRC formation while they are activated. The S-phase (DNA 
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synthesis phase) lasts 11 to 12 hours in mammals. During this phase, not only are the 
chromosomes duplicated but the chromatin structure is transferred to the new sister chromatid. 
At the end of S-phase, sister chromatids are held together by Cohesins, giant ring-like 
structures. During the following G2 phase the cell expresses genes to prepare mitosis. G1, S 
and G2 phase together are called interphase. The G2/M transition is the next big step in the cell 
cycle. Through expression of G2/M cyclins M-Cdks are accumulated. Though phosphorylated, 
they stay inactive due to inhibition by Wee1. In G2/M transition Wee1 is suppressed and Cdc25 
is meanwhile activated and removes the inhibitory restrictions of M-Cdks. A double positive 
feedback loop occurs – M-Cdks activate their own activator Cdc25 and inhibit their own 
suppressor Wee1 – which initiates mitosis, a cascade of reactions that takes up to one hour in 
mammals. Chromosome segregation and nucleus division are separated into five major phases: 
Prophase, Prometaphase, Metaphase, Anaphase and Telophase. During Prophase the 
chromosomes condensate and the mitotic spindle assembles: a microtubule-based machinery 
with two distinct poles, the centrosomes. In Prometaphase the nucleic envelope is broken 
down and the chromosomes attach to the spindle at the plus ends of the microtubules. During 
Metaphase the chromosomes are now aligned and the sister chromatids are attached to 
opposite poles of the spindle by kinetochore microtubules. Now the kinetochore microtubules 
get smaller and the spindle poles separate, and both pull the chromatids apart from each other. 
During this process, which is called the Anaphase, four motor proteins play an important role: 
Kinesin-5 has two motor domains and attaches to antiparallel microtubules, pulling them apart; 
Kinesin-14 attaches to one microtubule and pulls the antiparallel one apart; Kinesin4/10, which 
are also called chromokinesins, associate with the chromosome arm and push the arm away 
from the spindle pole while Dynein links the plus ends of the astral microtubules to the actin 
cytoskeleton and moves towards the minus end, which pulls the poles apart. The metaphase to 
anaphase transition is controlled via regulated proteolysis. Key regulator is the anaphase 
promoting complex (APC/C) or cyclosome, which is activated in mid-mitosis via Cdc20 or 
Cdh1 in early G2 phase [15]. Ubiquitination and, therefore, destruction of the Securins, which 
protect the protein linkage between sister chromatids, and activation of S- and M-cyclins end 
the Anaphase. Now Telophase starts and the sets of daughter chromatids reach the poles and 
decompensate. The division of the cytoplasm begins with contraction of the contractile ring. 
The positioning of the contractile ring during cytokinesis is induced by the positioning of the 
spindle poles. Now membrane-enclosed organelles are distributed, the ER is separated in two, 
the Golgi is reorganized, and two new daughter cells are formed. At the end of mitosis APC/C 
activation leads to overall inactivation of Cdks and destruction of geminin. ORC and Cdc6 are 
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dephosphorylated and the preRC can form again. SCF, another ubiquitination system, is 
required to regulate CKIs in late G1 phase and depends on F-box proteins. This complex is 
responsible for activation of S-Cdks and degradation of G1/S cyclins in early S-phase [7]. 
Obviously, the cell cycle is the result of tremendous intracellular molecular reorganization. The 
cellular architecture defined by the cytoskeleton and membranes has to be reshaped and 
organelles have to be moved to assure functional daughter cells. Altogether an orchestra of 
cellular trafficking. 
1.1.2. Cell-cell interactions: Cell junctions and the extracellular matrix (ECM) 
Since a pile of cells does not form an organism by default, these cells must make contacts to 
each other to communicate in order to build a higher three-dimensional structure. These cell-
cell and cell-extracellular matrix (ECM) contacts govern the architecture of the organism, its 
shape, strength and the arrangement of different cell types through controlling cellular 
movements within the organism. They are critical for each aspect of organization, function and 
dynamics of multicellular life [16]. Defects of these result in numerous diseases [17]. We can 
divide cellular interactions by tissue: in connective tissue and epithelial tissues. In connective 
tissue cells are connected to the ECM rather than to each other. The matrix fulfils most 
functions of mechanical support. The ECM is made and oriented by the cells within it by three 
major proteins: glycosaminoglycans (GAG) form chains and hydrated gels and consist of 
proteins of the collagen family; elastin gives elasticity to the tissue; and fibronectin organizes 
the matrix and binds integrins. Cell-matrix anchoring junctions control cell proliferation and 
survival. They recruit intracellular signaling proteins at sites of cell-matrix adhesions and 
mediate response to mechanical stress. There are two main cell-matrix anchoring junctions: 
hemidesmosomes, formed by α-6-β-4-integrins and type XVII collagen and actin-linked cell-
matrix junctions formed by various integrins. Integrins are transmembrane proteins that can 
link the ECM to the cell membrane. In the case of hemidesmosomes, ECM ligands are 
intermediate filaments and the intracellular receptor is plactin and BP230. In case of actin 
linked cell-matrix junctions, the ECM ligands are actin and adaptors are talin, kindling, 
vinculin, paxilin and kinases [7]. On the other hand, in epithelial tissue, cells are tightly bound 
to each other rather than to the ECM. Consequentially, the ECM is less pronounced and serves 
mostly as a thin mat called the basal lamina, which consists mainly of collagen and laminin. 
There are three main types of cell-cell junctions (1) tight junctions, (2) gap junctions, and (3) 
anchoring junctions. Tight junctions seal gaps between epithelial cells, while gap junctions 
allow the passage of small, water soluble molecules. Anchoring junctions link cells together 
and resist mechanical stress. They must be dynamic and are therefore made by cadherins, which 
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make hemophilic adhesions. These hemophilic adhesions are relatively weak, and there must 
be many of them present in order to resist mechanical stress. They play a crucial role in cell 
sorting mechanisms. There are two kinds of anchoring junctions: desmosomes and adherens 
junctions. Desmosomes connect intermediate filaments between cells and are made of the 
noncanonical cadherins desmoglein and desmocollin. Adaptors for the intermediate filaments 
are plakoglobin and desmoplakin. Adherens junctions connect actin filament of two cells with 
each other. There are classical cadherins on both cells, and adaptor proteins such as α-, β- and 
γ-catenins link the cadherins to the actin cytoskeleton. These junctions make 
mechanotransduction possible via the remodeling of mechanical stress from the cell-layer to 
the actin cytoskeleton [7]. 
Fig 1. Cell junctions. Schematic presentation of different intercellular junctions and ECM-cell junctions. 
1.1.3. Cell specialization: Stem cells, differentiation and tissue renewal 
Multiple cells, although connected to each other and surrounded by a supportive matrix, do not 
always form an organism. For complex organisms to form, numerous different cell types are 
required to fill various functions, enabling them to form complex tissues. The process of 
developing specialist cells is called differentiation. The fertilized egg is omnipotent and cells 
lose potency as they approach terminal differentiation during the cascade of cell divisions. 
Molecular lifetime plays a crucial part in differentiation during embryonal development. 
Internal oscillators and external signals are interpreted during cell fate decision. Various gene 
cascades partially determine the future shape of a cell; one of the most striking examples is the 
evolutionary conserved Hox gene cluster, a genetic machinery to impart specific features to 
regions along the anterior-posterior axis during development [2], [18]. The overall body 
structure of every vertebrate has a repetitive, periodic structure. These segments originate from 
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the mesoderm, which gets segmented in regular somites during embryogenesis. The posterior 
- the most immature part of the mesoderm slab (presomitic mesoderm) - supplies the required 
cells: as the cells proliferate, this mesoderm retreats tailward, extending the embryo. In this 
process it deposits a trail of somites formed from the cells that group together into blocks as 
they emerge from the anterior end of the presomitic region. The special character of the 
presomitic region is maintained by a combination of Wnt/Fgf signaling produced at the tail end 
of the embryo [19]. A conserved gene-expression oscillator acts as a clock to control vertebrate 
segmentation (Notch/Delta) and determines segment size: 30min in Danio rerio, 90min in 
Gallus gallus and 120 in Mus musculus [20]. This clock is crucial to segmentation and widely 
conserved between vertebrate. Hes genes, which are a key component of the Notch signaling 
pathway, transcriptionally inhibit Delta and its own expression. Hes is expressed until it can 
inhibit its own transcription, and after degradation it is transcribed again. The timespan of the 
oscillator and, therefore, the size of one segment depends on the molecular lifetime of Hes 
mRNA and Hes protein. As cells escape the Wnt/Fgf signaling, Notch oscillation arrests in one 
state or the other. The intercellular Notch signaling pathway keeps this intracellular clock 
synchronized between neighboring cells. 
There are various ways of differentiation, but the most common textbook example starts with 
a stem cell. Stem cells can divide indefinitely and hold the potential to give rise to both new 
stem cells and less potential and more differentiated cells. This naturally irreversible process 
of changing into another more specialist cell is called differentiation. During this process 
expression patterns change and stemness-associated genes are turned off while cell fate-
promoting genes are turned on. This happens numerous times during development and governs 
self-regenerative processes as well as tissue formation. The size, shape, metabolism and 
membrane potential of a cell can change during differentiation, while the genetic code stays 
the same. Reorganization of the cellular framework of course requires intracellular transport 
and reorganization of organelles, proteins and RNAs. During embryonic development 
totipotent zygotes and early blastocysts give rise to pluripotent embryonic stem cells, which 
themselves give rise to multipotent stem cells, oligopotent and unipotent niche stem cells, 
which are kept for a lifetime and that can give rise to just terminally differentiated cells. 
Changing the transcriptome of a cell requires transcription factors and more than a decade ago 
Yamanaka et al. [21] discovered a mixture of transcription factors that are responsible for 
stemness maintenance. These factors (c-Myc, Oct4, Sox2 and Klf4) seemed not only 
responsible for keeping stemness but also for inducing stemness in somatic cells and the 
discovery gave rise to the large field of induced pluripotent stem cell (iPSC) research. During 
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the last years it became evident that each of these transcription factors can be replaced by a 
combination of downstream or related transcription factors, chemical reagents and miRNAs 
[22], [23]. During canonical differentiation cells react to external signals like growth factors 
with receptors on their cell membrane that lead to phosphorylation cascades within the cell 
and, finally, activation of one or more cell fate determining transcription factors [24]. The role 
of signaling during epigenetic control is, without doubt, enormous and the signaling pathways 
responsible for cell fate decisions are numerous. The most prominent members of this family 
of factors are: Wnt, Fgf, Bmp, Tgf and Lif, which are all used in cell culture to control in vitro 
differentiation as well as to culture stem cells. Another way of differentiation is the more 
intrinsic mechanism of asymmetric cell division in combination with asymmetric distributed 
maternal determinants. This mechanism is the predominant way of differentiation in organ 
homeostasis, for example in the liver or gut of mammals. Both genetic systems have a couple 
of determinants, which all have to be modified during differentiation: pioneering factors like 
Sox2, Oct4 and Nanog have to be shut down; the polycomb repressive complex (PRC1/2), 
which is abundant in embryonic stem cells and silences cell fate decision genes, has to be shut 
down; members of the trithorax group proteins that remodel the chromatin and are responsible 
for multiple histone modifications have to be reorganized; nucleosomes are repositioned; DNA 
methyltransferases like Dnmt1 are transiently excluded from the nucleus so that the cells can 
erase and organize a new DNA methylation pattern; and, last but not least, a number of post-
transcriptional control systems are remodeled, for example, the let-7/lin28 system [23]. 
1.1.4. Cell movement: Internal structure and organization of the mammalian cell 
The extraordinary structure of complex organs is the result of the interplay and formation of 
numerous cells that differ in shape, size, function, membrane potential and metabolism. These 
differences, results of various differentiation events, are caused by internal structural 
reorganizations, intracellular transport and localization of proteins and RNAs. As transcription 
factors and signaling pathways determine the fate of a cell, membranes and the cytoskeleton 
define boundaries and provide the framework for all cellular functions. And the intracellular 
organization of a cell determines its function and scope. Membranes are crucial for cellular 
life; they define boundaries between different cells and within the cell as they envelope the 
nucleus, the endoplasmic reticulum (ER), the Golgi, mitochondria, the lysosome and the 
centrosome. Ion gradients can be established with semipermeable membranes and can be used 
to catalyze reactions, to synthesize ATP, to deliver signals, or to transport bigger molecules 
[25]–[28]. They contain proteins that act as sensors or receptors for external stimuli or factors 
and therefore enable information transfer between cells or organelles. Their canonical structure 
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is a 5nm thin bilayer of lipids and proteins that is held together mainly by noncovalent 
interactions. They are dynamic and fluid structures, two-dimensional liquids with diverse 
functions. Proteins within the membrane move canonically just within the plane of the 
membrane and serve as transporters, receptors, links, destabilizers and stabilizers and also the 
lipid composition of the membrane itself, which is predominantly made of phospholipids, 
sphingolipids and sterols, changes its functions and characteristics [29]. 
The cytoskeleton organizes the shape, robustness and structure of a cell in space and time and 
enables the cell to interact with other cells and the environment. Many cells change their shape 
during lifetime and the basis for all of these changes are molecular rearrangements in the 
cytoskeleton and intracellular trafficking along the cytoskeleton [30]. The cytoskeleton does 
mainly consist of three components: (1) actin filaments, (2) microtubules and (3) intermediate 
filaments. All of these assemble from protein subunits that impart specific physical and 
dynamic properties and can span hundreds of micrometers. Although the single subunits of all 
three major components are rather small and diffuse very quickly and additionally are held 
together by weak noncovalent links, the assembled structures are a solid macromolecular 
framework throughout the complete cell. Actin and tubulin are both polarized molecules and 
also form polarized structures, which enable directed intracellular movements that are 
indispensable to cellular life. Additionally, both provide enzymatic subunits that can catalyze 
ATP or GTP respectively, which helps to remodel the cytoskeleton more quickly. Actin 
filaments determine the shape of the cell surface and are crucial for locomotion. Due to the 
polarity of the actin subunits they have a fast growing plus end and a slow growing minus end. 
They form single helices that underlie the plasma membrane and provide shape and strength to 
the lipid bilayer, while enabling the cell to contract. They also form static or dynamic cell 
projections such as lamellipodia or filopodia. Both subunits and the structure of actin filaments 
are extraordinal conserved between animals. There are several actin binding proteins that vary 
the properties of the filament; formins and Arp2/3 are responsible for nucleation and therefore 
assembly of unbranched (Formin) and branched (Arp2/3) networks. Profilin binds actin 
subunits and speeds the elongation. Tropomyosin stabilizes the filament while various capping 
proteins, tropomodulin and thymosin, prevent the assembly. Gelsolin severs the filament and 
only binds to the plus ends. Cofilin binds D-actin and accelerates the disassembly. Fimbrin, α-
actinin and filamin crosslink the fibers,thereby strengthening the network as well as ezrin, 
radixin,moesin proteins (ERM) and spectrin, that link the network to the plasma membrane. 
Additionally, each actin monomers carries an ATP or ADP molecule and, dependent on the 
hydrolysis state of said molecule, the filament either grows or is disassembled. There are three 
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canonical actin homologues in mammalian cells, α-, β- and γ-actin, which vary slightly in their 
sequence but have very different functions; while α-actin is expressed only in muscle cells, β- 
and γ-actin are found in almost all non-muscle cells. Actin filaments are often bundled to 
provide more strength and accession surface for accessory proteins that act as adapters or 
transporters. Under optimal conditions the filament nucleation is the rate-limiting step in actin 
formation and once the critical size of the polymer is reached the elongation happens very 
quickly and monomer availability controls the filament assembly. Intracellular movements of 
organelles can be powered by actin polymerization and motorproteins can be used to regulate 
active intracellular transport of molecules along the actin cytoskeleton. Actin-binding motor 
proteins are members of the Myosin family. Cell migration is vastly governed by actin filament 
formation at the migrating tip of the cell. The coordination of rapid actin-network formations 
at these protrusions forms the lamellipodium and sometimes finger-like structures at the 
leading edge (filopodia) that enable locomotion of the whole cell. 
During this process the initial membrane extensions by actin polymerization due to Arp2/3 
activity are induced by signaling receptors. Extracellular Egf or Pdgf is detected by Cdc42/Rac 
transmembrane GTPases and triggers lamellipodia formation at the front edge of the cell. 
Additionally, lysophosphatic acid (LPA) is detected by Rho transmembrane 
GTPases,triggering stress fiber formation and contraction at the rear end of the cell. Myosin-II 
contractions at the rear end of the cell cause organelle and cytosol forward flow within the cell. 
During retraction of the rear part, cell attachments (focal adhesions) that are rich in signaling 
receptors are recycled by endocytosis [31], [32]. Each of these processes rely on the correct 
localization of receptors on the cell surface. 
In contrast to the flexible and rather simple actin filaments, tubulin polymers build the stiff and 
tubular basic framework of the cytoskeleton. Microtubules are hollow tubes made of 13 
protofilaments that have multiple contacts and a distinct structural and dynamic polarity. They 
are used to move and anchor cell organelles and molecules at distinct places and build the so-
called highways within the cell for long distance transport, for example in axons. They are 
made of α- and β-tubulin which are frequently found in the cytoplasm and exist in multiple 
isoforms, making microtubules versatile in their properties. They can form cilia or flagella 
which are used as motile whips and sensory devices for the cell, with a distinct (9x2)+2 
structure and intraflagellar transport of molecules along the tubulin polymers [33], [34]. They 
can also form bundles through the cell for intracellular transport of various items and emanate 
from the centrosome in animal cells. Microtubules, though they are complex and large 
structures, can be rearranged quickly by multiple proteins and do undergo dynamic instability. 
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β-tubulin binds GTP, which acts as a switch for polymerization. While GTP-β-tubulin tends to 
polymerize, GDP-β-tubulin rather depolymerizes [35]. Motorproteins make use of the polarity 
of microtubules and can move either to the plus end (dyneins) or to the minus end (kinesins) 
of the microtubule. γ-TuRC nucleates the assembly of microtubules and associates with the 
minus end. TIPs remain associated with the plus ends and can link it to other structures. 
XMap215 stabilizes the plus ends and Map stabilize the microtubule overall while katanin 
severs microtubules and kinesin-13 induces disassembly. Stathmin binds tubulin subunits and 
prevents polymerization, while Map2, tau and plectrin are responsible for filament bundling 
and cross linking. 
Intermediate filaments, in contrast, provide mechanical strength. They are made of small 
fiber-like proteins that are twisted together using a combination of end-to-end and side-to-side 
protein contacts. They line the inner face of the nuclear envelope and protect the nucleus. 
Within the cytosol they twist together and form strong cables that hold epithelial sheets together 
or help to solidify long structures. All intermediate filaments can provide a platform for 
motorproteins and can therefore be used for active transport or anchoring of molecules within 
the cytosol. The order of intermediate filaments within the cell is regulated by providing or 
depriving attachments within or with other cell structures. The fibers are held together by direct 
covalent links, and modifications of fiber subunits regulate features of the fiber. They provide 
a stable and large-scale structure and enable polarity, which often stays for the lifetime of the 
cell [36]. 
 
 
 
Fig. 2 The cytoskeleton. Schematic presentation of the cytoskeleton. 
1.2. Mechanisms and importance of cellular polarity 
Cell polarity is the outcome of and reason for multiple cellular processes including junction 
formation, cytoskeletal organization, organelle positioning, protein and RNA trafficking and 
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functional specialization of membrane domains. Architecture and shape must be tightly 
regulated in vivo to fulfil requirements of function and signaling, especially in multicellular 
life. There are four types of cell polarity: (1) apico-basal cell polarity (ABCP) or epithelial cell 
polarity; (2) planar cell polarity (PCP) the polarity across the plane of an epithelium; (3) 
asymmetric cell division (ACD) involved in cell renewal of stem cells and differentiation of 
daughter cells; and (4) front-rear cell polarity (FRCP) involved in directed cell migration and 
signaling [10]. Key to all of them is the direct or indirect intracellular transport of molecules 
and organelles as well as a polar cytoskeleton. The fundamental property of ABCP, FRCP and 
ACD are antagonistic interactions between two polarity modules, the Scribble homolog module 
and the Par module [37], [38]. Throughout embryonal development ACD plays a key role in 
generating different cell types and most cells need to establish functionally distinct domains 
along an axis of polarity. The interaction of these functional units is essential to multicellular 
life. The functional units of the cell are proteins, lipids and nucleotides. As in most cellular 
processes protein interactions are central to the control of cellular polarity and vice versa. 
Intracellular localization of molecules in various ways is fundamental to all asymmetric 
distributions and therefore polarization. Moreover, polarized cells need to respond to external 
stimuli that coordinate polarity at the tissue level. The establishment of asymmetry within the 
cell relies on intricate networks of molecular interactions between cortically localized proteins. 
Main complexes of ABCP, FRCP and ACD are the Partitioning defective proteins (PAR) 
complex (Par3, Par6, aPck) which plays a critical role in apical domain identity together with 
the Crumbs (Crb) complex (Crb/PalS1/Patj) and the Scribble (Scrib) protein complex (Scrib, 
Lgl, Dlg), which defines the basolateral domain [39]. The establishment of polarity, however, 
involves many other proteins including the kinase Par1, the 14-3-3 proteins Par5 and the 
Coracle group proteins Yurt, Coracle, Neurexin IV, NaK-ATPase as well as at least two types 
of membrane lipids: phosphoinositides and glycosphyngolipids. The crosstalk to various 
signaling pathways is crucial since cell polarity relies on extracellular signals and intracellular 
landmarks that initiate polarization through a signal transduction cascade. 
A prominent example of de novo polarity formation is the epithelial cyst. Apical markers such 
as Podocalyxin and Crumbs3 initially localize all around the membrane. Upon cell division 
they are transcytosed via Rab11 positive recycling endosomes to an apical membrane initiation 
site (AMIS) that forms around the midbody and is marked by Par3, Cingulin and components 
of the exocyst. Cingulin is recruited by direct binding to the midbody microtubules and 
interacts with Rab11 vesicles and Fib5. The fusion of these transcytotic vesicles at the AMIS 
generates an apical domain which forms a polarized minicyst [40], [41]. A variety of Rab 
  
25 
 
GTPases are require for trafficking and fusion of these vesicles, where Rab35 is of special 
importance and binds to the cytoplasmic tail of podocalyxin to capture vesicles around the 
midbody. Once polarity is established it needs to be propagated and cell junction formation 
must be coordinated. In most epithelial cells polarity is maintained and transduced by Par 
proteins (Cdc42, Par6, aPkc, Crumbs, Stardust, Patj, Scribble, Par3, Discs large (Dlg), Lethal 
2 giant larvae (Lgl) and Par-1). The maintenance depends on mutual antagonism between 
apical and lateral factors [42]. 
aPkc phosphorylates several serines in a basic domain of Lgl that binds membrane 
phospholipids, introducing negative charges that prevent lipid binding and thereby excluding 
Lgl from the apical region. Polarity factors can also regulate the localization of other proteins 
by altering the membrane lipid composition. Phosphatidylinositol 4,5 bisphosphate (PIP2) is 
enriched apically and phosphatidylinositol 3,4,5 trisphosphate (PIP3) basolateral [43]. Par3 
localizes to the apical junction that forms the boundary between these domains and has been 
proposed to contribute to the differential distribution of PIP2 and PIP3 by recruiting Pten, 
which catalyzes the conversion of PIP3 to PIP2 and PI3 kinase, which catalyzes the opposite 
reaction. One landmark of epithelial polarity is the localization of E-cadherin to adherens 
junctions, which hold epithelial cells together. Par3 is required for cadherin localization in the 
mammalian epithelium by targeting its exocytosis to the junction domain. The C-terminal, 
lysine rich part of Par3 recruits the exocyst complex, which is required for the fusion of E-
cadherin containing vesicles with the plasma membrane. Polarization has widespread effects 
on the organization of the cytoskeleton and vice versa. Many components of the initial polarity 
modules need the cytoskeleton for directed transport and upon activation they reshape the 
cytoskeleton to fulfil requirements of polarization. Actin is mainly organized locally from sites 
of cell-substrate or cell-cell adhesions that themselves are controlled by the polarity system. It 
has, for example, been shown that Cdc42 activates myosin light chain kinase Mrck and thereby 
induces apical actin-myosin contractility, which plays an important role in the expansion of 
apical domain and microvilli formation [10], [31], [40], [44]. 
1.2.1. Cell polarity in neuronal plasticity 
Neurons are along the largest and most morphologically complex cells. They are highly 
polarized, and their function relies on correct intracellular localization of proteins, RNAs and 
organelles. Those processes enable the distinction between multiple compartments within the 
cells like the axon, dendrites, synapses, soma and cellular organelles, which all rely on their 
spatial distinct proteome and transcriptome. Neuronal polarity is fundamental for the correct 
interpretation and transfer of intrinsic cues and converting them to cytoskeletal rearrangements 
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or extracellular signaling and vice versa and therefore enables synaptic activity and sculpts 
neuronal plasticity [45]. The main function of neuronal cells, receiving, processing and 
propagating signals, is tightly coupled to their morphology. Neuronal polarity is established 
very early in development and maintained throughout the entire life of a neuron. There are 
several steps in establishing neuronal polarity and it is most probably the result of a 
combination of external and internal several cues. The process starts with an initial, symmetry 
breaking cue which is canonically provided by extracellular signaling. This cue gives a spatial 
orientation and is interpreted by intracellular signaling networks to establish distinct domains. 
This signaling induces cytoskeletal reorganizations and rearrangements that produce the 
axonal and the dendritic subdomain. Once established, polarity must be maintained throughout 
the entire life of the neuron [45]. Constant transport of protein and RNA and selective endo- 
and exocytosis ensure the correct repertoire of factors for each domain. The initial symmetry 
breaking cue can also be intrinsic, for example in neuronal-epithelial progenitor cells, which 
are already bipolar cells and give rise to ganglion cells. Mechanosensory neurons can inherit 
their polarity from the site of cell division of their progenitor cell through an accumulation of 
Rho1 and AuroraA at the site of cytokinesis, followed by an enrichment of PtdIns (4,5) and 
P2. The subsequent clustering of D, E-cadherins and Bazooka/Par-3 determine the first site of 
protrusion outgrowth. Two examples of intrinsic polarity regulation are cortical and 
hippocampal neuronal cultures [46], [47]. As cells are dissociated before differentiation, they 
lack the higher organization of the tissue. They start to grow immature and undetermined 
protrusions into many directions. The first morphological manifestation of polarity occurs in 
stage 3 when one neurite, which will give rise to the axon, begins to grow faster and extends 
longer. Upon this event, all other protrusions will become dendrites. Though, the lack of 
external symmetry breaking factors in neuronal development is rather unlikely since correct 
and directed neuronal wiring is critical for neuronal network formation. In most situations there 
are external factors that provide a compass for polarization, which is usually a gradient of a 
stimulus and the correct interpretation of that stimulus directs polarization. Cortical pyramidal 
neurons, for example, are ‘born’ in the ventricular zone. They migrate apically along the radial 
glial processes and at the subventricular zone they start to extend several neurites. At this step 
they are called multipolar. Polarity is initially manifested during migration when one minor 
neurite grows rapidly and becomes the leading process, upon which all the other outgrowths 
become trailing processes. Those minor neurites retract to give rise to a bipolar cell in the 
intermediate zone. Importantly, the leading and trailing process eventually gives rise to the 
apical dendrite and axon, respectively. Therefore, the polarity is generated via directed neuron 
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migration [48]. Tgf-β, which emanates from the ventricular zone, is the main diffusible cue 
that induces cortical neuron polarity and is also in vitro sufficient to stimulate axon 
specification and growth. Other prominent diffusible cues are Bdnf and Nt3 which are 
important for axon induction and multipolar to bipolar transition, where Bdnf acts in an 
autocrine or paracrine way to self-amplify. In about one third of all cases the leading edge 
(future dendrite) appearance precedes that of the trailing edge, indicating that polarity can be 
manifested prior to axon specification by the aforementioned signals [46]. N-cadherin, which 
is expressed in a polarized manner in newborn neurons at the SVZ, promotes first neuronal 
outgrowth in vitro and is required for multipolar to bipolar transition. Since all of these factors 
are also involved in migration, the interpretation of cause and effect knockdown or knockout 
studies is problematic. Axon-axon contacts are also important for early axonal development. 
Tag1 is expressed by mature neurons.Multipolar cells grow their axons along the Tag1 tracks 
of existing neurons. Substrates of the ECM, such as laminin, tend also to promote axon 
formation. The laminin receptor Itgb1 is required for axonal outgrowth and was suggested to 
regulate polarity via Lkb1 pathway and microtubules. Additionally, at least four different 
intracellular signaling pathways are crucial for the establishment of neuronal polarity: Tgf-β, 
Bdnf, Wnt and Rac. Several positive and negative feedback loops control external and intrinsic 
signals. For example, the local enrichments of the Wnt receptor Lin-17 via the Wnt ligand Lin-
44, upon which does response to the Wnt signal and leads to signal amplification. Another 
example of signal amplification is Bdnf-triggered Bdnf secretion, which leads to a cascade of 
phosphorylations within the cell. Also, negative regulation of axonal fate in future dendrites is 
controlled in various ways. While cAMP promotes axonal growth, cGMP promotes dendritic 
fate [49]. Calcium waves from the primary axon act inhibitory on other outgrowths [50], [51]. 
The anterograde transport of a polarity regulator, coupled to its retrograde diffusion, leads to 
its concentration in the longest process [52]. RhoA inhibition in vitro leads to suppressed 
neurite outgrowth and inhibition of the downstream Rho kinase Rock leads to multiple axon 
formation [53], [54]. 
In mammalian neurons, the small GTPases Cdc42 and Rac1 link the Par complex to actin. 
Activated Cdc42 is part of the Par-3/6 complex in neurons. Indeed, Cdc42 mutants have shorter 
axons and in cell culture Cdc42 KO cells do not have any axons, show aberrant actin dynamics 
and excessive phosphorylation of the actin regulator cofilin, which is also required for polarity 
induction [55], [56]. Actin regulation via Par-3/6 complex, Rac activation and recruitment of 
the GEFs Tiam1/Stef together lead to over-activation and inhibition of Par3/6 and impair 
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neuronal migration and multipolar to bipolar transition. Rac1 mutants also show severe defect 
in axon formation [57].  
Microtubule formation is also regulated by polarity signaling. The Lkb1 pathway induces 
phosphorylation of Map and Tau via SAD kinases and thereby reduces Tau binding to 
microtubules. Phosphorylation of Stathmin/Opt18 inhibits its microtubule destabilizing 
activity and leads to various cytoskeletal rearrangements. As stated, cytoskeletal regulators are 
main downstream targets of polarity signaling. Microtubules are extended in general and sorted 
during neuronal polarization. Axon microtubules are mainly ‘plus end out’ whereas they are 
not sorted in dendrites. This is usually used in immunofluorescence to label axons and 
dendrites: Map2 is typically used to label the somatodendritic part and dephosphorylated Tau 
to label the axon [58]. Neuronal microtubules have many protein modifications, are long lived 
and are much more stable. Their modifications affect mainly the kinesin dynamics. In young 
neurons a massive nucleation of microtubules in the newly formed axons occurs, leading to 
many and stable microtubules that can be used for faster and more reliable molecular transport 
to the axon and therefore faster growth of the protrusion [59]. Neuronal polarity is closely 
linked to microtubule polarity. It is not completely known how microtubule polarity is 
established, however there are several known regulators of microtubule polarity: (1) Trim46 
bundles parallel microtubules and its knockout leads to Map2/Tau diffusion and 25% of 
microtubules growing in the wrong direction [60]; (2) Dynein may be required to establish 
uniform microtubule polarity by transporting plus-end-out microtubules into the axon and 
removing minus-end-out microtubules [61]; (3) in C. elegans Crimp2 homolog Unc33 is 
required to establish microtubule polarity. Unc33 binds tubulin dimers and is transported by 
Kif5 [62]. 
The actin cytoskeleton is reorganized too. Axons of mature neurons contain periodic sub-
membrane actin rings that are organized by beta-spectrin and adductin, whereas dendrites 
contain way fewer rings [63]. Another actin structure of the axon is a mesh-work at the axon 
initial segment (AIS) that is thought to regulate transport in and out of the AIS [64]. 
Additionally, actin dynamics play a crucial role in the early stages of polarity establishment: 
Axonal growth cones show more dynamic actin than the minor neurites. Cofilin is enriched in 
the axon growth cone and destabilizes actin filaments in order to allow microtubule growth 
into the future neurite [65]. Also, Cdc42 destabilizes actin and therefore promotes microtubule 
growth into the axon. Rac1, Cdc42 and actin waves from the soma towards the growth cone 
result in higher concentration in the axon than in the dendrite and rhythmic growth at the 
growth cone [31].  
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Despite those molecular mechanisms shaping neurons and therefore the synaptic network, it 
was shown that local protein synthesis is crucial for memory formation and synaptic plasticity. 
Not only does the synaptic potentiation by Bdnf require local translation [66] but also long 
term facilitation in aplysia [67], long-term depression facilitated by metabotropic glutamate 
receptor activation [68], late-phase long term potentiation (LTP) [69], dopamine-induced 
plasticity [70] and homeostatic plasticity induced by a blockade of spontaneous 
neurotransmitter release [71]–[73]. However, in most cases the specific proteins are not known. 
 
1.2.2. In the wrong place at the wrong time: Cellular polarity in development, disease 
and cancer  
Cell polarity and its fundamental processes, the intracellular localization of proteins and 
mRNAs, and the organization of internal and external structure are crucial for multicellular 
life. Disturbances in polarity govern multiple diseases and play an important role in several 
forms of cancer. Many perturbations in cell polarity genes lead to cancer, whether they are 
mutations, transcriptional or post-transcriptional deregulations. In fact, the cell polarity 
modules Scribble (Scrib), Discs-large (Dlg) and lethal-2 giant larvae (Lgl) have a tumor-
suppressive role in mammalian epithelial cancer [37], [74]. They play a scaffolding role in 
various pathways and are involved in tissue growth, differentiation and cell migration. Also, 
the Par module and Crb are deregulated in many forms of cancer [75]. The tumor suppressive 
roles of Dlg, Scrib and Lgl were first discovered in Drosophila melanogaster [76] and result in 
excessive cell proliferation and formation of neoplastic tumors. There are four mammal 
orthologues of Dlg (hDlg, PSD-93, NE-Dlg and Psd95), two of Lgl (Lgl1 and Lgl2) and only 
one of Scrib, which makes the functional analysis of Scrib in mammalian systems more 
amenable. In mice it suppresses epithelial-mesenchymal transition (EMT) and the knockout is 
embryonic lethal [77]. The tissue specific KO of Scrib in mice leads to hyperproliferation and 
cell morphology changes, leading to tumorigenesis in prostate, breast, lung and skin epithelial 
tissues. KO studies of Dlg1-4 or Lgl1&2 are more difficult, yet result in defects of PCP and 
therefore failures in neuronal tube closure and sheet migration, which are embryonic lethal 
[38]. It is not surprising that disturbances in those main polarity regulators are fatal to 
mammals, however defects in downstream localization of specific mRNAs and proteins are the 
cause of many genetic diseases. Myotropic dystrophy, for example, is caused by an expanded 
CTG or CCTG microsatellite repeat in the 3’ UTR of the dystrophia myotonica protein kinase 
gene (Dmpk) or the first intron of CCHC zinc finger nucleic acid binding protein (Cnbp). Both 
mutations act as scaffolds and lead to a recruitment of Mbnl into nuclear foci. Mbnls are 
regulators of alternative splicing and are involved in fetal-to-adult isoform transition. Mbnl1 
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and Mbnl2 are known to act on mRNA stability and localization and the membrane-bound 
local translation in numerous cases [78]–[81]. Loss of function of those regulators leads to 
various mis-splicing events and causes multiple phenotypes of myotonic dystrophy by 
deregulation of intracellular localization of: (1) chloride channel 1 (Clcn1) causing myotonia 
[82]; (2) insulin receptor (IR) causing insulin resistance [83]; (3) bridging integrator 1 (Bin1) 
causing muscle weakness [84]; (4) calcium channel (Ca(V)1.1) causing muscle weakness [85]; 
(5) sodium channel 5a (Scn5A) causing cardiac arrhythmia [86] and cardiac troponin T 
(CTnT), also causing cardiac arrhythmia [87]. 
The dysregulation of mRNP assembly and localization changes the fate of multiple mRNAs, 
since it governs all steps of posttranscriptional regulation. Hyper- or hypo-assembly of mRNPs 
can lead to spinal muscular atrophy (SMA) or amyotrophic lateral sclerosis (ALS) [88]. 
Alhough the formation and composition of stress granules is well characterized, the regulation 
and transport of mRNPs is not well understood. Defects in the survival of motor neuron (SMN) 
complex, which acts as an assembly machine for multiple RNPs [89], leads to SMA. As the 
SMN complex interacts with multiple RBPs and is part of RNA transport granules in axons, it 
is likely that SMN has a noncanonical role in mRNA transport or metabolism. Mutations in 
key components of the SMN complex result in defects of axonal mRNA transport and local 
translation for example of Gap-43 and Cpg15 [90]. 
The fragile-X-syndrome (FXS) might be the most studied example of a localization defect 
leading to a genetic disease, since it is the most frequent mental retardation after Down 
syndrome. FXS is characterized by increased synaptic protein synthesis and stimulus-
insensitive synaptic protein synthesis, causing defects in synaptic plasticity. It results from 
deregulations in transcription or localization of Fmrp, which itself is an RNA-binding protein 
responsible for spatial, activity-dependent protein synthesis [91]. Fmrp regulates the activity 
of P13K, a component of the mTor pathway, which is involved in transmitting external stimuli 
into intracellular protein synthesis in the synapse. Apart from general dendritic protein 
synthesis, the mTor pathway is responsible for the regulated translation of CaMKIIa. 
Autism, which itself is a mixture of mental disabilities, can be caused by mutations in Rbfox1, 
which has a nuclear and a cytoplasmic isoform (paralogues are NeuN and Rbm9). Both proteins 
are master regulators of autism-associated genes and have well characterized functions in 
alternative splicing. Additionally, the cytoplasmic isoform of Rbfox1 binds target mRNAs and 
increases their stability and might have an antagonizing function to miRNAs. It is responsible 
for the expression of multiple synapse-associated genes [92]. 
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In general one can say that granule formation, mRNA localization and spatial translation are 
crucial for neuronal functions, plasticity and survival [93]–[97]. The regions of proteins 
involved in granule formation are often low-complexity regions and mutations in those regions 
are linked to several and severe mental and neurodegenerative diseases [98]. 
1.3. The “triple T” destiny of an mRNA: Transcription, Transport, 
Translation 
The fate of an RNA is controlled in various ways. Its origin, the process of transcription, is a 
complex and highly regulated process. Its destiny is regulated by multiple cis- and trans-acting 
factors and its functions vary from delivering ‘just’ the message for protein production, helping 
enzymes in target recognition or having itself a catalytic activity. All RNAs are polymerized 
by RNA polymerases either in the nucleus or in mitochondria. Depending on the type of cell, 
the developmental stage of the cell, extracellular cues and of course the message itself, mRNAs 
are transcribed, transported and translated through various molecular mechanisms, tightly 
regulated by internal sequences and modifications. 
1.3.1. Transcription: The birth of a new RNA 
There are three different RNA polymerases: RNA polymerase 1-3 (RNA-PolI, RNA-PolII & 
RNA-PolIII), which all recognize different promotor sequences. RNA-PolI, localized in the 
nucleoli and transcribes most ribosomal RNAs (rRNAs). Its promotor is a highly species-
specific bipartite promotor and spans -31 to +6 region of the gene and therefore overlaps with 
the gene itself. Efficient transcription also requires an upstream promotor element [99].  
RNA-PolII is responsible for most mRNA transcription events. It is localized in the 
nucleoplasm and can recognize several complex and diverse promotor sequences. The most 
common elements of promotor regions for RNA-PolII are: (1) CpG islands, GC-rich regions 
upstream from the actual promotor regions, which are common for housekeeping genes; (2) 
TATA-box elements, AT-rich sequences located 25-30nt upstream from the transcription start 
site and bound by the TATA binding protein (Tbp); (3) downstream promotor elements (DPE); 
(4) transcription factor II B (TfIIB), recognition element (BRE); (5) motif ten elements (MTE); 
and (6) the initiator element (Inr), which includes the four first initiating nucleotides and exists 
in about half of all genes recognized by RNA-PolII. In addition to promotors there are 
enhancers, trans-acting transcriptional activators that can have variable positions and 
orientations and are recognized by transcription factors that stimulate RNA-PolII binding to 
the promotor [100].  
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RNA-PolIII is also located in the nucleoplasm and transcribes precursors of the 5S rRNA and 
tRNAs as well as a variety of other nuclear and cytosolic noncoding RNAs [101].  
The process of RNA-PolII transcription is well studied and starts with the formation of the 
preinitiation complex (PIC). Tbp binds to the TATA box element and kinks and partially 
unwinds the DNA so that transcription factor II D (TFIID) can bind. TfIIA, TfIIB and the tata 
binding protein association factor (Taf) interact with TBP and RNA-PolII, and other initiation 
factors join. The composition of canonical and noncanonical transcription factors in the PIC 
determines the regulatory ability, but at least Tbp, TfIIB, TfIIE, TFIIF and TfIIH must bind to 
initiate transcription. Canonical transcription factors are: (1) TfIIA, which stabilizes Tbp and 
Taf binding; (2) TfIIB, which also stabilizes Tbp and recruits RNA-PolII; (3) TfIID, TBP and 
TAF, which recognize the TATA-box element, recruit TFIIA and B and have regulatory 
functions; (4) TFIIE, which recruits TFIIH and stimulates its helicase activity, enhancing 
promotor melting; (5) TFIIF, which facilitates promotor targeting and stimulates product 
elongation; and (6) TfIIH, which is an ATP-dependent helicase and which melts the promotor 
so that RNA-PolII can initiate. Once the PIC is formed, RNA-PolII requires different 
elongation factors to bind the phosphorylated CTD of Rbp1 and accelerate its transcription. 
Unlike prokaryotic transcription, which has a determined termination sequence, eukaryotes 
lack the determined termination. Premature mRNAs further undergo co-transcriptional splicing 
events and posttranscriptional modifications, such as capping and A-tailing, which determine 
the further future of the transcript [7]. 
1.3.1.1. Splicing and alternative splicing 
The most striking difference between prokaryotes and eukaryotes concerning the genome is 
the structure of genes with introns and exons in eukaryotes compared to uninterrupted genes in 
prokaryotes. In eukaryotes, pre-mRNAs are variable in length and much larger than expected 
from the protein size (2-20kb). They are processed by cutting out noncoding regions, or introns, 
and ligating the neighboring coding regions, orexons. This process is called splicing. In 
humans, the number of introns varies from zero to 364 within a single gene, with intron length 
varying from 65nt to 800,000nt. Exons vary in length between 150nt to 17,000nt [7]. The 
production of functional mRNAs starts with the transcription of the full gene. Capping occurs 
soon after initiation and splicing starts already during the process of elongation. The mature 
RNA emerges after poly-adenylation and splicing and is transported to the cytosol. Splicing is 
a two-stage reaction in which, at first, a lariat structure of the intron is formed, which is 
eliminated in the second step when the exon junction is ligated. First a 2’,5’-phosphodiester 
bond forms between an intron adenosine residue and the introns 5’ terminal phosphate. The 5’ 
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exon is thereby released and the intron assumes a lariat structure, in which the adenosine at the 
lariat branch point is typically located within a conserved sequence 20 to 50 residues upstream 
of the 3’ splice site. In the second step the free 3’OH group of the 5’ exon displaces the 3’ end 
of the intron, forming the phosphodiester bond with the 5’-terminal phosphate of the 3’exon 
yielding the splice product. The intron is thereby eliminated from the structure, linearized and 
rapidly degraded. The invariant GU at the intron’s 5’ boundary and the invariant AG at its 3’ 
boundary are necessary and sufficient for a splice junction. Splicing occurs without free energy 
input. Since splicing happens during transcription, skipping of a splice junction and, therefore, 
skipping of an exon is rare. The process is mediated by snRNPs in the spliceosome. The 
spliceosome consists of nuclear ribonucleoproteins, specifically 5 RNAs and 150 polypeptides, 
and is comparable in size to the ribosome. All spliceosomal RNPs (Ux-RNPs) have the same 
core-proteins, which are called Sm proteins, that bind the Sm motif. U1-snRNP is outstanding 
and partially complementary to the consensus sequence of the 5’ splice junction and therefore 
recognizes the splice junction. Splicing offers evolutionary advantages since it enables proteins 
built of so-called “functional blocks” to be recombined [102], [103]. Alternative splicing can 
form multiple proteins from one or more genes. SR proteins (Serine – Arginine proteins) carry 
an RNA recognition motif (RRM) and bind specific exonic splice enhancers (ESEs) and recruit 
the splicing machinery in both canonical and alternative splicing processes. Contradictory 
hnRNPs bind to intronic or exonic splicing silencers (ESSs /ISSs) and block the binding of the 
splicing machinery. The combination of ESEs, ESSs, ISSs, SR-proteins and hnRNPs 
determines the predominant splicing variant. There are various different events combined in 
the term of “alternative splicing” and more than 95% of all mature human RNAs are the 
outcome of at least one of them [104]. Intron retention is, as the name suggests, the retention 
of an intronic sequence in the mature mRNA, whereas exon skipping describes the exclusion 
of an exon in the mature RNA. Circular splicing results in circular RNAs (circRNAs) and is 
the ligation of a splice donor site to an upstream acceptor site. Cryptic or non-canonical splice 
sites can be used just under specific conditions and vary the mature RNA outcome, whereas in 
trans-splicing a splice junction of one transcript is ligated to another transcript. All of these 
processes are utilized by eukaryotes to modify, regulate and coordinate their transcriptome 
[105], [106]. Failures in splicing lead to noncanonical mRNAs and therefore nonfunctional or 
malfunctional genes. Correct splicing is crucial especially in the context of RNA transport, 
since the exclusion or inclusion of RBP binding sites alters RNP formation and therefore the 
intracellular fate of the mRNA. It has been shown that alternatively spliced transcripts often 
show different localization patterns and that this process is used by the cell to control the spatial 
  
34 
 
transcriptome [79], [98], [107], thus post-transcriptional modifications in general are widely 
used to control gene expression in neurons. The impact of alternative splicing on differential 
localization and local translation was part of various studies [108]. 
Shigeoka et al. found that the axonal translatome showed more diversity of mRNA isoforms 
than the somatic translatome [109]. They used their dataset of axonal ribosome associated 
mRNAs to test in silico 164 alternative events that produce two isoforms both in the axonal 
and in the retinal compartment. Though they could not detect a general trend in translation 
efficiency towards the longer isoform as it was postulated by Taliaferro et al. [110], they 
observed a clear bias of the PSI (percentage spliced in) value calculated by MISO [111] towards 
the two extremes, indicating that only one of the two isoforms is preferentially translated in the 
axon. Unfortunately, they do lack information about the general abundance of mRNAs in the 
compartments and cannot distinguish between isoform-specific localization or local 
translational regulation. Additionally, they found several back-splicing events resulting in 
circular mRNA isoforms in the axonal compartment pinpointing towards the translation of 
circRNAs in the axon. Using a FRAP (fluorescent recovery after Photobleaching assay) with a 
diffusion-limited fluorescent reporter they identified two alternative exons of the genes Acot7 
and Stx3 that seem responsible for axon-specific translation of the reporter. 
In 2018 Tushev et al. published an extensive alternative 3’ UTR analysis of neuronal 
compartments. Using rat hippocampal microdissection to separate the neuropil layers from the 
somatic layers and employing a  sequencing technique enriching for 3’ UTRs,  they identified 
a huge diversity in mRNA transcripts, showing specific enrichment for a particular 3’ UTR 
isoform [112]. In contrast to Shigeoka et al., they found that 3’ UTR isoforms of neuropil 
localized transcripts are significantly longer and do inherit more and duplicated regulatory 
elements. Finally, they state that the neuropil-enriched 3’ UTRs isoforms have significantly 
longer half lives.  
1.3.1.2. Capping and poly-adenylation 
Eukaryotic mRNAs carry 5’ caps, m7G residues joined to the 5’ end of the transcript via 5’-5’ 
triphosphate bridge formation. These are added to the transcript co-transcriptionally when the 
transcript is about 30nt long and identifies the translation start site. Capping involves several 
enzymatic reactions: (1) the removal of the leading phosphate group by an RNA 
triphosphatase; (2) the guanylylation of the mRNA by the capping enzyme; (3) the methylation 
of the guanine by guanine-7-methyltransferase; and (4) sometimes also be O2’-methylation at 
the first or second nucleotide. It protects the transcript from 5’ exonuclease activity [113].  
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On the other side the transcript is 3’ A-tailed. Since the 3’ ends of transcripts are imprecise due 
to the nature of termination, A-tails are added to uniform and protect the 3’ ends. Despite the 
imprecise 3’end of the premature transcript, they usually start at specific positions and are 
added in a two-way reaction. The transcript is cleaved 15 to 2nt after the AAUAAA sequence 
by cleavage factors I and II (CfI and CfII). Subsequently, the poly-A-tail is added by 
poly(a)polymerase (Pap), which acts independent of templates and is activated by cleavage and 
polyadenylation specific factor (Cpsf). Once the adenosine-chain has been elongated to about 
10nt the AAUAAA sequence is no longer needed. Cpsf binds to the phosphorylated CTD of 
RNA-PolII and therefore couples polyadenylation to transcription. The length of the A-tail is 
determined by the binding of multiple copies of the poly-a-tail binding protein II (PabpII) 
[114]. The A-tail is a protective end for 3’ exonucleases and shortens with the lifetime of an 
mRNA. It is bound by the poly-A binding protein (Pabp), which protects the mRNA and is also 
involved in translational regulation [115]. Pabp also regulates intracellular localization of the 
messenger RNA. Although Pabps predominantly diffuse and shuffle freely between the nucleus 
and the cytoplasm, the sub-cellular distribution can alter dramatically upon viral infection or 
other forms of cellular stress [116]. Very short life mRNAs do not have A-tails, for example 
histone mRNAs with an average lifetime of under 30min. 
 
1.3.2. Importance and mechanisms of RNA localization 
The spatial environment of a functional unit within the cell alters its functional potential. 
Therefore, many proteins and RNAs are not evenly distributed within the cytoplasm but are 
localized to specific cellular compartments to fulfil the required functions. There are several 
advantages of RNA localization over protein localization: (1) there are fewer mis-localized 
proteins if the translation happens on the spot; (2) one RNA can give rise to several proteins 
and therefore the localization of an mRNA is energetically more efficient for the cell; (3) the 
cell can react more quickly to external stimuli, which is of special importance for huge cells 
like neurons; and (4) spatially translated proteins do carry compartment-specific modifications 
and can therefore differ from unlocalized translated protein products. The regulation of 
transport and spatial translation are critical to all aspects of eukaryotic life. There are several 
mechanisms known for the localization of transcripts, which can be divided by directionality. 
There are many forms of direct and active transport described in literature either for single 
mRNAs via adaptor RNA binding proteins (RBPs) and motor proteins, as batches of transcripts 
via transport granules, multi-RNA and multi-protein aggregates that can also be transported 
via motor proteins along the cytoskeleton [96], [117]–[119] or via anchoring to cargo vesicles 
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or organelles that do travel along the cytoskeleton [26], [28], [120]. In contrast to these 
mechanisms, intracellular inhomogeneity of transcripts can also occur indirect via pre-
localization of effectors. In detail, these effectors mediate mechanisms such as spatial 
degradation, local translational regulation, or local anchoring. All these modes of localization 
require the correct identification of a mRNA and interpretation of the internal localization 
signal. Additionally, active transport requires a molecular motor, which is added to the mRNA, 
granule or organelle and which can direct the cargo to its destination. Some mechanisms require 
translational downregulation during the transport and spatial de-repression while others can 
occur co-translationally [34], [117], [121]. 
 
 
 
Fig. 3 Methods of mRNA localization. Spatial mRNA enrichment can be achieved via local degradation, local 
mRNA protection, diffusion and spatial anchoring, active transport and all combinations of those phenomena. 
 
1.3.2.1. Proteins that bind and manipulate RNAs in versatile ways (RBPs) 
Although ribonucleotides can have a catalytic function themselves, they do require proteins for 
most of their functions, which are the predominant active molecules within the cell. RNA 
binding proteins (RBPs) are, in general, all proteins that bind to RNA and can therefore 
potentially change the fate or function of the RNA. They generally need an RNAbinding 
domain or adapter proteins to contact the RNA. The predominant form of an mRNA in the cell 
is never the unbound state, as it might be in some biochemical assays, though in nature mRNAs 
act more like scaffolds and are packed with a dynamic coating of various proteins. In most 
cases it is the protein that changes properties of the RNA, but this can also happen the other 
way around. Very prominent examples are sgRNAs in the CRISPR/Cas9 system or miRNAs 
that act as adapters or guides and help the protein to recognize its targets. RBPs can generally 
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be grouped by the following functions: translational regulators (repressors, de-repressors and 
initiators); nucleotide metabolism regulators (exo- and endonucleases, ligases, polymerases 
and members of the splicing machinery); RNA modifiers (for example RNA 
methyltransferases, A-tailing enzymes or the capping machinery); structural modifiers (for 
example helicases); and RBPs involved in localization (adaptor proteins that link RNAs to 
motor proteins, for example). RBPs can also be grouped by their way of binding. There are 
numerous known canonical binding motifs, such asthe RRM, KH, RGG, C2H2/CCCH (zinc 
finger), dsRBP, PUF, PAZ and DEAD-box proteins and, on the other hand, non-canonical 
RNA binding motifs like DZF, PDZ, NDR, HSPA1A [122] or unstructured or intrinsic 
disordered regions (IDRs). They can bind either the bases of the ribonucleotides, which makes 
them easier to detect via crosslinking methods, or the ribose backbone, which makes them 
barely detectable by crosslinking methods. A third way of classifying RBPs is by the RNP that 
is formed. In cell biology it is widely accepted to speak about cajal bodies [123], paraspeckles 
[124], processing bodies [125], stress granules [126] and transport granules [127]. The mRNA 
and RBP composition of these RNPs is, in many cases, redundant. Also, the term granule is 
misleading, since it normally refers to solid phase objects, while RNPs can occur in versatile 
states and are very often liquid phase separations. The binding of RBPs to RNAs can occur 
either in a sequence-specific manner, by relying on a structural motif, a combination of both, 
or in a completely non-specific manner. In mice, about 1400 RBPs have been identified so far 
and experiments have shown that the RNA protein interactome is highly dynamic and can 
change dramatically due to stimuli [122]. A lot of monogenic diseases are the result of 
mutations in either RNA binding domains or in RBP-recognition elements that impair both the 
correct interaction of a specific RNA and its RBP [128]–[130]. A prominent example of these 
mechanisms is the survival of motor neuron protein (Smn), which is part of a multi-protein 
complex regulating spliceosomal small nuclear ribonucleoproteins (snRNPs). Low levels 
ordysfunctional Smn result in spinal muscular atrophy, a motor neuron disease. Smn is known 
to associate with various RBPs, although the nature of this interaction is unknown. Donlin-Asp 
and colleagues found in 2017 that Smn proteins promote the interaction of Imp1 proteins and 
the 3’ UTR zip code of β-actin, leading to the assembly of the trafficking mRNP that associates 
with the cytoskeleton [131].  
1.3.2.2. Zip codes: RNA sequences that regulate mRNA localization 
The sequence specific binding of RBPs to mRNA, which leads to localization, is mediated by 
zip codes, that is, RNA elements that mediate localization in cis. This term was first introduced 
in the early 90’s by Robert Singer and colleagues [132] and refers to a sequence of the RNA 
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that regulates its localization. Modifications, either in the trans acting RBP or the cis acting 
RNA element, can lead to defects of localization. Localization elements (LE) or zip codes are 
typically encoded in the 3’UTR of the mRNA, although they can also be found within the ORF. 
They can vary in size from a few nucleotides to over 1kb and they can be recognized by various 
RBPs or just one [118]. One of the best-studied examples is the β-actin zip code. It is a 54nt 
long sequence in the 3’ UTR of the mature mRNA. It was identified by narrowing down the 
3’UTR of β-actin fused to a reporter RNA [133]. The motif is bound by two RBPs with 
different binding mechanisms. The core motif is a 28nt bipartite localization element forming 
a stem loop structure that is recognized by ZBP1 (zip code binding protein 1). Additionally, 
HuD binds an A-rich part of this motif sequence specific. β-actin requires the presence of the 
zip code in its 3’UTR to be targeted to the leading edge of migrating fibroblasts, dendritic 
filopodia and axonal growth cones. Zbp1 is the key factor that binds the β-actin mRNA in the 
nucleus and is involved in its localization and translational repression. The hnRNP homolog 
Ksrp binds beta actin mRNA subsequently after maturation and facilitates nuclear Zbp1 
association. HuD joins the complex once the mRNA leaves the nucleus [134]. 
Other well-studied examples are the mRNA of myelin, which contains an 11nt long element 
called A2RE in its 3’UTR that is recognized by hnRNP and facilitates transport into 
oligodendrocytes, or bicoid mRNA in drosophila melanogaster, which is recognized by 
egalitherian, an RNA adaptor protein involved in the dynein mediated transport. Ash1 in yeast 
has four distinct zip codes (E1, E2, E2B and E3) that do not share homology but mediate 
localization through the same RBP, She2p, which enables myosin-based transport [135].  
No clear pattern of zip codes is known so far, which is unsurprising, since there are numerous 
ways of localization mediated by different RBPs. First protein coatings of mRNAs are 
implemented already by pre-mRNA processing in the nucleus and, once in the cytosol, the 
ribonucleotide particle can gain or lose more RBPs. In terms of transport, these factors may 
define stability and translatability and mediate the contact to motor proteins or anchoring 
proteins. mRNAs are often transported in large and diverse multiprotein complexes. These 
complexes might also contain miRNAs and lncRNAs [93]. Defining which RBP binds to which 
zip code and, therefore, which RBP binds to which mRNA, holds critical information about 
how mRNA trafficking and localization is regulated in different cellular environments. The 
identification of zip codes de novo involves accurate knowledge about localization of mRNAs 
to subcellular compartments and a precise reporter system. The predominant RNA movement 
in the nucleus is diffusion. Active transport of mRNAs occurs for the first time when they leave 
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the nucleus. This process takes about 0.2s but the mRNA remains bound to the nuclear 
membrane for seconds, for reasons of quality control and RNP formation. Following that, the 
fate of the mRNA is either free diffusion through the cytoplasm or anchoring to a transport 
system. In all studied cases of RNA transport it is a combination of multiple mechanisms; the 
average outcome of all processes results in a inhomogeneous distribution of the mRNA[119]. 
Single RNA tracking of lacZ mRNA in mammalian cells, for example, revealed that 50% of 
the mRNA is freely diffusing, while 25% remains confined by microtubule base domains, 20% 
stays associated with the cytoskeleton and just 5% moves along the cytoskeleton [136]. Oscar 
mRNA in drosophila melanogaster during embryogenesis shows a similar pattern. The 
localization is regulated by several trans acting factors such as staufen and hnRNP A/B, which 
mediate active transport via kinesins that move the RNP along the microtubule cytoskeleton 
[34], [137]. However, microscopy revealed that most mRNAs are diffusing and only 13% are 
actively transported – and 7% are also transported to the wrong pole due to misdirected 
microtubules [138], [139]. Therefore, the directionality and organization of the cytoskeleton 
defines the accuracy and efficiency of directed mRNA transport, which is the case for the clear 
majority of actively transported RNAs. It is speculated that the preferred way of localization 
in most cells is free diffusion through the cytoplasm, coupled to local entrapment via anchoring 
proteins rather than energy-consuming active transport [30]. 
There are several examples known for both phenomena in the drosophila oocyte. Oskar and 
Nanos are transcribed by nurse cells in the drosophila embryo and transported to the poles of 
the oocyte. While nanos mRNA is freely diffusing and anchored at the poles of the oocyte 
[140], oskar mRNA is continuously transported to the posterior pole via kinesin-1 [141]. 
Though the active localization is just slightly biased towards the anterior end, the overall 
distribution is very distinct due to additional anchoring of oskar upon arrival at the destination 
[142]. The different mechanisms in this case might indicate the importance of contemporary 
transport. Bicoid mRNA that is localized to the anterior pole and induces head formation 
exhibits a combination of localization events in the drosophila embryo. It is randomly 
transported via dyneins in particles of constant size but varying RNA content. Since the 
microtubule cytoskeleton at the anterior part of the oocyte is not directed, it cannot be localized 
just through transport. It has been shown that the maternal coating of the mRNA from the nurse 
cells is crucial for its correct anchoring at the anterior pole via the pseudonuclease exuperantia 
(Exu), which mediates spatial P-body sequestration [143].  
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There are three known distinct ways of local mRNA anchoring: (1) active transport via 
microtubules and anchoring via actin binding, which requires an adaptor switch at the 
destination[34], [144]; (2) turning the motor off at the destination – switching motor activity 
of the RNP adaptors, which can act in their inactive form as an anchor [145], [146]; and (3) 
transmembrane anchors [26], [120]. 
The cellular environment of a mature neuron is a totally different situation. Due to the large 
distances mRNAs must travel and the complex spatial environments, active transport is 
required to keep the local transcriptome intact. In mature and active neurons, half of the mRNA 
population is motile. Most RNPs agitate in oscillatory movement with speeds up to 2µm/s. 
There is current evidence that RBPs (such as Fmrp) alter the speed and efficacy of RNP 
travelling in neurons. Deletion of Fmrp led to decreased travelling speed but did not influence 
the length of travelling, which indicates that Fmrp might be an adaptor for motor proteins [147], 
[148]. Why RNPs oscillate in neurons is not completely understood, but one explanation might 
be that this mechanism always ensures a fresh assortment of mRNAs at the point of 
requirement, preventing malfunctions caused by (1) old and damaged mRNAs or (2) mRNAs 
carrying outdated information in their modifications [93], [149]. The regulation of mRNA 
transport in neurons is thought to play a crucial role in neuronal plasticity [150]–[152]. Local 
translation is necessary for synapse-specific modifications and mRNA have to be stored locally 
as, for example, Arc mRNA, which is retained beneath spines in a UTR dependent manner 
[153]. The directed movement of different RNAs to different compartments is most probably 
mediated by a combination of localization techniques. RNAs usually do not move alone, as 
transport in batches is much more efficient. Furthermore, the predominant state of mRNA 
during transport is translationally repressed and they are activated or released upon stimuli 
[95]. The formation of these “batches”, transport granule formation, is most probably a 
symphony of interplays between various RBPs, many mRNAs and adaptor proteins. They are 
held together via weak hydrophobic interactions between components of the granule,forming 
viscous droplets of some kind [126], [154], [155]. The weak interactions of those components 
enable a fast release and therefore de-repression upon the right stimuli.  
Apart from cargo granules, mRNAs and proteins can also be transported in vesicles. On the 
one hand, the constant movement of vesicles through the cell along the microtubule 
cytoskeleton can be used to transport RNA anchored to transmembrane proteins, but on the 
other hand, vesicles can also inherit RNAs at their origin and deliver those at the place of 
cytosis [156]–[159]. 
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Mechanisms of spatial degradation can also mediate RNA localization. This requires 
spatial recognition of the RNA via RBPs that mediate degradation or stabilization of the 
transcript. A prominent example, once more from Drosophila melanogaster, is the RBP 
staufen. During embryogenesis it is localized to the anterior pole of the oocyte. The staufen 
mediated mRNA decay pathway influences the local translatome. Stau1 binds Stau1-binding 
sites (SBS) within the 3’UTR of target mRNAs. During staufen mediated decay (SMD) the 
dsRNA binding is happening through either intramolecular dimerization of 3’UTR elements or 
by base pairing with lncRNAs (Alu elements) [137].  
In neurons a prominent example is the Semaphorin3A (Sema3a) response system. Spatial 
translation in the neurite growth cone is crucial for the correct response to external stimuli. 
Local ubiquitination and degradation of RhoA, which is a mediator of Sema3a signaling, is 
continuously happening. Inhibition of RhoA degradation removes protein synthesis required 
for Sema3a-induces growth cone collapse. The local ubiquitination (Ngf induced and Smurf1 
mediated) of newly synthesized proteins is major feature of local translation and growth cone 
response. Sema3a response needs continuous local translation and therefore induction of intra-
axonal RhoA synthesis. Sema3a mediated growth cone collapse is reversible and can happen 
again after a short recovery time [160], [161]. 
1.3.3. Spatial translational control: Mechanisms of posttranscriptional gene regulation  
To ensure proper intra- and extracellular functions, the molecular machinery must be regulated 
in a sophisticated way. Transcription is regulated by various transcription factors, DNA and 
chromatin modifications. Post-transcriptionally, RNAs are regulated by splicing, modifications 
and localization and their translation into proteins is regulated by numerous mechanisms. Most 
RNAs also play crucial roles in spatial protein production [162]. 
1.3.3.1. RNA editing 
RNAs can be modified in multiple ways. Single bases or sequences can be exchanged, deleted 
or inserted. The editing machinery hereby involves guide RNAs for the correct recognition of 
target mRNAs. Most common is the substitutional editing. Adenosine or cytosine bases can be 
deaminated to Inosine and Uridine, respectively. Inosine is read as a Guanidine during the 
process of translation. These mechanisms contribute to protein diversity either directly via 
changing the coding sequence or indirectly by creating new or removing old splice junctions. 
Adar2 for example (Adenosine deaminase acting on RNA) edits its own pre-mRNA by 
changing an AA sequence to AI, which is read by the spliceosome as a new splice site (AG). 
This alternatively spliced isoform has a new translation start site and forms an altered protein 
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product. It was shown that exogenously induced RNA-editing can be used to include or exclude 
localization signals in endogenous RNAs. Recent studies focusing on endogenous mRNAs 
suggested that hyper-editing of the 3’UTR could influence transcript export from the nucleus 
and it has been suggested that A-to-I hyper editing drives association with p54nrb/NonO, which 
drives paraspeckle formation [163]–[165]. However, other studies showed that A-to-I hyper 
edited mRNAs localized preferably to the cytoplasm and that their nuclear export is not 
restricted [166]. In general, it has been shown that miRNA as well as RBP binding sites can be 
altered by Adar mediated A-to-I editing and therefore the fate of the mRNA is changed 
although the precise functional significance of 3’UTR editing remains unclear [167]. 
1.3.3.2. Nonsense-mediated mRNA decay (NMD) 
Nonsense mediated decay (NMD) is a surveillance pathway that exists in all eukaryotes. Its 
main function is to reduce errors in gene expression. It eliminates mRNAs that contain 
premature stop codons, as the products of these mRNAs might be dangerous, since they could 
potentially have dominant negative functions over their canonical products, competitive 
functions, or completely new functions. The process of detecting aberrant transcripts occurs 
during translation. The first ribosome translating a message removes the exon-junction-
complex (EJC) from the mature mRNA. If the stop codon is within 50nt from the last EJC or 
downstream from it, all components will be removed during the first round of translation and 
the transcript will be treated normally. When the ribosome leaves the mRNA prematurely due 
to a noncanonical stop codon, all downstream EJC will stay attach to the mRNA. Remaining 
EJC proteins are recognized by proteins of the NMD machinery. Termination of translation 
leads to the assembly of the termination complex composed of Upf1, Smg1 and release factors 
eRF1 and eRF3 on the mRNA. Upf1 can interact with remaining EJC proteins and especially 
Upf2 and Upf3, triggering phosphorylation of Upf1. Phosphorylated Upf1 interacts with Smg5, 
Smg6 and Smg7 [168]. Smg7 is thought to be the terminal effector in NMD as it accumulates 
in P-bodies, which are cytoplasmic sites for mRNA decay. In both yeast and human cells, the 
major pathway for mRNA decay is initiated by the removal of the 5’ cap followed by 
degradation by Xrn1, an exoribonuclease enzyme [169]. It has been shown that NMD 
associated proteins are localized to axon growth cones and that NMD is important for axon 
guidance [170]. In spinal commissural neurons, which are a well-studied model for axon 
guidance, the axonal growth cone is initially attracted towards the midline floor plate [171]. 
However, the axon must undergo a drastic switch of responsiveness upon crossing the floor 
plate, since this is just an intermediate target and after crossing the floor plate the axon growth 
cone is repelled by the same stimulus. This switch in responsiveness is represented on the 
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molecular level as a change in expression of the axon guidance associated with receptor Robo3 
[172]. It was shown that the two isoforms of Robo3 (Robo3.1 and Robo3.2) have opposing 
functions [173]. The isoform switch, however,is not obtained through induced alternative 
splicing but rather through fast degradation of the Robo3.2 isoform due to a retained intron 
with a premature stop codon [174].  
Furthermore, the Arc mRNA, which is located at the synapse, undergoes targeted NMD upon 
stimulation of a receptor (Nmdar). The mRNA contains a retained intron and, therefore, a 
premature stop codon but is not targeted by NMD due to its translational repressed state. Upon 
activation of the Nmda receptor the translation boosts and the mRNA becomes a target for 
NMD [170]. 
These examples show that NMD can be targeted and stimulus-dependent and can act as a mode 
of mRNA localization. Another mRNA decay pathway is the deadenylation from the 3’ end, 
following message degradation. This process can be triggered by various mechanisms 
including noncoding RNAs like miRNAs. 
 
1.3.3.3. RNA regulation by noncoding RNAs: miRNAs, siRNAs, piRNAs, snoRNAs 
and lncRNAs 
RNA interference (RNAi) is a gene silencing process that can lead to either degradation of an 
mRNA or inhibition of its translation. Main players in this mechanism are small 
ribonucleotides named micro RNAs (miRNAs) or small interfering RNAs (siRNAs) that are 
partially or completely complementary to their targets. Due to their complementary nature they 
can bind their targets via base pairing and guide processive enzymes to the mRNA. siRNAs 
originate from double-stranded RNAs that are recognized and processed into smaller fragments 
of 21 to 25 nucleotides by Dicer, an RNAse III family member [175]. These small, double-
stranded RNA pieces exhibit 2nt overhangs on both sides and are transferred to the RNA-
induced silencing complex (RISC) simultaneously to their generation through Dicer-RISC 
association. The guide RNA, which is the strand with the lower free energy of binding at the 
5’ end is selected, bound by Ago and exposed while the passenger RNA is degraded. The 
exposed guide RNA then enables the sequence-specific targeting of mRNAs via 
complementary base pairing. Due to perfect complementarity, Ago proteins loaded with 
siRNAs act as endonucleases and cut the target mRNA [176]. 
piRNAs are another form of small regulatory RNAs. In contrast to siRNAs or miRNAs, their 
biogenesis is not regulated by RNAseIII type enzymes that convert the double-stranded 
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precursor into single-stranded, functional, small RNAs but they originate from single-stranded 
RNAs. piRNAs exist in the germ line (ovaries and testicles) and are a bit larger than miRNAs, 
typically 26-31nt. They are less conserved and do not expose any specific secondary structure. 
They were predicted to act on transposons, since most of them are antisense sequences of 
transposons. Some are essential for spermatogenesis in mice, such asthe Miwi, MiwiII and Mili 
associated piRNAs. They act primarily on methyltransferases. Some of them are also loaded 
onto Ago3 [177]–[179]. 
lncRNAs, long noncoding RNAs, are defined by their length (>200nt) and build another group 
of not translated RNAs. Recent studies, such as the FANTOM5 project [180], [181] have 
identified about 30.000 lncRNAs. On average they are lower in abundance than mRNAs in 
mammalian cells. Interestingly, they are highly tissue-specific (80% show tissue-specific 
patterns, whereas just 20% of mRNAs show tissue-specific patterns) and are conserved in 
sequence but not in transcription between species [182], [183]. There are numerous known 
methods of activity so far. Some examples include the regulation of gene-specific and 
nonspecific transcription, splicing, translation, siRNA directed gene regulation, X-
chromosome imprinting (Xist) [184] and epigenetics (Hotair) [185]. 
Endogenous expressed, ~22nt large interfering RNAs are called miRNAs. They originate from 
own gene clusters, transcribed by RNA PolII, or from introns of mRNAs that form imperfect 
mRNA stem loop structures. These structures are recognized and excised by Drosha and Dgrc8. 
The resulting pri-miRNA, which is a ~70nt small double-stranded RNA stem loop, is exported 
from the nucleus and cytosolically cleaved by Dicer, which liberates the ~22nt double-stranded 
miRNA complex. The duplex of guide and transfer RNA is simultaneously delivered to the 
RISC complex and the strand with the thermodynamically less stable base pairing at the 5’ end 
is selected as the mature miRNA and loaded onto AGO while the other strand is degraded. Like 
siRNAs, miRNAs can guide Ago or the complete RISC via base pairing to the target RNA, but 
in contrast to miRNAs they do not exhibit perfect base pairing over their complete length in 
animals. Important for target recognition is the seed region, nucleotides 2-7/8 of the miRNA, 
which often show perfect complementarity [186]. Ago loaded with a miRNA rarely shows 
endonuclease activity in animals due to imperfect binding. Targets are rather translational 
repressed by other components of the RISC and/or decapped and deadenylated, which leads to 
5’ to 3’ degradation. It has been shown that miRNAs play a crucial role in sculpting gene 
expression in eukaryotes and exhibit temporally and tissue-specific expression profiles [187]. 
However, it remains unclear why their function is of crucial importance, since the effect of a 
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single miRNA is conventionally rather small (twofold). Most studies depict their necessity in 
the fact that most genes are targeted by multiple and sometimes different miRNAs. Several 
models of potential miRNA function have been proposed from classical switches to gene 
expression buffers and expression decoys, yet all have in common the fact that miRNAs 
guarantee precision and robustness to gene expression patterns [176]. Until today about 2500 
miRNAs have been annotated and more than 60% of the human transcriptome have been 
predicted to be regulated via miRNAs, though it is still not clear to which degree translational 
repression or target destabilization contribute to this effect. There are examples known where 
translational repression is completely uncoupled from transcript degradation, but these are 
rather rare [188]. It is not completely understood how translational repression of targets is 
happening on the molecular level, although experimental evidence of recent studies points 
towards a repression of translational initiation rather than a repression of elongation. Recent 
studies have shown that some miRNAs are found spatially enriched in the axon and are 
therefore part of the spatial translational regulation machinery, causing differential localization 
of proteins [96], [189]. It was suggested that the sequence specific regulation of the spatial 
translatome is also controlled by miRNAs [96], [190]. Several nervous system functions rely 
on miRNA-target interactions such as dendritic branching [191], spine morphology [192] and 
axonal pathfinding [193]. The conditional knockout of Dicer in mice neurons resulted in 
reduced branching, increased spine length and axon tract abnormalities [194]. Mir-134 was 
found to have particular importance since it localizes to dendrites and regulates synthesis of 
Lim kinase 1 (Limk1), which controls dendritic spine development in hippocampal neurons 
[195]. Furthermore, it is important for the translational dependent growth cone attraction of 
Xenopus spinal neurons [196], [197]. It has been shown that RISC components are present in 
axons in vitro and in vivo [198] and recently a dataset of miRNAs in sympathetic neurons was 
published [199] as well as a dataset for axon specific miRNAs in the developing cortical system 
[200]. All together this data suggests a comprehensive function of miRNAs in the regulation 
of spatial translation. 
 
1.3.3.4. mRNA m6A methylation: Writers, readers and erasers 
There are about 150 different known RNA modifications. N6-methyladenosine (m
6A) is the 
most abundant internal modification in mammalian mRNA. The methylation of rRNAs and 
tRNAs has long been known,  but recent advances in antibody-based sequencing techniques 
have also revealed abundant m6A methylation in mRNAs [201]. m6A methylation is thought 
to be involved in tumor genesis, embryogenesis, circadian rhythm, viral replication, non-
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coding RNAs, alternative splicing, translational regulation, cellular differentiation, disease and 
meiosis, sex determination and dosage compensation [202]. Components of the m6A 
methylation machinery colocalize with RNA PolII, which results in methyltransferation very 
early in the lifetime of an mRNA. It might represent an ancient mechanism of positively fine-
tuning gene expression [203]. The m6A methyltransferase complex comprises two methylases, 
namely Mettl3 and Mettl14, as well as adapter proteins, including Wtap, Rbm15, and 
Kiaa1429. m6A methylation is reversibly removed by two demethylases: Alkbh5 and Fto. m6A 
methylation induces structural rearrangements and can inhibit Watson-Crick pairing. There are 
several examples known for functionally important m6A methylation of mRNAs. Most of 
those functional methylations are within the 5’ UTR of transcripts. It has been shown that 
eukaryotic initiation factor 3 (eIF3) directly binds to m6A methyl groups and can recruit the 
43S initiation complex and thereby bypass cap independent translation [204]. Also, Ythdf1 
recognizes m6A methylations and promotes translation via recruiting the initiation machinery 
leading to cap independent translation. HuR, a well-established RNA stabilizing protein that 
binds to U-rich segments of 3’UTR and precludes miRNA binding, also recognizes m6A 
modifications. There is evidence that the spatial constriction between m6A and HuR sites 
govern the interaction of modified transcripts with HuR [205]. 
It has also been proven that m6A methylations can play a role in metastasis and cancer. Malat1, 
a metastasis related lncRNA in lung carcinoma, utilizes the m6A switch to recruit Hnrnpc 
[204]. Also, methyltransferase like Mettl3 and Mettl14 and RNA-binding motif protein 15 
(Rbm15) are all highly expressed in myeloid leukemia compared with other cancers. Their 
alterations are linked with poor prognosis, suggesting that elevated m6A levels predispose to 
this type of cancer.  
Additionally, m6A enhances functions of the lncRNA Xist for X-chromosome inactivation 
[203]. Likewise, m6A has been proven to play a role in the regulation of alternative splicing, 
although it appears not to participate in localizing splice sites in large introns. m6A 
methylations within alternative exons induce their inclusion via direct recruitment of the m6A 
reader Ythdc1 and downstream splicing factor Srsf3. This restricts binding of the exon-
skipping factor Srsf10 and promotes inclusion of the exon [206]. The loss of the m6A eraser 
Alkbh5 increases overall m6A methylation and results in more cytoplasmic mRNA, suggesting 
more rapid nuclear export of m6A marked mRNAs or higher stability of them [207]. The 
knockout of the RNA methyltransferase Mettl3 additionally altered poly-adenylation site 
selection, indicating a role of m6A methylation in alternative poly-adenylation [208]. During 
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stress response, for example due to ultraviolet radiation or heat shock, 5’ m6A methylations 
are induced and cap independent translation of specific transcripts is upregulated. This 
mechanism involves the nuclear re-localization of Ythdf2 to prevent m6A removal by the Fto 
demethylase [209]. 
m6A has also been implicated in regulating mRNA decay. When transcription was paused with 
actinomycin D in cells lacking the m6A writers Mettl3 and Mettl14, the decay of many mRNAs 
was decelerated. The Ythdf2 protein recognizes m6A methylation via its YTH domain in 
mammals and directs target mRNAs to cytoplasmic P-bodies by recruiting the CCR4-NOT 
deadenylation complex, initiating deadenylation and degradation of methylated transcripts 
[209]. 
m6A effects on miRNA processing have also been published, where m6A methylation seems 
to be required for processing pri-miRNAs via binding of Dgcr8 and recruitment of Drosha 
[210]. It was suggested that m6A methylation might play a role in localization of target 
mRNAs, though this could not be experimentally detected so far. 
1.3.3.5. Translational initiation and cap-binding proteins 
The initiation of translation is a complex and highly regulated mechanism in eukaryotes. It 
requires at least 12 initiation factors (eIFn). It begins with eIF2:GTP, which escorts the initiator 
tRNA Met-tRNAiMet to the 40S subunit. Together with several other initiation factors they form 
the 43S preinitiation complex. Initiation almost always occurs at the first AUG after the m7G-
cap. This AUG is embedded in the consensus sequence “GCCRCCAUGG”. eIF4F, a 
heterodimeric complex of eIF4E, G and A, binds to the m7G cap through the cap binding 
protein. Now eIF4G also binds PABP and circularizes the mRNA. This is thought to prevent 
initiation on broken transcripts or to allow faster reinitiation. The eIF4F-mRNA complex is 
subsequently joined by other initiation factors and the whole RNP is bound by the 43S 
preinitiation complex. Subsequently the ribosomal subunit scans the mRNA until it encounters 
the first AUG and forms the 48S initiation complex. The recognition is achieved mainly by 
base pairing with the bound Met-tRNAiMet. eIF2 catalyzes hydrolysis of its bound GTP and 
thereby induces the release of all initiation factors. The 60S subunit joins in a GTP dependent 
reaction, catalyzed by eIF5B, and forms the 80S translating ribosome, which is now able to 
decode the RNA code into a chain of amino acids [7].  
In addition to the canonical cap-mediated initiation of translation, ribosomes can bind and 
translate mRNAs internally thanks to so-called internal ribosomal entry sites (IRES). These are 
complex secondary structures of mRNAs that can recruit ribosomes internally without the need 
of the cap structure. They were first identified in virus mRNAs, but recent studies showed that 
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also endogenous eukaryotic mRNAs can inherit IRES structures that are active under certain 
conditions. They provide another layer of translational regulation as they are not affected by 
changes in the canonical initiation machinery and can therefore provide robust translation 
under adverse conditions [211], [212]. 
 
1.3.3.6. mRNA structure and stability 
The structure of a pre-mRNA or mature mRNA does have an impact on all aspects of its life. 
Secondary structures can be recognized by RBPs, can inhibit or promote translation, can inhibit 
or promote splicing and can also influence the stability of the transcript. This means that 
information is not only stored in the sequence of the transcript but also in the structure. This 
allows more information to be stored in the genome without increasing its size [213]. Structural 
analysis of mRNAs has been and still is very complex and often rather approximative, since 
the structure depends the symphony of all forces acting on the polynucleotide. Since the 
molecular environment of the cell is extremely complex and dynamic and therefore not easy to 
model, most studies are either in silico or based on in vitro experiments under controlled 
conditions. Numerous forms of secondary and tertiary structures are known though the genome 
wide knowledge about structures was limited due to low throughput RNA structure probing 
techniques. Recent advances in structural analysis were made by methods such as 
fragmentation sequencing (FragSeq [214]), parallel analysis of RNA structure (PARS [215]) 
and selective 2-hydroxyl acylation analyzed by primer extension (SHAPE [216]), giving first 
insights into the endogenous RNA structure landscape on a genome-wide level. These 
techniques highlight the diversity and complexity of transcriptome and show on the other side 
that this research field is still in the early stages. It is now appreciated that structure can have 
influence on all classes of RNAs and throughout the whole lifetime [217]. 
The known influence of RNA structure on alternative splicing is mainly to bring together splice 
sites, expose them or mask them. For example, the human growth hormone GH1 is expressed 
in two isoforms with a big difference in expression. This effect relies on the fact, that the splice 
site of the lower abundant isoform is hidden by a favored stem loop structure. Also, the survival 
motor neuron protein Smn exists in two isoforms (Smn1 and Smn2) which differ in inclusion 
of one exon (7). This gene does not change the coding sequence, rather the splicing pattern, by 
introducing an inhibitory element to the 3’ splice site in Smn2, which results in skipping of 
exon 7. The 5’ splice site is weak and hidden in a stem loop structure and strengthening the 
splice site leads to the exclusion of E7, while weakening it leads to its inclusion [218]. It has 
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been generally shown, that alternative splice sites have a higher GC-content than constitutive 
or skipped ones, which might suggests more stable secondary structures [217].  
Ribosomal influence on mRNA structure is evident. The translating ribosome on the mRNA 
can penetrate secondary structures up to a certain mechanical strength [219], although these 
structures do alter the speed of translation [220]. Hairpins upstream of the initiation site can 
also inhibit initiation. This effect is most pronounced when the hairpin is near the G-cap. It was 
shown that the GC-content in the 5’ UTR changes translation rates [221]. Secondary structures 
downstream of the initiation site can facilitate recognition of weak initiation codons. Secondary 
structures in the 3’UTR also alter translation. Structures can be recognized by diverse proteins. 
One prominent example is the 3’UTR of Tf which forms an iron response element and is bound 
by iron regulatory proteins when intracellular iron is low [222]. 
1.3.3.7. uORFs, alternative ORFs and overlapping ORFs  
Approximately 40% of all mRNAs in mice exhibit alternative open reading frames [223]. 
These can either be upstream from the canonical reading frame or even overlapping with the 
canonical open reading frame. In general, they repress translation of the main ORF [224]. The 
probability of having a uORF increases with the increasing length of the 5’ UTR, although 
uAUGs and uORFs are less frequent than statistically expected, underlining their negative 
selection pressure [225]. The ribosome sometimes skips the first AUG if it’s too near to the 5’ 
end or if the sequence environment is not recognized. If they are recognized by the 40S 
ribosomal subunit, however, they will downregulate translational efficiency of the following 
ORF. Once again, the secondary structure is of high importance, as is the distance to the Kozak 
sequence [226]. Known uORFs differ in length, number, distance from the cap structure, 
whether it overlaps the ORF or not and distance between the uORF-STOP and the main ORF 
START. Eukaryotic ribosomes can reinitiate after termination. This is the rate limiting effect 
of uORF-altered main ORF translation. The time for translation of the uORF is also important 
for the reinitiation rate. Reinitiation rates are difficult to study, since discrimination of 
reinitiation and leaky scanning is rather complicated. The best-studied example in human is 
maybe Atf4, which has two uORFs. uORF1 is just three amino acids (aa) in length, whereas 
uORF2 is 59aa long and overlaps with the main ORF. Under normal conditions (eIF-TC 
abundant) uORF1 is efficiently transcribed, and scanning 40S subunits after uORF1 will 
acquire eIF2-TC before reaching uORF2 and will reinitiate. Since uORF2 overlaps with the 
coding frame and is also longer than uORF1, it inhibits translation of the main ORF. During 
stress conditions, eIF2-α subunit phosphorylation is increased, which reduces the eIF2-TC 
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concentration. The 40S subunit that resumes scanning due to lack of eIF2-TC will skip the 
uORF2 and eventually reinitiate at the main ORF [227]. 
Inhibition or stalling uORFs  often also triggers NMD, since the stalled ribosomes on the ORF 
cannot knock off the splice junctions proteins on the canonical ORF [228]. 
1.4. Methodical evolution in studying RNA localization in neurons: From the 
FISH to the mouse TRAP and beyond 
Studying RNA localization evolved tremendously during recent years. Starting in 1969 [229] 
with intricate, in vitro, low throughput and extensive cost technologies like in situ hybridization 
(ISH), fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) based 
experiments modern, next generation sequencing (NGS) based methods allow the user to study 
the localization of thousands of transcripts at the same time. In general, methods can still be 
divided into low and high throughput-based technologies, each of which has advantages and 
disadvantages. 
Low throughput-based techniques like the aforementioned ISH and IHC are restricted to few 
transcripts due to the nature of microscopy, yet enable the user to gain detailed information 
about specific transcripts. Advances in single molecule FISH (smFISH [230]) provided insights 
into the journey of single RNAs through the cell, while the usage of sophisticated reporter 
constructs allows us to study the translational state of the transcript in parallel  [231]. All of 
these techniques suffer the same limitations however, which include (1) resolution limitations 
of the optical system, (2) detection limits of the camera system and resulting size of the reporter 
and (3) robustness of the biological system under imaging conditions. Initial experiments were 
conducted using radioactive reporter probes in ISH [229]. This has become a valuable method 
for studying the localization and expression levels of single nucleic acid sequences in a tissue, 
cell or even subcellular compartment. It is used to identify changes in expression and 
localization during embryonal development or cancer genesis. It detects a specific sequence 
through a hybridization procedure with a labelled complementary sequence in a fixed tissue or 
cell sample. Radioactive labels were first replaced by chemical reactions and have now been 
exchanged for fluorescent labels, giving the assay the catchy name fluorescence in situ 
hybridization (FISH [232]). Numerous technical advancements in probe engineering and the 
protocol improved the resolution, specificity and speed of FISH, making it irreplaceable in 
modern cell biology. In 1998 Singer and colleagues improved the resolution to the single-
molecule degree, making the detection of single RNA [230] molecules in a fixed tissue or cell 
possible. The usage of multiple short probes per transcript, each coupled to a fluorophore, 
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amplifies the signal to the level of detection of modern light detection techniques. Single 
molecule FISH is now a powerful tool to study the localization and transcriptional state of 
specific transcripts in single cells, although it is still limited to relatively long and few 
transcripts per experiment and fixed samples, therefore providing just a snapshot of RNA 
localization. 
Microinjections of labeled mRNAs into live cells enabled  the tracking of mRNA trafficking 
live in neurons for the first time. Reporter RNAs are transcribed in vitro in the presence of 
fluorescently labelled UTPs. These mRNAs are introduced into living cells using an injection 
needle with a pressure-injection system. Although it is tedious and time consuming, this 
method gave first insights into the intracellular movement of mRNP particles [233], [234].  
The introduction of endogenously expressed mRNA reporters in combination with target-
specific, fluorescent and endogenously expressed fusion proteins enabled Bertrand et al. in 
1998 for the first time to circumvent microinjections and simultaneously reach molecular 
resolution [235]. Multiple systems advanced from this point, all of which are based on 
fluorescent proteins fused to bacteriophage capsid proteins such as MS2, PP7 or λ in 
combination with multiple bacteriophage specific stem loop structures in the reporter [236], 
[237]. Thanks to positioning of the stem loops within the reporter and usage of multiple 
fluorophores it is now possible to track the journey of a single mRNA molecule live in a cell 
and simultaneously visualize the first round of translation of said reporter [231]. 
All of these techniques are still limited to single or few target mRNAs or reporters. Recent 
milestones in transcriptome analysis evolved RNA sequencing methods to a point at which 
it has become an inexpensive and fast way to study transcript abundance in a specific sample. 
Single cell-based techniques such as single cell sequencing and single cell real time PCR 
provide valuable information about variations in transcript abundance within cell populations 
and tissues, but are restricted to complete and dissociable cell types. Combinatory experiments 
of microdissections, cell organelle separations or cell compartment separations and subsequent 
transcriptome profiling is now the only way to study RNA localization on a global level. 
Limitations are due, of course, to the nature of the experiments: (1) the resolution and accuracy 
of the physical separation of subcellular compartments; (2) the physiology of the biological 
sample; and (3) the resolution on the cellular level. There are several published methods for 
the fractionation of subcellular compartments: (1) microdissection, followed by density 
centrifugations [238]; (2) microdissections, followed by affinity purification of cell specific 
RNAs [109]; and (3) cell culture-based techniques [152]. However, the cellular resolution of 
  
52 
 
most of these techniques remains rather poor, since the input demand of modern transcriptome 
profiling techniques in combination with low RNA yields of subcellular fractions usually 
requires the pooling of multiple cells. The homogeneity of the cellular sample is, therefore, a 
big challenge for all experiments. 
1.4.1. In vivo systems to study intracellular localization in neurons 
There are several published in vivo approaches focusing on subcellular RNA localization. 
Aside from giant cells like developing Drosophila egg cells, neurons are the most practical and 
widely used systems. A neuron can be divided into multiple fractions, but the most common 
physiological fractions are the dendrites, the axon, the cell body with the nucleus and the 
synapse, although the synapse is an intercellular structure, since it consists of a presynaptic 
nerve end, the synaptic cleft and the postsynaptic part. The accuracy of subcellular 
fractionation and purity of the test samples varies dramatically between the different 
approaches.  
1.4.1.1. Microdissection followed by sucrose, Ficoll or Percoll density gradient 
centrifugation 
The mouse brain is divided into at least 26 different physiological areas, all characterized by 
specific neuronal and nonneuronal cells [239]. The number of different neuronal and 
nonneuronal cell types varies from publication to publication and recent single cell sequencing 
techniques, in particular, have revealed that there might not be such a clear separation between 
cell types since most gaps are filled with innumerable subtypes and variations within one 
homogenous appearing cell populations might be tremendously [240]. Therefore, the isolation 
and biochemical analysis of subcellular fractions has to start with the purification of a 
homogenous cell population. Physiological dissections of brain areas under the microscope are 
called microdissections. Centrifugation allows brain microdissections to be further 
homogenized and synaptosomes to be isolated. Synaptosomes are isolated nerve terminals that 
encapsulate upon mechanical fractionation of the neuron. They consist of the presynapse, 
which contains the presynaptic vesicles, mitochondria and a postsynaptic density. 
Synaptosomes can be isolated via density purification. The first synaptosome purifications 
were generated in 1958 by Hebb and Whittaker [238] using the complete brain, but recent 
publications all use prior purification of cell fractions [239], [241], [242]. The homogenization 
is generally done via sheer force. Crude enrichments of synaptosomes can be achieved by 
pelleting myelin and other debris, transferring the supernatant to another tube and pelleting the 
microsomal P2 pellet at high speed. Even purer preparations are obtained by applying this 
crude synaptosome fraction to a density gradient centrifugation, using either sucrose [238], 
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Ficoll [243] or Percoll [244] gradients. Purified synaptosomes contain enough material for 
biochemical assays, maintain metabolic activity and membrane potential, and can still be 
stimulated to release neurotransmitters [245]. They are also used for further separation of 
synaptic vesicles, presynaptic cytomatrix and the postsynaptic density. Among impurities of 
the initial cell populations, the purification of synaptosomes tends to include impurities from 
mitochondria, the ER and other large cellular organelles. Recent publications revealed the 
sophisticated transcriptome [92], [246]–[249] and proteome of synaptosomes [250]–[252].  
1.4.1.2. Microdissection coupled to NGS 
Advances in microdissection techniques and detailed knowledge about physiological areas of 
the brain and the containing cell types have lead to various transcriptome analyses of simple 
brain slices. The challenge in these experiments is to dissect a homogenous sample consisting 
of just one cell type and subdividing this sample into fractions that can be analyzed via 
sequencing or microarray techniques. Reproduction of microdissecting tissues enriched for 
dendrites coupled to subsequent microarray analysis of the RNA content by different groups 
appeared to be impossible[239], [241], [242]. In 2012 Cajigas et al. published a deep RNA 
sequencing-based approach to analyze the transcriptome in the synaptic neuropil [246]. They 
micro-dissected the hippocampal neuropil and isolated fractions enriched for either CA1 
neuron cell bodies or CA1 neuron dendrites. Comparing the extracted RNA pools between 
those fractions they identified 8,379 mRNAs associated with dendrites or axons in the 
hippocampal neuropil and confirmed their results via imaging of several candidates in primary 
hippocampal neurons. Due to the impurities of the microdissection they used a massive in silico 
filtering approach to identify the neuropil associated genes and filter out genes that might 
belong to glia, interneurons, blood vessels, nuclei or mitochondria [246]. Enriched genes in 
inhouse and published datasets of glia cells, astrocytes and oligodendrocytes [253], [254] were 
subtracted from the neuropil transcriptome. Also a combined list of interneuron specific 
transcripts from several publications [254]–[256] was filtered out. Finally mRNAs enriched in 
blood vessels [257] and mitochondria as well as transcripts coding for nuclear proteins were 
subtracted, leaving a list of 2,550 mRNAs that were annotated as the axonal and dendritic 
transcriptome. This pool of mRNAs includes transcripts for most biological functions and 
extends other previously published datasets by a factor of 25. This data suggests an enormous 
potential for spatial protein synthesis in the neuropil being a main player of the local proteome, 
although the massive filtering approach and the type of sequencing used causes an obvious loss 
of information. Subtracting enriched genes from interneurons, glia cells, astrocytes, 
oligodendrocytes and blood vessels may conceal many genes that are also part of the axonal or 
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dendritic transcriptome. Also, the subtraction of nuclear associated transcripts, though it might 
seem logical, bares the risk of losing many transcripts that either have an additional function 
besides the nuclear one or are translated in the distal part of the cell, though they function in 
the nucleus. Examples for the distal translation of proteins baring an NLS [258] or even the 
axonal translation of transcription factors like the cAMP response element binding protein 
Creb, coupled to retrograde transport [259], were previously published and are naturally, lost 
due to this massive filtering. The experimental setup is also insufficient to catch non-
polyadenylated transcripts such as circular RNAs, miRNAs or other noncoding transcripts. 
Finally, the experimental setup, together with the massive filtering, enables a snapshot to be 
taken of the neuropil transcriptome, leaving out the question of which transcripts might be 
intracellular enriched in the spatial compartment compared to the somatic compartment. 
Another type of microdissection coupled to deep sequencing was published in 2014 by Junker 
et al. [260]. Using massive cryotome histology coupled to low input RNA sequencing, followed 
by mathematical image reconstruction, they published a high-resolution 3D atlas of gene 
expression of a Danio rerio embryo. Cryo-dissecting microslides and extracting RNA for deep 
sequencing was performed here on a multicellular level but in theory this experiment could 
also be performed on huge cells like Drosophila melanogaster egg cells. The microdissection 
must be performed multiple times from different directions to enable mathematical image 
reconstruction, which limits this technique to uniform samples that can be aligned in silico after 
analysis.  
 
1.4.1.3. Microdissection followed by affinity purification techniques coupled to 
NGS 
In 2015 Ainsley et al. published a new method for collecting in vivo dendritic mRNA from 
mouse hippocampal CA1 pyramidal neurons [151]. They circumvented the challenge of 
physically or computationally separating dendrites from glia, astrocytes, blood vessels and 
interneurons by endogenous tagging of ribosomes in pyramidal neurons. This was 
accomplished by inserting an artificial fusion gene coding for the ribosomal protein L10a and 
GFP under Tet+-control. This fusion gene was crossed into a mouse strain with Tet-on 
expression under the pyramidal neuron specific promotor Camk2a, leading to a cell type 
specific expression of the fusion gene. Tissue punches of the CA1 layer containing dendrites 
of the pyramidal neurons or the soma of CA1 neurons were analyzed. Crude lysate extraction 
via homogenization and immunoprecipitation of tagged ribosomes with associated mRNAs 
enabled them to explore the spatial translatome of pyramidal neurons. They identified 1,890 
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mRNAs to be bound preferentially by ribosomes in the dendrites of activated CA1 neurons. 
This finding highlighted the importance of local protein synthesis in dendrites to build the 
spatial proteome and, furthermore, the importance of mRNA localization in neurons. They 
collected samples at several timepoints of intensive synaptic activity (e.g. rest state and fear 
conditioned mice) and identified differences in ribosome associations upon synaptic activity. 
Dendritic RNAs appear to associate rapidly with ribosomes following a novel experience, 
providing strong support for their functional importance. Though it was shown in vitro before 
[261], this study showed in vivo translatome changes upon synaptic activity for the first time. 
Genes involved in translation and associated to cytoskeletal functions were most enriched in 
this condition. As the experimental setup allowed them to circumvent the massive filtering 
approach used by Cajigas et al., they were also able to identify enrichments for mRNAs 
encoding for proteins associated with nuclear functions such as chromosome organization (e.g. 
histone 4) and transcriptional regulation (e.g. transcripts of the mediator complex). In total 848 
out of the 1,890 detected transcripts were also detected in previous studies but were filtered out 
due to association with (1) nuclear functions, (2) glia specific expression, (3) interneuron 
specific expression, or (4) blood vessel specific expression. 
This finding agrees with models of synaptic plasticity that predict local stimulus sensitive 
translation as a main player of memory formation. This phenomenon was demonstrated in 
previous studies in synaptosomes [262] and in vitro cell culture [261]. Here, they provide the 
first in vivo experimental evidence for the synaptic triggering model, which is widely used to 
explain memory formation on the molecular level of the synapse. It proposes that an “activated 
synapse” adopts a protein synthesis independent “tagged” state that enables the neuron to 
capture plasticity related products (PRPs), such as mRNAs, that are translated in dendrites and 
proteins that are synthesized in the soma. The recruitment of these PRPs to the synapse 
stabilizes structural and functional changes within the synapse and enables long-term storage 
of memory. Synapses that are not activated will not capture PRPs required for the stable state. 
This model presumes a pool of local mRNAs in a translationally repressed state and a 
translational boost upon a specific stimulus. Cytoskeletal remodeling is, of course, a main 
requirement for structural changes in the synapse. 
In 2016 Shigeoka et al. published a similar approach to catch snapshots of the axonal 
translatome in developing neurons [109]. They developed a similar method called Axon-
TRAP-Ribo-Tag [263], which relies on the endogenous tagging of cell specific ribosome. In 
contrast to Ainsley et al., they used a Rpl22-HA fusion protein, which is specifically expressed 
in retinal ganglion cells (RGCs). The aim of this study was to capture changes in the axonal 
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translatome during embryonal development. Therefore, samples from retinal ganglion axons 
taken at three timepoints during the embryonal development (E17.5, P0.5, P7.5) and in the 
adult mouse were compared to the somatic fraction extracted from the retina. The total number 
of axonally translated mRNAs was higher in early stages of development, peaking at P0.5, and 
decreased postnatally. In contrast, the somatic translatome was more stable. Previous studies 
demonstrated that proteins are synthesized in developing axons, although it remained 
controversial as to whether mature axons exhibit local protein synthesis, also because previous 
studies found few or no ribosomes in mature axons [264]. However this was refuted by several 
studies that do indicate that ribosomes exist in mature CNS axons [265]–[267] and that their 
number is dynamically regulated [268]. 
This study proved for the first time the presence of active ribosomes in mature axons in the 
adult CNS. Interestingly, this study showed that only a subset (694 out of 2,576) mRNAs was 
spatially translated at all timepoints, revealing a high variability in translational regulation and 
perhaps as well in mRNA localization during neuron maturation. The study did not find 
transcripts associated with nuclear functions such as components of chromatin arrangement in 
axons of RGCs. Together with a similar finding in the Drosophila melanogaster visual system 
[269] this study shows that the maturation of presynaptic terminals is regulated by tightly 
controlled spatial protein synthesis. 
About 15% of the ribosome-bound mRNAs might not undergo translation but are 
translationally inhibited. The retinal samples, which are used as somatic controls, unfortunately 
contain short axons and dendrites of the intra-retinal circuitry as well as their cell bodies. The 
expression of tagged ribosomes in non-retinal cells might also influence results. Finally, this 
study, like previous studies, focuses on just one small part of the spatial molecular 
environment; without detailed knowledge about the local transcriptome and proteome it is 
impossible to say whether ribosome association with local mRNA pools change or whether the 
pools themselves change (e.g. different mRNAs get localized). 
 
1.4.2. Cell culture-based systems and their usage in investigating RNA localization 
Cell culture-based systems produce more homogeneous cell samples. Results are not always 
easy to transfer to in vivo systems, but many general mechanisms are the same in cells growing 
in a complex tissue or in a culture dish. Also, they are way easier to manipulate. The origin of 
cells is of high relevance in this context. Cell lines that are cultured for decades tend to 
accumulate genetic defects and are not likely to reflect any endogenous cell type anymore. 
Additionally, most available cell lines are either genetically immortalized to regain 
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proliferating potential, are cancer cell lines, or must be cultured as stem cell lines and 
subsequently differentiated into the cell of interest. In contrast, primary cell cultures can be 
prepared by extracting cell material of the organism of interest and culturing these cells in 
conditioned medium. Of course, the extraction of just one cell type is not always easy, 
depending on the cell type of interest. 
When studying neuronal localization, the cell system must be neuronal. The following chapter 
will discriminate between (1) immortalized cell lines, (2) neuroblastoma cell lines, (3) stem 
cell lines and (4) primary cell lines used to study mRNA localization in vitro. 
Immortalized cell lines in this context are neuronal precursor cell lines that are extracted from 
the fetal organism and prevented from terminal differentiation via genetic modifications. A 
prominent example of these cells is the ‘Lund Human Mesencephalic’ cell line (LUHMES). 
This cell line was generated and characterized by the Leist lab in 2005 [270] as a model to 
study Parkinson’s disease. It is a subclone of the human mesencephalic cell line MESC2.10, 
which originated from Lund university. The cell lines were immortalized by introducing a 
tetracycline-responsive v-Myc gene under control of the TET-off system. They can be easily 
cultured and proliferated. Upon tetracycline-induced downregulation of the v-Myc gene and 
simultaneous cAMP and GDNF treatment, they proceed in terminal differentiation and form a 
homogenous cell population of dopaminergic neurons, exhibiting biochemical and 
physiological dopaminergic markers and extensive neurite morphology. Functionally, they 
display spontaneous electrical activities and are able to release and take up dopamine, 
suggesting high similarity to human dopaminergic neurons [271].  
Most common cell culture systems are based on endogenously “immortalized” cell lines, 
cancer cell lines or, in this case, neuroblastoma cell line [272]. There are numerous cell lines 
commercially available that all inherit the same background. Altogether they are defined by 
their origin from neuronal crest derived progenitor cells [273]. They do all have the potential 
to differentiate into neuronal cell types upon stimulus and keep proliferating potential ex vivo 
[274]. They are an easy and cost-effective test system for many biological questions and often 
used for drug screening systems for example for neurotoxins. Due to their origin and journey 
through many labs, most of them already carry multiple drug resistances and often also multiple 
mutations, peaking in polyploidy, making them not the best system for genetic cause and effect 
studies. Prominent examples of used neuroblastoma cell lines are PC12 (rat), SH-SY5Y 
(human), LAN-5 (human) or N1E-115 (mouse). Problems with these cell lines are the poorly 
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defined and controlled way of differentiation, the accumulation of genetic modifications and 
drug resistances, and their cancerogenic origin.  
Stem cell lines such as induced pluripotent stem cells (IPS) or embryonic stem cell lines (ESC) 
are, as their names suggest, either dedifferentiated somatic cells that gained pluripotency, or 
extracted stem cells. Culturing these cell lines must be strictly controlled to prevent premature 
differentiation. Cell density, external stem cell transcription factors or inhibitory reagents must 
be used to keep those cells in their pluripotent or embryonal state. Due to their nature they have 
the potential to differentiate into various cell types, including neuronal cell lines, by adding 
external differentiation factors such as Brn2, Olig2, Zic1, Myt1l or Ascl1 [275], [276]. Of 
course, these factors can also be genetically integrated under a controllable promotor in the 
cell, which makes it a more defined and controlled system. The combination of differentiation 
factors, depriving stemness promoting factors, and media variations is crucial to generate 
homogenous neuronal cell populations. 
The most sophisticated neuronal cell culture is the culture of primary cell lines originated 
directly from the organism of interest. These cells must be mechanically extracted via 
microdissection, enzymatically isolated, if possible and needed, sorted for specific cell types 
and then cultured under conditions enabling them to proceed in their endogenous 
differentiation program [277]. Impurities in the resulting cell line can therefore be the result of 
either imprecise microdissection or slight variations in the process of differentiation. Since the 
differentiation potential of stem cells decreases during their embryonal development, the 
timepoint of extraction is crucial for the generation of homogenous cell lines. Neuronal cells 
are, especially easy to damage during the process of microdissection and isolation due to their 
size and morphology. Common primary neuronal cultures include hippocampal, cortical and 
spinal cord cultures [277]. 
All these ex vivo test systems are used to study molecular localization. Some are more, and 
some are less like neuronal cells in the intact tissue, but all of them have advantages in usage 
for different biochemical assays. Since most neuronal cell cultures grow attached to a surface, 
they can all be used for microscopy and low throughput analysis of RNA localization. To gain 
material for high throughput biochemical analysis of subcellular compartments, these cells 
must be compartmentalized either mechanically or biochemically. 
 
  
59 
 
1.4.2.1. Microfluidic chambers 
Microfluidic platforms can be used to isolate and direct the growth of CNS axons without the 
use of neurotrophins, providing a highly adaptable system to model many aspects of CNS 
neuro-degeneration and injury. In general, these systems consist of micro-vessels that are 
connected with micro-tubes of defined diameter. Liquid flow through these capillary vessels 
can be controlled by the experimental installation. Microfluidic platforms are perfect systems 
to study spatial manipulation of neurons. Due to their cost-intensive composition and 
regulation they are not suitable for high throughput biochemical approaches, although they are 
perfectly suitable for most forms of microscopy-based experiments. They enable extremely 
clean separation of subcellular compartments and, by varying the length and diameter of the 
tubes, also clear differentiation between axons and dendrites or neurons [152]. 
1.4.2.2. Campenot chamber 
The Campenot chamber was the first device used in in vitro tissue culture to separate cell bodies 
from axons [278]. Campenot chambers are compartmented Teflon dividers attached to a 
collagen-coated petri dish via a thinly applied silicone grease layer. Typically, the nerve growth 
factor (Ngf) or similar growth factors promote neurite outgrowth through the grease layer and 
enable a clean separation between neurite outgrowths and somatic compartments that stays in 
the chamber [152]. The installation of these chambers is very fragile while the cell number is 
limited, making it not suitable for the generation of large amounts of biological material. 
Campenot chambers are traditionally used for spatial manipulations of neurons. They are more 
affordable than microfluidic devices and do not have to be regulated as precisely. Cortical, 
hippocampal and spinal cord neurons have so far not been successfully cultured in Campenot 
chambers, which further limits their application in localization experiments. It is mostly used 
to study target-derived neurotrophin-initiated signaling and retrograde signaling during axon 
development and synapse formation [279], [280].  
1.4.2.3. Modified Boyden chamber 
The Boyden chamber experiment was first introduced in the 1960s by Stephen Boyden [281] 
as an assay to examine mechanisms of cell migration. It consists of a two-compartment culture 
vessel separated by a porous membrane. Attractors on the outside of the membrane induce cell 
migration, which can be quantified by microscopy. Modified Boyden chambers are 
compartmentalized culture vessels, separated by a porous membrane of such a size that the cell 
cannot completely migrate through the pore. They are commercially available as cell culture 
inserts in numerous variations of size, material and pore size. Neuronal cells can be cultured 
on top of the membrane and outgrowing neurites can be attracted to the other side of the 
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membrane by a coating reagent. Traditionally, these coating reagents are parts of the basal 
lamina, such as laminin. Since the coating can be applicated by the user, these culture vessels 
are suitable for various cell types, including primary cell cultures. In contrast to microfluidic 
devices, the separated cell culture vessels can’t be regulated as defined and these systems are 
not optimal for microscopy-based techniques due to the three-dimensional culturing. 
Nonetheless, modified Boyden chambers allow a clean, easy and cost-effective mechanical 
separation of subcellular compartments. In combination with a homogenous cell line, this 
culture system is perfect for studying molecular localization in neuronal outgrowths because 
by nature, it enables the user to extract higher amounts of material [81], [282].  
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2. Author contribution 
 
Primary data analysis of RNA-seq, small RNA-seq experiments and K-mer enrichment 
analysis of the modified RESA experiment was performed by Vedran Franke (Akalin group, 
MDC-BIMSB bioinformatics platform). The RiboSeq data was generated by Camilla Cioli 
Mattioli (Chekulaeva group, MDC-BIMSB) and analyzed by Vedran Franke (Akalin group, 
MDC-BIMSB bioinformatics platform). The spatial LC-MS/MS data used for validation of the 
spatial SILAC data of Ascl1-iNs was generated by Alessandra Zappulo and analyzed by Koshi 
Imami. The primary analysis of the LC-MS/MS data from the N1E-115 cells was performed 
by Guido Mastrobuoni (Kempa group, MDC-BIMSB). The primary analysis of the LC-MS/MS 
data, as well as the SILAC and pSILAC data from the Ascl1-mESC and Ascl1-iNs, was 
performed by Koshi Imami (Selbach group, MDC-BIMSB). The primary analysis of the 
QuaNCAT data was performed by Erik McShane (Selbach group – MDC-BIMSB). The 
circRNA and lncRNA analysis on RNAseq data coming from Ascl1-iNs was performed by 
Andrei Filipchyk (N. Rajewsky group – MDC-BIMSB). The primary analysis of the modified 
RESA experiments and motif enrichment analysis was performed by Esteban Peguero Sanchez 
(Chekulaeva group – MDC-BIMSB). 
Parts of this thesis were published in “RNA localization is a key determinant of neurite-
enriched proteome” (Nature communications Zappulo et al. 2017). 
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3. Aim of the thesis 
The aim of this thesis was to identify local protein and RNA pools in the used neuronal 
cell systems, to identify the impact of RNA localization on the establishment of local 
proteins pools and get insights into spatial protein production in neuronal cell systems.  
The second part of this work aimed on establishing a method for the de novo identification 
of zip codes in the used neuronal systems.  
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4. Material and Methods 
4.1. Material 
4.1.1. Equipment and consumables 
4.1.1.1. Consumables for cell culture 
Name Manufacturer Serial number 
µ-Slide 8 Well ibiTreat ibidi GmbH 9344 
Cell counter slides Luna 872010 
TC 6-well plate Sarstedt 50589 
Sterile Filter 0.22µM  500ml Life Technologies TPP99505 
Millicell Hanging Cell 
Culture Insert, P 
Merck Chemicals GmbH MCSP06H48 
neoLab-Wattestäbchen Alu-
Stiel 150 mm 
NeoLab Laborbedarf 21022 
Wattestäbchen Holzstiel 150 
x 2,5 mm 
NeoLab Laborbedarf 290121021 
 
4.1.1.2. Consumables for biochemistry assays 
Name Manufacturer Serial number 
5&10% Bio-Rad Protean 
TBE precast gel 
Bio-Rad 4565014 & 4565034 
EPPENDORF DNA/RNA 
LoBIND S/L TUBES,1.5ML 
Eppendorf 0030108051  
 
Qubit Assay Tubes Life Technologies Q32856 
Microseal 96-Well Skirted 
PCR Plates 
Biorad MSP-9601 
Biosphere Fil. Tip 1000 blau Sarstedt 70.762.211 
Biosphere Fil. Tip 200 farblos Sarstedt 70.760.211 
Biosphere Fil. Tip 20 farblos Sarstedt 70.1114.210 
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SafeSeal SurPhob Spitzen, 
1250 µl, steril 
Biozym Scientific GmbH VT0270 
SafeSeal SurPhob Spitzen, 
100 µl, steril 
Biozym Scientific GmbH VT0230 
SafeSeal SurPhob Spitzen,10 
µl 
Biozym Scientific GmbH VT0200 
Deckgläser für Mikroskopie 
18 mm Ø, Nr. 1 
NeoLab Migge GmbH 2637558 
OBJEKTTRÄGER 
ISO8037/I GESCHN 
EINS.MATT 
VWR International GmbH 631-0411 
BRAND(TM) PCR-TUBES, 
0.2 ML, COLOURLESS 
Sigma-Aldrich Chemie 
GmbH 
BR781305-1000EA 
PCR-Gefäße, 8er, PP, ohne 
Deckel 0,2 ml 
NeoLab Laborbedarf 104981325 
PCR-Deckel, 8er, für PCR-
Gefäße farblos 
NeoLab Laborbedarf 104981334 
RiboRuler High Range RNA 
ladder 
Life Technologies SM1823 
40% Acrylamide/Bis 
Solution, 19:1 
Bio-Rad Laboratories GmbH 161-0144 
Quali - "Low binding" 
Microcentrifuge Tubes, 0,6ml 
Kisker Biotech G016 
Quali - "Low binding" 
Microcentrifuge Tubes, 1,7ml 
Kisker Biotech G017 
Quali - "Low binding" 
Microcentrifuge Tubes, 2,0ml 
Kisker Biotech G018 
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4.1.1.3. Equipment 
Name Manufacturer Serial number 
SP8 Laica  
SP5 Laica  
Trans Blot Turbo Bio-Rad 1704155 
Mini Trans-Blot Power 
Supply 
Bio-Rad 1658033FC 
CFX 96 touch qRT-PCR Bio-Rad 10000068706 
Mini Protean Tetra cell Bio-Rad 1658003FC 
Bioanalyzer 2100 Agilent G2939BA 
Qubit® 2.0 Fluorometer Thermo Fisher Scientific 1104004846 
Bioruptor Diagenode UCD-300 
Gene Pulser II Bio-Rad 165-2105 
Luna automated cell counter Logos Biosystems CTM0011 
 
4.1.1.4. Analysis – software 
Name Manufacturer Version 
CFX Manager Bio-Rad  
LAS X Laica  
R   3.3.3 
RStudio   1.0.136 
Serial Cloner  Serialbasics 2.6.1 
Illustrator CS6 Adobe 16.0.0 
nSolver nanoString 2.6 
Integrative Genomics Viewer  2.3.72 
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Fiji (ImageJ) Wayne Rasband 1.48t 
 
4.1.2. Chemicals and enzymes 
Name Manufacturer Serial number 
Western Blocking Reagent, 100 ml Sigma-Aldrich 11921673001 
FastAP Thermosensitive Alkaline 
Phosphatase 
Fermentas Life Sciences EF0651 
PageRuler Plus Prestained Protein 
Ladder 
Thermo Fisher Scientific 
GmbH 
26619 
Histone H3 Antibody-100 µL Life Technologies GmbH PA531954 
Phusion High-Fidelity DNA 
Polymerase 
Fermentas Life Sciences F-530L 
Alexa Fluor 647 Goat Anti-Guinea 
Pig IgG (H L) 
thermo scientific A 21450 
Formaldehyde, 16%, methanol free 
20x10ml 
Polysciences Europe 
GmbH 
2637557 
Non-fat skimmed milk powder AppliChem A0830,1000 
Urea, MB Grade Merck Millipore 66122-500GM 
CoverGrip Coverslip Sealant Biotium 23005 
TEMED Electrophoresis reagent, 
25 ml GEB 
Thermo Geyer SA/T9281/000025 
GeneRuler 1 kb Plus DNA Ladder-
5 x 50 µg 
Life Technologies GmbH SMF-1082-5-BS 
L-Glutamine, 200 ml Sterile 
filtered 
Sigma-Aldrich Chemie 
GmbH 
G7513-100ML 
Laminin from Engelbreth-Holm-
Swarm Murine Sarcoma Basement 
Sigma-Aldrich Chemie 
GmbH 
L2020-1MG 
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Membrane, Aqueous Solution, 
1mg/ml 
Alexa fluor 488 Goat Anti-
Chicken 
Life Technologies GmbH A11039 
Alexa Fluor 488 Donkey Anti-
Mouse IgG (H L) Antibody 
Life Technologies GmbH A21202 
Poly-L-Ornithine Hydrobromide VWR International 114-15 
DMSO, Cell culture grade Genaxxon Bioscience M6323.0250 
recombinant mouse LIF Amsbio Amsbio AMS-263-100 
dNTP Mix, 10mM each Thermo Fisher Scientific 
GmbH 
11853933 
BD Matrigel GFR-RED. 
Phenolfrei 
Bioline 734-1101 
prolong Gold Antifade Mounting 
with DAPI 10mL 
Life Technologies GmbH P36931 
peqGOLD TriFast 100 ml 
DNA/RNA/Protein 
VWR Internat. GmbH 
(Peqlab) 
30-2110 
RQ1 RNase-free DNase Promega M6101 
Mini-PROTEAN TBE Gels, 5%, 
30 microliters 
Bio-Rad Laboratories 
GmbH 
456-5013 
Endura electrocompetent cells Lucigen 60242-1 
NuPAGE Novex 4-12% Bis-Tris 
Protein Gels, 1.0 mm, 10 well-10 
gels  
Life Technologies GmbH NP0321BOX  
Agencourt® RNAClean™ XP, 40 
mL 
Beckman Coulter GmbH A63987 
TGIRT™-III Enzyme Ingex TGIRT50 
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GSK-3 inhibitor Merck Millipore 361559-5MG 
StemMACS PD0325901 (10 mg) Miltenyi Biotec GmbH  
GlycoBlue Coprecipitant (15 
mg/mL)-5 x 3 
Life Technologies GmbH AM9516 
Bio-Rad Protein Assay Dye 
Reagent Concentrate 
Bio-Rad Laboratories 
GmbH 
500-0006 
Low Molecular Weight DNA 
Ladder 
New England Biolabs N3233 L 
Penicillin/Streptomycin 10.000 
E/10.000 
Biochrome A 2213 
D(+)-Saccharose für die 
Molekularbiologie 
AppliChem GmbH A2211 
Agencourt® AMPure® XP, 60 mL Beckman Coulter GmbH A63881 
Tris(hydroxymethyl)aminomethan
e molecular biology grade 
Serva Electrophoresis 37186.04 
SDS für die Molekularbiologie AppliChem A2263,0100 
RNase OUT Life Technologies GmbH 10777019 
 
4.1.3. Kits 
Name Manufacturer Serial number 
PLASMID MINIPREP DNA 
Purification Kit 
roboklon GmbH E3500-02 
NUCLEOBOND XTRA 
MIDI PLUS, 1 PAK 
Macherey Nagel MN/00740412/000050 
Lipofectamine 
messengerMAX 
Thermo Fisher scientific 
GmbH 
LMRNA008 
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Lipofectamine 2000 
Transfection reagent 
Thermo Fisher scientific 
GmbH 
11668019 
JetPrime Peqlab 13-114-15 
GeneJET Gel Extraction Kit 
250 rxn 
Life Technologies GmbH K0692 
Qubit dsDNA HS Assay kit 
500 assays 
Life Technologies GmbH Q32854 
Qubit RNA HS Assay kit Life Technologies GmbH Q32855 
Qubit Protein Assay kit 500 
assays 
Life Technologies GmbH Q33212 
TruSeq® Small RNA Library 
Prep Kit 
Illumina RS-200-0012 
TruSeq® Stranded Total 
RNA LT 
Illumina 20020596 
Bioanalyzer DNA1000 Agilent Technologies 5067-1504 
Bioanalyzer High Sensitivity 
DNA Kit 
Agilent Technologies  5067-4626 
Bioanalyzer RNA nano Agilent Technologies 5067-1511 
Bioanalyzer RNA pico Agilent Technologies  
Ribo-Zero Magnetic Gold Kit 
(Human/Mouse) 
Biozym Scientific GmbH 191845 
ERCC RNA spike ins Thermo Fisher scientific 
GmbH 
  4456740 
 
TranscriptAid T7 High Yield 
Transcription Kit-50 
reactions 
Life Technologies GmbH K0441 
mMESSAGE mMACHINE 
T7 in vitro transcription kit 
Thermo Fisher Scientific 
GmbH 
AM1345 
 
  
70 
 
Click-iT protein extraction kit Thermo Fisher Scientific 
GmbH 
C10416 
Poly(A)-Tailing Kit Thermo Fisher Scientific 
GmbH 
AM1350 
Phire Animal Tissue Direct 
PCR Kit 
Life Technologies GmbH F140WH 
MAXIMA FIRST STRAND 
CDNA SYNTHESIS KIT 
Thermo Fisher scientific 
GmbH 
K1642 
SensiFast SYBR no-rox 
2000xreactions 
BIOLINE BIO-98020 
Direct-zol RNA mini-prep kit Zymo R2052 
 
4.1.4. Buffers, solutions and media 
Media and solutions 
Name Manufacturer Serial number 
DPBS without Ca and Mg PAN Biotech P04-36500 
10x Tris/Boric Acid/EDTA 
(TBE), 1 L 
Bio-Rad Laboratories GmbH 161-0733 
MEM Non-Essential Amino 
Acids Solution, 100X 
Sigma Aldrich M7145-100ML 
100X Nucleosides, 50ml Merck Millipore ES-008-D 
Neurobasal(R) Medium (1X), 
liquid 
Life Technologies GmbH 21103049 
Fetal bovine serum 
embryonic stem cell 
Life Technologies GmbH 10828028 
Dulbecco's Modified Eagle 
Medium (D-MEM) 
Life Technologies GmbH 61965059 
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Opti-MEM I reduced serum 
Medium 
Life Technologies GmbH 31985062 
TrypLE Express (1X) Phenol 
red 
Gibco 12605028 
Knockout DMEM Life Technologies GmbH 10829018 
KnockOut Serum 
Replacement 
Life Technologies GmbH 10828028 
Fetal bovine serum Life Technologies GmbH 10270-106 
Advanced DMEM/F-12-10 x 
500 mL 
Life Technologies GmbH 12634028 
SILAC Advanced DMEM/F-
12 Flex Media 
Life Technologies GmbH A2494301 
N2 supplement 100x, liquid Life Technologies 17504044 
B27 serum-free supplement 
50x, liquid 
Life Technologies 17502048 
LB-Agar (Luria/Miller) 2,5 
kg 
Roth - Carl Roth X969.3 
LB-Medium (Luria/Miller) 
2,5 kg 
Roth - Carl Roth X968.3 
Cell culture media 
N1E Growth medium (555ml): 500ml DMEM, 50ml FBS, 5ml Pen/Strep (100x) 
  
N1E Differentiation medium:  500ml Neurobasal, 5ml Pen/Strep (100x)  
PUCK’s saline solution:  0,17 mM Na2HPO4, 0,22 mM KH2PO4, 20 mM Hepes, 138 
mM NaCl, 5,4 mM Ca2Cl, 5,5 mM Glucose, 58,4 mM Sucrose 
2i medium (420.85ml):  200ml Advanced DMEM/F12, 200ml Neurobasal, 4ml L-
Glutamine (100x), 4ml ßME (55mM), 4ml N2-supplement (100x), 8ml B27-supplement 
(50x), 50µl LIF (107 U/ml), 400µl GSK-3 Inhibitor (3mM), 400µl PD0325901 (1mM) 
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mESC medium (295.025ml): 250ml Knockout™ DMEM, 35ml ES-FBS, 2.5ml L-Glutamine 
(100X), 2.5 ml ßME (55mM), 2.5ml Non Essential Amino Acids (100x), 2.5ml Nucleosides 
(100x), 25µl LIF (107 U/ml) 
Feeder’s medium (277.5ml): 250ml Knockout™ DMEM, 25ml ES-FBS, 2.5ml L-Glutamine 
(100X) 
AK medium (595.025ml): 250ml Advanced DMEM/F12, 250ml Neurobasal, 5ml L-
Glutamine (100X), 2.5ml ßME (55mM), 75ml Knockout-Serum Replacement, 5ml Pen/Strep 
(100x) 
Monolayer medium (104ml): 100mL Advanced DMEM/F12, 1ml N2-supplement (100x), 
2ml B27-supplement (50x), 1ml Pen/Strep (100x) 
mESC Freezing medium (10ml):  5ml ES-FBS, 3.2ml mESC medium, 0.8ml 2i medium, 
1ml DMSO 
 
4.1.5. Oligos 
qRT-PCR oligos 
gene FW primer REV primer 
Bmper GCCTGGGATTACCTGCTGC ACACATTATGCAAGGGTTGTCTG 
Camk2b ACCACTACCTGATCTTCGACC CCGCCTCACTGTAATACTCCC 
Cdc42bpg GGCCTTGGCTACTAAGATGGC TTGGCACGGATCTCAGCTTC 
Col3a1 CTGTAACATGGAAACTGGGGAAA CCATAGCTGAACTGAAAACCACC 
Crtap CGCCGAACTACGCCTCTTC TGCTTCAGGAGATAGGTGTGA 
Dab2 CCTTCATTGCTCGTGATGTGA CCCCAAACAAATCCATCTGGTC 
Fbll1 CGAGGGCGTGTTCATCTACC CTGCCAATTTGGAGCGGAAG 
Gng3 GCACTATGAGTATTGGTCAAGCA GTGGGCATCACAGTATGTCATC 
H2AFY2 CGGTTGATGCGCTACTTGAAA CAATGACCGCAGCCATGTAGA 
H3f3a TGTGGCCCTCCGTGAAATC GGCATAATTGTTACACGTTTGGC 
Igf2 CCGAGAGGGACGTGTCTAC GTCTCCAGGTGTCATATTGGAAG 
kif1c GGAGCCTCCGTGAAAGTTG CCGAAGTATGCGACCAGTAAGA 
Lamb1 AGACCCGAAGAAAAGACAGGC CCATAGGGCTAGGACACCAAA 
ldlrap1 CTCAAGTACCTTGGTATGACGC CTGTAAATGGACACGTTCTCGAT 
Mbnl2 CCCAAAAGTTGCCAGGTTGAA CTGGGTTTTTAAGTGTGTCGGA 
Mme CTCTCTGTGCTTGTCTTGCTC GACGTTGCGTTTCAACCAGC 
Mov10 GAGGTTCGAGAGTTTTCTGGC TCGTGGTTGTAAATCGTCCGC 
Myo1c-1 GAGCAACCCCGTGTTAGAGG ACTTTTCCAGGAGGTAACTGAGA 
Myo1c-2 ATGGAGAGCGCCTTGACTG TCGGTAGGGATTGACAGAGAC 
Nid2 CTCTTTCCTTACGGGGAGTCG GGCATCGTAGAAACGCAGG 
nucleolin AAAGGCAAAAAGGCTACCACA GGAATGACTTTGGCTGGTGTAA 
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Nup210 GTGACGCCATCGTTGATCTCA GTCCAGTCGAAGACCAGTCC 
Nxf7 ATGTGCTCTAATGAAAGGAAGCA GCTCAGGGAAGAAACCCTGT 
pura ATCCGCCAGACAGTCAACC TCCACTCCATAGTCGTCGATG 
Rbm17 TGAAGGCTGGTCCAAAAACTT CCGGAGCAAGCACTGTACT 
RBM47 GCCATGAACAGCGATCCAAC CCGGTGCGCTCTATCAGTG 
18S rRNA AAACGGCTACCACATCCAAG CCTCCAATGGATCCTCGTTA 
St3Gal6 GGGGAACAAATGGCTATTGGT AGGGCAACGGAAAATTATTGGT 
Stx3 GAAGGCACGGGATGAAACTAA GGACAGTCCAATAATCAACGCTA 
Tagln CCAACAAGGGTCCATCCTACG ATCTGGGCGGCCTACATCA 
Tpt1 CATCAGCCATGACGAGCTGTT CTCTGTTCTACTGACCATCTTGC 
Tubb3 TAGACCCCAGCGGCAACTAT GTTCCAGGTTCCAAGTCCACC 
Vangl1 GATACCGAATCCACGTATTCTGG TCTGCCATCTTTATTCCTTGGTG 
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RESA amplification oligos  
RESA # SEQUENCE_ID PRIMER_LEFT_SEQUENCE PRIMER_RIGHT_SEQUENCE 
1 
Kcnk12-ENSMUSG00000050138-
ENSMUST00000055221 CTCCAGGTAGAGCGGCCG AAGAAAGCGCCATCTCGGAG 
2 
Hspg2-ENSMUSG00000028763-
ENSMUST00000030547 CTCATAGGCACCCACCTGC TCCCTCTAGGACCCAAGAGC 
3 
Myo1d-ENSMUSG00000035441-
ENSMUST00000041065 TGACTGCTGCACATCAGAGG CAGTCACACCCCGAATTCCA 
4 
Hapln3-ENSMUSG00000030606-
ENSMUST00000032827 AGGCCTAGACTGGTGCAATG ATCCAAGCAATCCCCCAACC 
5 
Mfge8-ENSMUSG00000030605-
ENSMUST00000032825 TAATGCTCAGTCCTGCCAGC GTAGCAAGCCAGCAGAGGTC 
6 
Gm2399-ENSMUSG00000078141-
ENSMUST00000104944 GGTCTATGTGAGTTGGGGCC ACTAGCCAGCAAAGGGTGAG 
7 
Fam129b-ENSMUSG00000026796-
ENSMUST00000028135 CCTCCAGGCTTCTGTTGGAC ACCCCCAAGGCACTAGAGAA 
8 
Mov10-ENSMUSG00000002227-
ENSMUST00000106774 TAGCAAGTTCAGCTGCCGAA GCTTTCTTCCTCCCCCTTCC 
9 
Snai1-ENSMUSG00000042821-
ENSMUST00000052631 CATCCTCGCTGGCATCTTCC AAACATCTTTCTCCCGGGGC 
10 
Smtn-ENSMUSG00000020439-
ENSMUST00000170588 AAGTCCTAACCCCTGCTTGG CAAAACGCTGCGTGTGTACA 
11 
Tmem109-
ENSMUSG00000034659-
ENSMUST00000038128 AGAAGAGTGACAAGGGCGTC ACTGCAGCCATGATTCCACA 
12 
Jph2-ENSMUSG00000017817-
ENSMUST00000109425 CTACCAGTGCCAGGAGTTCC TTGGCATCCTGAACCCATCC 
13 
Arhgap10-ENSMUSG00000037148-
ENSMUST00000076316 CTCCTGTAGCTCCCGGCC TTTACAGAGGGGCCTTGTGG 
14 
Stard10-ENSMUSG00000030688-
ENSMUST00000164479 GGCTCTCTGCAAGGACCAAG TGGGGCTGTGTGGTTCATTT 
15 
Gpx3-ENSMUSG00000018339-
ENSMUST00000125094 GTACCACTGATGCCCCCAC ACCCTCTCTCAGCCCTCAAT 
16 
Gaa-ENSMUSG00000025579-
ENSMUST00000106259 GTCCTAGGAGAGTCCGTCGT 
ACACTTCACAGTAAGTTTCTC
GAGT 
17 
Pde1b-ENSMUSG00000022489-
ENSMUST00000023132 GATTAGGGAACTGGGGGCTG GGAGTCACATGCGGTTCAGA 
18 
Fkbp10-ENSMUSG00000001555-
ENSMUST00000001595 TCTGAGGGCCAGAGTGTCAG TTTGAGTCCAAGACCCTGCC 
19 
Dusp9-ENSMUSG00000031383-
ENSMUST00000019701 CACATAAAGCCGCATGGAGC CACAGGTATTGCCAGCTCCA 
20 
Tln1-ENSMUSG00000028465-
ENSMUST00000030187 TTAATGCAGACCCAGCCCAG TGGAGTCTGACCTGTTTGGG 
21 
Dnaaf1-ENSMUSG00000031831-
ENSMUST00000093100 GACTGAACCCCAAGGCAGTC GGATATTCCCGAGAGCTGGC 
22 
Emilin1-ENSMUSG00000029163-
ENSMUST00000031055 ACAGGTGTAGACAGGGTGGA 
TCCTGAATAGTTTAGTACGGT
GGT 
23 
Arfgap1-ENSMUSG00000027575-
ENSMUST00000029092 TAGGAGCCTAGCACCCTAGC TGCACTGCTGGTCAAACTGA 
24 
Rab3il1-ENSMUSG00000024663-
ENSMUST00000121418 CCCAGGCCTGAAGTAAGCTC GCACGAGGCCAGTTAGGAAA 
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25 
Itga5-ENSMUSG00000000555-
ENSMUST00000023128 CCTGAGCCCTCCTGATCTCA 
AGGGTTGGCTAGGGAGAGA
G 
26 
Necap2-ENSMUSG00000028923-
ENSMUST00000030760 GCACAACCTTTTCCTCAGCC TCTGGTCACACAAGGTCAGC 
27 
Anxa6-ENSMUSG00000018340-
ENSMUST00000108883 
AGAGGACTAAAGCTCCTGACC
T CAAAGCTCAAGTCAGGCAGG 
28 
Csrp1-ENSMUSG00000026421-
ENSMUST00000097561 CTCAGAGTGAGGCTGCCAC TCAACAGCCCATGCCTACAG 
29 
Plod1-ENSMUSG00000019055-
ENSMUST00000019199 CGATCCCTAACTGCCCAGTG CAGTGACAGGTAACGCAGGT 
30 
B4galt5-ENSMUSG00000017929-
ENSMUST00000109221 TGAGATGCGAAGAGAAGCCG GCTCTGTGCTGTCCTCTGAG 
31 
Cdc42bpg-ENSMUSG00000024769-
ENSMUST00000025681 CTCCCCCTGATGCCCTCT TCTTTCACTCCCCACCCTGT 
32 
Itgb5-ENSMUSG00000022817-
ENSMUST00000115028 TGGACTGAGGCTCCTGGATG 
ACGATCAACTGGAAAAAGCC
A 
33 
Tinagl1-ENSMUSG00000028776-
ENSMUST00000030560 CTAGGCGAGGTGGGATCCA 
AGTGAGGGCCTAGAGAAGG
G 
34 
P2rx5-ENSMUSG00000005950-
ENSMUST00000006104 GCTCTTGGCAGGGAACAGAT CATCAAGGCTGGGCTTCTGA 
35 
Rcn3-ENSMUSG00000019539-
ENSMUST00000019683 TGAGCTCTGATCCCCATGTC AGGCAGGACAGGTTAGCTTG 
36 
Ldlrap1-ENSMUSG00000037295-
ENSMUST00000037828 GGGGAGAGGGGGAGAAAGAT CCCAAAAGCAGAGCTACCGA 
37 
Naga-ENSMUSG00000022453-
ENSMUST00000023088 AGAATGACAGGCTACGGCAG TAGCGACCTGAGGGAGCTAA 
38 
Lmf2-ENSMUSG00000022614-
ENSMUST00000023283 AAATAGCGTCGTGTGCTACCA 
ATGGAGAACATTGAGCTACA
AGGA 
39 
Slc29a1-ENSMUSG00000023942-
ENSMUST00000167692 CCTGTGGGGACAGAAGAACT CCTCTGAAGGCACCTGGTTT 
40 
Wars-ENSMUSG00000021266-
ENSMUST00000160477 CAGAGCAGCTGTCCAGTGAA CCCTTGTGCCTTCAGAGAGG 
41 
Pdgfrb-ENSMUSG00000024620-
ENSMUST00000115274 GACATCACTCCATTTTGCCCG TCCGGTGTCTAAATGTGGGT 
42 
Kcng1-ENSMUSG00000074575-
ENSMUST00000109191 GTCCTCCCTCTAAGCCCAGA GGCTCTATCGCTTCTGGTCC 
43 
Lgi4-ENSMUSG00000036560-
ENSMUST00000039775 AAAGACCCTGGAAGTGGCTG 
GGGGTAACAGTCACGAGTG
G 
44 
Ccdc134-ENSMUSG00000068114-
ENSMUST00000089174 GAGTTGTAGCCCTGGACCAG CAATGAAGGCACAGCACAGG 
45 
Myh9-ENSMUSG00000022443-
ENSMUST00000016771 GAGCTTCTCCTGCAGCCC ACTGTAGTGGTGACAGCTGC 
46 
Fxyd3-ENSMUSG00000057092-
ENSMUST00000167369 CAGGTGCCAGAGACTCTGTG TCAAGCCAACATGACCTGCT 
47 
Slc13a5-ENSMUSG00000020805-
ENSMUST00000021161 TTAGGAAGAGCCGCAAGAGC GCAAGCCTTCAACAGTGTGG 
48 
Egfl7-ENSMUSG00000026921-
ENSMUST00000139801 
AGAACAGAAACTGCAGTTGGT
G GAGTTCTTTCTCCGGGCTCC 
49 
Egflam-ENSMUSG00000042961-
ENSMUST00000160207 GACATCAAGCTGGGAGCCTT AGCTACAAAATCAGGGGGCC 
50 
Tead4-ENSMUSG00000030353-
ENSMUST00000006311 TTGGAGAGCAATGGTAGGGG ACATGTGGATGTGCTCAGCA 
51 
Myh6-ENSMUSG00000040752-
ENSMUST00000081857 TAACCTCTCCAGCAGACCCT TGGACTTGTGCCTAGCTGTG 
52 
Erp29-ENSMUSG00000029616-
ENSMUST00000111802 GGCCCTTAGAGCTCTGGACT GCCATCCTGTCCCTGTTTCA 
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53 
Stat3-ENSMUSG00000004040-
ENSMUST00000103114 ATCTTTGGGCAATCTGGGCA ACTGGGCTGTGTGATGGATG 
54 
Slc12a4-ENSMUSG00000017765-
ENSMUST00000034370 TATTCCTGAGCCCCGATGGA GCTCCATTCCACTTGGCTTG 
55 
Mettl7b-ENSMUSG00000025347-
ENSMUST00000026398 CTCTCCCCAAGGATGCCATC GGCTGCTTTATTGAGTGCCG 
56 
Stra6-ENSMUSG00000032327-
ENSMUST00000170397 AACCACATCACCCTGCCTTT 
GGAATGTTCCTCAGAGGCAC
A 
57 
Plekhg3-ENSMUSG00000052609-
ENSMUST00000075249 AAGGAGAGAACAGCCACGTG GTGTGTCCATTGGCAACCAC 
58 
Des-ENSMUSG00000026208-
ENSMUST00000027409 AGGAATTCAGTGTCCTGGCC ACCCTTCCATTTCCCCTAACT 
59 
Tmem88-ENSMUSG00000045377-
ENSMUST00000050140 TGGGTCTGAGGTGCTTAGAGT GGTACCAGGACACCACATCG 
60 
Fgf3-ENSMUSG00000031074-
ENSMUST00000155320 CACCTGGAAAGCCCTCTGAG CAGTCCCCTATTCCTCCCCA 
61 
Hyou1-ENSMUSG00000032115-
ENSMUST00000161318 TATAACCCCAGCTCCTGCCT CCAACCAGCCTGAACTGCTA 
62 
Tagln2-ENSMUSG00000026547-
ENSMUST00000111230 ACTCTCTCTCCTTCCCCTGC AACTCGTGTTCGTCAAGCCC 
63 
Emilin3-ENSMUSG00000050700-
ENSMUST00000057169 GGATCGATGCACAGAAAGCG GGGCAAACACTGAATGCAGG 
64 
Pbxip1-ENSMUSG00000042613-
ENSMUST00000038942 CCCTGCACTGGTACCACTTT GACATGGAAACCAGAGGCCA 
65 
Hkdc1-ENSMUSG00000020080-
ENSMUST00000020277 GGACATCTAGGTGGCCCAG 
AATGCAGAAAACAGCGACAC
C 
66 
Yap1-ENSMUSG00000053110-
ENSMUST00000173264 
TCCGATCCCTTTCTTAACAGTG
G TATCTAGCTTGGTGGCAGCC 
67 
Ldlr-ENSMUSG00000032193-
ENSMUST00000034713 GAGCCGTCTCTTTCCGGGAT CTCAAAGCAACGCACAGGAC 
68 
Lrrc38-ENSMUSG00000028584-
ENSMUST00000052458 AGATGACTGAGCCACCTCCT GCTTCTATTCCCCCTCAGCC 
69 
Col4a2-ENSMUSG00000031503-
ENSMUST00000033899 GAATCTGTGAGGCTCCCGC TGACACAGGTTGTAGGACGC 
70 
P4hb-ENSMUSG00000025130-
ENSMUST00000026122 
TGTAGTGCAGAAGCCAGATCT
G TTCATTCAGCCCCAGTGTCC 
71 
Lrpap1-ENSMUSG00000029103-
ENSMUST00000030986 CTGATCCTACAGTGGCTGGC TGTGAACCCATGTGCCGTAG 
72 
Chst15-ENSMUSG00000030930-
ENSMUST00000077472 GAGCTGAGTCCCTTCTGCAG TCACCCAAAACACTGCCTGT 
73 
Cndp2-ENSMUSG00000024644-
ENSMUST00000025546 CAGTTTCCTCGGAGTGCTGT TAGCTGCAACTGGACTGGTG 
74 
Hdlbp-ENSMUSG00000034088-
ENSMUST00000170883 AGAAACCTTTCCAGCCTGCT GCCCTAGGCTCCTCAACATC 
75 
Susd2-ENSMUSG00000006342-
ENSMUST00000095541 AGAGCACACTTGGCTGACAG GGCAGGGCTCAAACTCTGAT 
76 
Syne3-ENSMUSG00000054150-
ENSMUST00000095439 GCACAGGTGACCTTCTGCA AGACACGCCCACATTCGTAG 
77 
Adamtsl4-ENSMUSG00000015850-
ENSMUST00000117782 TTGAAACGGGTCCCAGAGAC CTTCTGGGGTGGGCATCATT 
78 
Fbxo2-ENSMUSG00000041556-
ENSMUST00000047951 CCCTGAACGACCTCCCCTA ATTGAGTGCCCACTTTGAGG 
79 
Pdzd3-ENSMUSG00000032105-
ENSMUST00000034618 AGGACATCCCTGTTCAGCCT 
TAAAGTGCTCACAAAGAGGT
CAGA 
80 
Flnb-ENSMUSG00000025278-
ENSMUST00000052678 GCCAATGCTGGACGTGTCC CGGTCTCCGTGTCTATTCCG 
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81 
Adam19-ENSMUSG00000011256-
ENSMUST00000011400 TTCTTACCCGAGTGCCTCCT 
GGACATGAGAGGGGAGGAC
T 
82 
Lipg-ENSMUSG00000053846-
ENSMUST00000066532 CAAGAAGTCCTGGCGTCCAC 
ACAAAGCTTCAAGCCAAATG
GA 
83 
Rrbp1-ENSMUSG00000027422-
ENSMUST00000016072 TGAGTCTCCTCGGCAAACTG ATGGCATTGACATCCAGGCA 
84 
Myo1e-ENSMUSG00000032220-
ENSMUST00000034745 GAAACTGACACGTGGGCAGA 
GAAGTAAGGGAGGACGGCA
G 
85 
Tmed3-ENSMUSG00000032353-
ENSMUST00000058488 CTCCTAGCCTCGAAGTCCCT CACAGTTCTGCCTCCAGGAG 
86 
Timp2-ENSMUSG00000017466-
ENSMUST00000017610 GGACCCGTAAGAAGGCTGAC TGAGTTATGCAGCAAGCCCA 
87 
Icam1-ENSMUSG00000037405-
ENSMUST00000086399 GAGCCTGCTGGATGAGACTC CAGCTTGCACGACCCTTCTA 
88 
Plod3-ENSMUSG00000004846-
ENSMUST00000004968 CCCCTGACACTCAACCAGTC ATTTGTGCATGGTGGGAGGC 
89 
Actn4-ENSMUSG00000054808-
ENSMUST00000068045 CTTGGCCACCCTGAACAGAG TAAACTCAAGGGGGCGAGTG 
90 
Flna-ENSMUSG00000031328-
ENSMUST00000114299 TGAGCCTGCCACCTAAGTTG TCACAGGACAACGGAAGCAA 
91 
Adgre5-ENSMUSG00000002885-
ENSMUST00000075843 GGATGTGAAGGCGAGTTCCA 
TGTGTGTCAACATTGAAAGG
TTT 
92 
Itgb3-ENSMUSG00000020689-
ENSMUST00000021028 ATGTGTGTGACGAGTGTGGG GAACAGAGCTACCTGCCAGG 
93 
Kank2-ENSMUSG00000032194-
ENSMUST00000034717 TACAGGGAGGAGCCAGTGAG GCCCCGACAGAGAAACAGAA 
94 
Lmna-ENSMUSG00000028063-
ENSMUST00000029699 GTAATCTGGGACCTGCCAGG 
AGGTGCAGATGGGAAATGG
G 
95 
Gns-ENSMUSG00000034707-
ENSMUST00000040344 GGCTGACCCTGTTTCTCCTC CAGTGAACAGGGTCCGTTGA 
96 
Cdh5-ENSMUSG00000031871-
ENSMUST00000034339 TAGGGTTCTGGTCTTTGGGC 
GTACATCTCATGCACCAGGG
T 
97 
Tax1bp3-ENSMUSG00000040158-
ENSMUST00000040687 AGTCAGCCACCGTCTAGACT GCAGGGGACAAGTTAGCCAT 
98 
Podxl-ENSMUSG00000025608-
ENSMUST00000026698 CTCTGATCTGTCTGCTGGCC AGAAAGGCCCCCACAAAACA 
99 
Adamts15-
ENSMUSG00000033453-
ENSMUST00000065112 GGGGAGACGCTTCAACAGAA TTAGGAGGAGGTCGCTGTCA 
100 
Cnn2-ENSMUSG00000004665-
ENSMUST00000004784 CACCCAGCATGCCAGCTC GATGTGGGACCTCAGGCAAA 
101 
Pdlim7-ENSMUSG00000021493-
ENSMUST00000155098 GAGATTGCCACCCTACTCCG CACACTGTTGCTAATCTGGCA 
102 
Cemip-ENSMUSG00000052353-
ENSMUST00000064174 AGTGTTGGCCGATGCTACAA CTGATGTCCTTGGCTCTGGG 
103 
Psd4-ENSMUSG00000026979-
ENSMUST00000102942 TTTGTCCCCCATGCACTCTC AGCTTGGTGGAAGACTGCTC 
104 
Fosl2-ENSMUSG00000029135-
ENSMUST00000031017 CTTAGAAGCCCTGGGACACG 
CGAGAACAAACCCGAGGGA
A 
105 
Vangl1-ENSMUSG00000027860-
ENSMUST00000159388 GACTTCAGCCTCGTGGTCAA TGGTTCGTGGAATGCACAGA 
106 
Gmppb-ENSMUSG00000070284-
ENSMUST00000047947 GAAGGATATGGAGGGCTGGC 
ATTATTCCAAACAGCCCTGG
G 
107 
Cnn1-ENSMUSG00000001349-
ENSMUST00000001384 GGCTGGCTGCTGCTCTTG GATGATGGTAGTCCCGGCAC 
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108 
Cgnl1-ENSMUSG00000032232-
ENSMUST00000072899 GACAAAGCCCCATTGTGCAC TCCCATGGAGGTAGCTGTGA 
109 
Pttg1ip-ENSMUSG00000009291-
ENSMUST00000009435 AGTTCTAAGGTGGCTGGCAC GTTCTGTGGCTTCATGCTGC 
110 
Slc7a1-ENSMUSG00000041313-
ENSMUST00000048116 GACTATCCCAGCGAGGAAGC GAGGGGTCTTGCCAGTGTAC 
111 
Ppfibp2-ENSMUSG00000036528-
ENSMUST00000098134 CTGTCCCTGATGCTGGTGAC TGCTGAAGGGCAAAGTGGAT 
112 
Copz2-ENSMUSG00000018672-
ENSMUST00000018816 
TTGAAATGAAGACCTTGGAATC
AA AGGCCTAGGACTGAGGATGT 
113 
Col5a1-ENSMUSG00000026837-
ENSMUST00000028280 CTAGGCTAGGAGCTGCTGAG TGTACCGTTTGGCCTGGAAT 
114 
Epha2-ENSMUSG00000006445-
ENSMUST00000006614 GCCGTGCCCAACAATACTTG 
TCAGTTTGAACCATCTGCAAC
T 
115 
Chst14-ENSMUSG00000074916-
ENSMUST00000110837 AATGACAGTAGGCCAGCACC 
TGCATTAGACAAGTGACAGC
CA 
116 
Slco3a1-ENSMUSG00000025790-
ENSMUST00000098371 GCTGAGGGCTGCTCTCTTAA ACAGACTACCACACGCAGAA 
117 
Htra1-ENSMUSG00000006205-
ENSMUST00000006367 GCAGGAGCCAGACTTCATGT AGTCACTGTACTCCGGGTTC 
118 
Fbln1-ENSMUSG00000006369-
ENSMUST00000057410 CTGGTTCTGAGGGCAGGTTG TGACATCCTGCCTCGTCATG 
119 
Eml3-ENSMUSG00000071647-
ENSMUST00000096241 GCTGGATGGTCTTGTCCCTC CACCGAGCAGAGGGTGTC 
120 
Ccdc102a-ENSMUSG00000063605-
ENSMUST00000077955 TGGCCTAGGACATCCAGGG 
AAGTCTGAGTTCATGTTCATG
GT 
121 
Krt13-ENSMUSG00000044041-
ENSMUST00000007275 ATTAACTCAGCCTGGCGTCC 
TGTAGAGACACTGAGAAGCC
A 
122 
Tmc6-ENSMUSG00000025572-
ENSMUST00000026659 TCACCATGATCCTGCAAGCA TGCACACCTCTGGTTTCAGC 
123 
Loxl2-ENSMUSG00000034205-
ENSMUST00000100420 
ACAGTAAAGAAGATCCTGGGC
C GGAGTTCAGCCCGATCACC 
124 
Wdr1-ENSMUSG00000005103-
ENSMUST00000005234 CTCACCCCAAGGACCGAATC TGCAAGGGGAGGGATTGTTC 
125 
Mydgf-ENSMUSG00000019579-
ENSMUST00000019723 TCAAGGGCCTTCATGTCCAC ATGGTTGTGAGCCACCATGT 
126 
Fhl3-ENSMUSG00000032643-
ENSMUST00000038684 GGCCCCTGAGTGGAGGAT 
AGGGCAACATGGAGCTGAA
A 
127 
Colgalt1-ENSMUSG00000034807-
ENSMUST00000047903 CAAACAGCCAAAGCCACTGC GGCAAGCAGTCATCCCAAGA 
128 
Serpine1-ENSMUSG00000037411-
ENSMUST00000077523 TTGACAGTGGGAAGAGACGC CCCTATGGGTACACGGTGTG 
129 
Cd248-ENSMUSG00000056481-
ENSMUST00000070630 TGTGTGATGGGGTGCAGATG TGAGGTTGGCACCCCATTTA 
130 
Lamc1-ENSMUSG00000026478-
ENSMUST00000027752 TAGTGGCGAGAGGGCTGTAA 
GCGGGGGAGGGATAAAACA
A 
131 
B4galt1-ENSMUSG00000028413-
ENSMUST00000030121 TTTACCCACAACCTGGCTCG ATGCCAAGGTCAGAGACAGC 
132 
Rassf3-ENSMUSG00000025795-
ENSMUST00000026902 CACAAGGGACTCCACAAGCT 
CCAGACACAATTTCAGGGGA
GA 
133 
Arpc1b-ENSMUSG00000029622-
ENSMUST00000085679 AGACTAGACTGCTGCCCTCA ATCAGGGCCTAGATGTCCGT 
134 
Car12-ENSMUSG00000032373-
ENSMUST00000071889 CCTGGCAGTCTCAGACATCC TGGATACTTCCTCAGGGCCA 
135 
Bag2-ENSMUSG00000042215-
ENSMUST00000044691 CCTTCAAATTCACCGGCCCT TCCTTTGGCCTGATGAACCC 
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136 
Rab13-ENSMUSG00000027935-
ENSMUST00000107373 CTTGCCTCCTATTCACCCTGA 
AGCAGCTAACAGTACCCAAC
A 
137 
Calr-ENSMUSG00000003814-
ENSMUST00000003912 TGAGCTGTAGAGGCCACACC ACCTGATGGCTACTCTCCCA 
138 
Sdc4-ENSMUSG00000017009-
ENSMUST00000017153 TACGCATGAAGCTTCCTCCC 
GGCACCAAGGCTAGAAGAG
G 
139 
Glipr2-ENSMUSG00000028480-
ENSMUST00000030202 AAGTAGCTCTCGCCAGCAAG AACAAAGACCAGCCAGCCTT 
140 
Tex264-ENSMUSG00000040813-
ENSMUST00000163441 
TGAGGAGTAATGATAAGCCCT
CA ATTCTGGGTTCTGGAAGCTCC 
141 
Adrb3-ENSMUSG00000031489-
ENSMUST00000081438 GTGAAGGGCCGTGAAGATCC TGAACCCTGGAATTTCCCCC 
142 
Dock5-ENSMUSG00000044447-
ENSMUST00000039135 CTGACTTTGCACCTCCGAGT 
GGAGGAGCTGTCAGTAGGG
A 
143 
Anxa2-ENSMUSG00000032231-
ENSMUST00000034756 TGAAGGGCTCAGCACAGTG ACGGTTTATTCACGACACAGT 
144 
Mbtps1-ENSMUSG00000031835-
ENSMUST00000098362 AGCCAGCCACAGAAGCTAAC 
ACGGTGAAATCAAGATCCCC
A 
145 
Trim25-ENSMUSG00000000275-
ENSMUST00000107896 GGCTGCTAGTTACTTGGGCA AGGGCAAGGTCTAGATGGGT 
146 
Col1a1-ENSMUSG00000001506-
ENSMUST00000001547 CGTGTAAACTCCCTCCACCC GTGGTGCTCTGAAACCCTGA 
147 
Lgmn-ENSMUSG00000021190-
ENSMUST00000021607 TGAACAGCTCGCTTCCCAAT CCATAGGGGCTTGCTTTCCA 
148 
Lima1-ENSMUSG00000023022-
ENSMUST00000073691 TGAAGAATGACCGGCCGC CACCCCGCCATACACATCAT 
149 
Sparc-ENSMUSG00000018593-
ENSMUST00000018737 TAAGTTCACGCCTCCTGCTG 
TGAAATGCTTGGAGGGGAAC
A 
150 
Pxdn-ENSMUSG00000020674-
ENSMUST00000122328 GCCTTAGTGTTCCCGAGCTT CCCAATGCAGTGGCTAGTCA 
151 
Cyr61-ENSMUSG00000028195-
ENSMUST00000029846 GTTCCTAGTGTGGGCTGGAC CCTCCCTCCCCAAAAGCTAC 
152 
Gria1-ENSMUSG00000020524-
ENSMUST00000036315 AGCAGACAGGAAACCCTTGG GCCCAGGTACCAAAGAGCAA 
153 
Ptk6-ENSMUSG00000038751-
ENSMUST00000016511 CTGGTCTGAGCTCCTTGGAC TGCTTCACAAGTGCTGGGAT 
154 
Mobp-ENSMUSG00000032517-
ENSMUST00000174193 AGAAGTGACCGAGAAGGGACT ACGCGACTCAGTGACGAATT 
155 
Stxbp2-ENSMUSG00000004626-
ENSMUST00000160708 TTGCCTCTGCCCTCTCCTAT 
AGACACACCAGAAGAGGAC
G 
156 
Parva-ENSMUSG00000030770-
ENSMUST00000106643 TGTGGAGTGAGACCCTGGG CCCTACTTCTCAGGCGATGC 
157 
Myh11-ENSMUSG00000018830-
ENSMUST00000090287 GAGCCACCAGGAGAGGAAAC TGAAAGTGACCATGGGTGCA 
158 
Ripk1-ENSMUSG00000021408-
ENSMUST00000167374 CTCTGGCAGTGGGAAGCAA TCAGTGTTCTGGTGGCCATC 
159 
Efemp2-ENSMUSG00000024909-
ENSMUST00000165485 ACCTTCTGAAGACCCTCAGG 
TTTAAGCAGAACGGTCATCC
CT 
160 
Kit-ENSMUSG00000005672-
ENSMUST00000144270 CCAAGTCCAACAGGCTTTGC TTCAGGGACTCATGGGCTCA 
161 
Elmo3-ENSMUSG00000014791-
ENSMUST00000109375 AGCCGTGACTCAAGTTAGGC 
ACTGGCACTTTCTCCAAAGG
A 
162 
Hspb2-ENSMUSG00000038086-
ENSMUST00000042790 CTGACTGCCAGCGATAGACC GGTTTATTCAGCCCCACCCA 
163 
Plac9a-ENSMUSG00000095304-
ENSMUST00000052286 CTGACTTCCAGGGATGGTGG 
ACATATGTGTGTGTGTGTGT
ATTT 
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164 
Pla2g12b-ENSMUSG00000009646-
ENSMUST00000009790 AAGAGAAGGTGGCTCTTCCAG TGTGAGGTGTCAACTGGCAA 
165 
Tnfrsf10b-ENSMUSG00000022074-
ENSMUST00000022663 GTGCGTTTGAAGTCAGCCTG CCACTGCTCTTAACCGCTGA 
166 
Mcc-ENSMUSG00000071856-
ENSMUST00000089874 GCACTCTGGCACCAAAGTTG CGGGCTCTTGAAGGTAGGTG 
167 
C2cd4a-ENSMUSG00000047990-
ENSMUST00000054500 TGCTATGAGCGCGGCTTC GACTGAAACAAAGCCCTGGC 
168 
Tagln-ENSMUSG00000032085-
ENSMUST00000034590 TTAGAAAGGGAAGGCCAGCC TTTCTGCACAGCTTTCCAAAA 
169 
Gucy2g-ENSMUSG00000055523-
ENSMUST00000069183 
TCTCAAGATGTTTGTAGAGCCC
C AGCAACCATATAGGCTGGGG 
170 
Bmp8a-ENSMUSG00000032726-
ENSMUST00000040496 GCATCCTGCTTCTACTACCTT CTCCCGAGACAGGCTCTTTC 
171 
Impa2-ENSMUSG00000024525-
ENSMUST00000025403 CACACACAGCTCGAAGGCTA CGTGGGCTTCGATAAAGGGT 
172 
Slco2b1-ENSMUSG00000030737-
ENSMUST00000032985 CTGGCCTTGCTTGCTCTTTG AGAGTCTCATCCCCGAGAGA 
173 
Lpin1-ENSMUSG00000020593-
ENSMUST00000111067 GAGAGGCTGCATCTCATCCC CTGTCTGTCTAGCCAGCACC 
174 
Rem1-ENSMUSG00000000359-
ENSMUST00000000369 CTCTCTCTGGGGTGATGGGA GTCTGAGACATCTGGGCCAG 
175 
Sox7-ENSMUSG00000063060-
ENSMUST00000079652 GAGCTGGAGGAATGGAGCC 
TGCCTGTGATAGTGTTTCACG
A 
176 
Mettl21b-ENSMUSG00000080115-
ENSMUST00000116231 GTCTCAGTGGAGGAATGGCA ATGAGTCCGGACACACACAC 
177 
Pik3cb-ENSMUSG00000032462-
ENSMUST00000136965 GCAGATATGGCCCAAACTGC TGAAGTCACGGGGCAAGTAC 
178 
Pacsin2-ENSMUSG00000016664-
ENSMUST00000056177 TATCCAGTGACAGCCCATGG 
AGGACTTGACAGCTTTTGGT
CA 
179 
Cers2-ENSMUSG00000015714-
ENSMUST00000015858 TGACTGAACCATTGTCCTAGCT TTGGTCTGAAATGGTCCCTCG 
180 
Crtap-ENSMUSG00000032431-
ENSMUST00000084881 GTCCACAGGGGCTAAGGAAC 
CAGGGATGAGAAAGCAGAC
CA 
181 
Dock8-ENSMUSG00000052085-
ENSMUST00000025831 AAAAAGCCACCTTTGCCGGT AGGTCACTCATGCCCAATGG 
182 
Serping1-ENSMUSG00000023224-
ENSMUST00000023994 CAGGGGTTGAGACAGGCTTG 
GGTTTGAACCGTAAAAGCTG
CA 
183 
Bgn-ENSMUSG00000031375-
ENSMUST00000169489 AAGAAGTAGAGGCAGTGGTTG ACCTCATAAGCAGCACTCCC 
184 
Prrc1-ENSMUSG00000024594-
ENSMUST00000025490 CATGTGAGAGCAGTGCGGG AGTGTGTGGCAGTACAGAGC 
185 
Trpv1-ENSMUSG00000005952-
ENSMUST00000102526 GGACACCATGAAGCAGCTGA TTAGCACTGCACAGAGTGGG 
186 
Asb17-ENSMUSG00000038997-
ENSMUST00000044089 AGCATGCATCTCTACACTGTCC CACTTCGGAGGCAGAGACAG 
187 
Lifr-ENSMUSG00000054263-
ENSMUST00000067190 ACCAGGTCACCCTTTGTCAC AGAACGCCAGATAGCTGCTG 
188 
Pvr-ENSMUSG00000040511-
ENSMUST00000043517 CGGTGCTGGGTAGACAGAAC TTGCATGTGGGAGGGCTTAG 
189 
Sord-ENSMUSG00000027227-
ENSMUST00000110551 GATCTATGCCCTCAGCCCAC CTCAGGTCTGGGCCATGATC 
190 
Stard8-ENSMUSG00000031216-
ENSMUST00000036606 GCTGACATTGCCAGGTGTCT GGGAGTAGCTGTGTGTGCAT 
191 
Fabp3-ENSMUSG00000028773-
ENSMUST00000070532 CTGCTCCGTCACTGACCG GGTGGCCTTGGTTCTGCTTT 
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192 
Lars2-ENSMUSG00000035202-
ENSMUST00000038863 TAGGACCCTCCTTCTCTGCC 
TCCCTGGTAGTTCTTTGAGAC
A 
193 
Baiap2l1-ENSMUSG00000038859-
ENSMUST00000055190 CGATGAAGATGCAGGGGACA TGGTTCCTGTACTCGTGTGC 
194 
Fbxo6-ENSMUSG00000055401-
ENSMUST00000105706 GTTAGTGGGCAGTCAGGCTC ATCGAAGCTGCCCTGAGAAG 
195 
Serpinh1-ENSMUSG00000070436-
ENSMUST00000094154 GTCCAAGAGTGGGCGTGG 
TCTGCTTTCACACACCTATAA
CA 
196 
Hmox1-ENSMUSG00000005413-
ENSMUST00000005548 AAATGCAATACTGGCCCCCA 
ACACAGAAGTTAGAGACCAA
GGT 
197 
Patj-ENSMUSG00000061859-
ENSMUST00000041284 ACTTTTTCACGAGACTGCTGC TTAACGCCGCCATTCCATCA 
198 
Irf4-ENSMUSG00000021356-
ENSMUST00000021784 GTGACTGTGCCCTGGCTTAT ATCTCTGAGTCCTGGTCCCC 
199 
Lama4-ENSMUSG00000019846-
ENSMUST00000019992 CTGACACAGCTGCAAGGCT GAAGCGGCTGGTCTCTGATT 
200 
Arhgef5-ENSMUSG00000033542-
ENSMUST00000031750 TGAGGAGTCTTCTGAGCTCA GAATGCCACCCTCACATTGC 
201 
Dnmt3l-ENSMUSG00000000730-
ENSMUST00000138785 AAGTCTTTCCTAGAACCAGGGC 
TGAAAAACTTCACAACAGGT
ACACA 
202 
Txndc12-ENSMUSG00000028567-
ENSMUST00000030296 
TGTGACATGAATGAGTGTTCTG
G 
TCTTGTGTTTGTTTTAACCCC
AGT 
203 
Arhgap6-ENSMUSG00000031355-
ENSMUST00000139146 ACACCCTGACCTGGAGAGAC 
ACCACTGAAAAATTTCACTGC
CA 
204 
P4ha2-ENSMUSG00000018906-
ENSMUST00000093107 TGACGTCCTTTTCTCTCCGC 
AAGCCACAACAAATAGAAAT
GTGA 
205 
Fkbp9-ENSMUSG00000029781-
ENSMUST00000031795 AGATCAGTGTGTGCCAAGGAG CACTGAATGAGTGCACAGCA 
206 
Mpeg1-ENSMUSG00000046805-
ENSMUST00000081035 
TCCAGCTTAATTGTCTCCAAAG
GA AAGGCTGAGACACTTGGAGC 
207 
Lamp1-ENSMUSG00000031447-
ENSMUST00000033824 GCCTGTTCTCACATCCCCAA GCATCGTTACAGGCAATGCA 
208 
Fndc1-ENSMUSG00000071984-
ENSMUST00000097425 GGCCTGCTGCAAGTTCATC 
ACAAATAAGATCTGAGGCAC
TTAGC 
209 
Ccna2-ENSMUSG00000027715-
ENSMUST00000147380 CAGCTCTGCGGTTGCTATGA TCTTGACAGTTGGCAGCACC 
210 
Ptprb-ENSMUSG00000020154-
ENSMUST00000092167 AAGCGAACGTCAGAGCTGAA TGGTGAGGGTTTGTGCAAGA 
211 
Gxylt1-ENSMUSG00000036197-
ENSMUST00000049484 ATGAGACAAGCAACGCCTCA GCTGAACCTCCAGAACGGAA 
212 
Ggta1-ENSMUSG00000035778-
ENSMUST00000102794 
TGTCTGACTTCAAATTGTGATG
GA CCCTCAAATTCCCCAGCCTT 
213 
Gorasp2-ENSMUSG00000014959-
ENSMUST00000112201 CAATGTTCAGAACCGACGTGG ACTGGAGTTTATTGCCGCGA 
214 
Capn6-ENSMUSG00000067276-
ENSMUST00000087316 TCATCAGAGAATCCTGACAGCT 
GTAAGGCAGTGTGGCAAAG
G 
215 
Pag1-ENSMUSG00000027508-
ENSMUST00000161949 TCCCATGTGTGCTTCATCCC AACACCCGTGTCAGTTCCTT 
216 
Pdlim1-ENSMUSG00000055044-
ENSMUST00000068439 GAGAGGACCTGCCCTGTCTA TAAGGGAGCATTCCAGGTGC 
217 
Pdgfra-ENSMUSG00000029231-
ENSMUST00000168162 AAGCCTGTGTGGATGACTGG TACCACACCACCATGTTGGG 
218 
Ckap4-ENSMUSG00000046841-
ENSMUST00000167671 AAGTGAACTGCGTGTGTGGG AAGAACACCCCCTCCAAACG 
219 
P3h2-ENSMUSG00000038168-
ENSMUST00000039990 
TGAGCTATAGAAAAGAGAGTG
CTC 
GACAGCAGCAGGAAGAGGA
G 
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220 
Myzap-ENSMUSG00000041361-
ENSMUST00000093823 GCACTCAGAGACATACGCCT TCAAAGTAGAGCGTGCGTGA 
221 
Tgfbr3-ENSMUSG00000029287-
ENSMUST00000031224 CTAGGTGGACAGATGGACGC GGTTACAGCAGGGGTGTTCA 
222 
Col12a1-ENSMUSG00000032332-
ENSMUST00000071750 TCTAAGTCTCCAGTGCTGCT 
TCTTGCAAACATTTCCAACTG
CT 
223 
Ankrd1-ENSMUSG00000024803-
ENSMUST00000025718 
TCTGAGAAAAGAGACTCAACA
GGA CAGCGCGTGTCCTTTTGATT 
224 
Thbd-ENSMUSG00000074743-
ENSMUST00000099270 GGGATTTGCTCCAGAGACCC GGCTTTGCTTGTGTTCTAGCG 
225 
Dennd2c-ENSMUSG00000007379-
ENSMUST00000172288 GCCAACGACAGTGTTTTCCC TCCCAAAAGCAGTCTCCCTG 
226 
Gadl1-ENSMUSG00000056880-
ENSMUST00000069651 TTCTTACCCCCAATGGCACC GAACAGATAGCTCCCTCCGC 
227 
Col4a1-ENSMUSG00000031502-
ENSMUST00000033898 ACTATGATGCTCGCCTCTGC TGCAGCAAAGCTTACAGGTT 
228 
Pdcd6ip-ENSMUSG00000032504-
ENSMUST00000035086 CGTGCTGCTGGTTCAGATCA TGCAAAGGTTTTGTCCAGCT 
229 
P4ha1-ENSMUSG00000019916-
ENSMUST00000009789 TTCCCTTGGCTCCTGTTGTC GTGTCTCATCTCGGCTCAGG 
230 
Grem2-ENSMUSG00000050069-
ENSMUST00000055294 CAACTGTCCCAGATCCACCC TGACAACACTGTGAGGCTGA 
231 
Fabp3-ps1-
ENSMUSG00000056366-
ENSMUST00000070435 CTGCTCCGTCACTGACCG 
GGCCTTGGTTCTGCTTTATTG
T 
232 
Plat-ENSMUSG00000031538-
ENSMUST00000033941 AAGCCCAGCTCCTTCAATCC 
TCATACAGTTCTCCCAACCAT
CT 
233 
Ankdd1b-ENSMUSG00000047117-
ENSMUST00000055607 CCCTCCACTGCTCCAGTCTA CATCCTCCTCCTCCACCCC 
234 
Bhlhe40-ENSMUSG00000030103-
ENSMUST00000032194 GATCTCCTGCTGCCTTGCTT AATGCCAGGCACATGACAAG 
235 
Tor1aip2-ENSMUSG00000050565-
ENSMUST00000111757 CAGAGGTGACATGGAAGGGC ACTCTCGTGTTCACAGGCTG 
236 
Sumf1-ENSMUSG00000030101-
ENSMUST00000032191 CTGACAGCCAAGAGGAGCTT 
TCACACACCCTGAATGGAGT
C 
237 
Kank1-ENSMUSG00000032702-
ENSMUST00000049400 AAGCATGGCCCTTGTGTGTA GGACCAAAGTAAACGTGGCG 
238 
Wisp1-ENSMUSG00000005124-
ENSMUST00000005255 GGTGTGTGGCTCAGGGTAAA ATTCAGGGCTGTCACTGTGG 
239 
Sdf2l1-ENSMUSG00000022769-
ENSMUST00000023453 GATGAGTGATGGGAGGGTGG ATTGAACAGGTTGGGGCCAG 
240 
Zfp568-ENSMUSG00000074221-
ENSMUST00000148442 
GAGTGAATGAGTTGCCATCAG
A TGCGCTACCACACCTATTGG 
241 
Echdc2-ENSMUSG00000028601-
ENSMUST00000116309 GGCAAGTGACCCAGCTAACT 
TGCAGCATGTTTATTAACACA
GGG 
242 
Vamp3-ENSMUSG00000028955-
ENSMUST00000030797 CCGATGAAACTGAAGCCCGA GTCAGACCAGGACAGAAGCC 
243 
Slc5a2-ENSMUSG00000030781-
ENSMUST00000118169 AGGGTGTTGGATGCCATGAG 
GGGCAGTTTTATTTTTGTATA
GGCA 
244 
Lpar3-ENSMUSG00000036832-
ENSMUST00000039164 CTAAGCCACGGACGCCTC AGGGATAACAGGTCCTCGCA 
245 
Tnc-ENSMUSG00000028364-
ENSMUST00000107372 GCGGGCATAAATTCCAGGGA CTGTCCAGACACGTTTGGGA 
246 
Cubn-ENSMUSG00000026726-
ENSMUST00000091436 GGAGAGCTGTGTGTAACCCC 
ACCCGTACTTTGACTTTTGTA
TAGT 
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247 
Hdc-ENSMUSG00000027360-
ENSMUST00000028838 TGGTGTAGAGTCCTCAATCAGA 
TGTTTTTCACATTACAAGCTC
AACA 
248 
Rcn1-ENSMUSG00000005973-
ENSMUST00000006128 AGACACTGGTTCTGGTGTGG TGCTCTGTACACAAGCCCAG 
249 
Thbs1-ENSMUSG00000040152-
ENSMUST00000039559 GCCAATCATAACCAGCGCTG 
GCACGTTCCTAGGAAAAAGG
G 
250 
Plaur-ENSMUSG00000046223-
ENSMUST00000002284 TGGACCTGACTCCTGAGCC 
CTGAGGAGGTAGAGGCAGG
T 
251 
Palld-ENSMUSG00000058056-
ENSMUST00000121785 CGCCCTTGTTGAAGCTGAAA AGTTAATCCCAAGCCCAGCA 
252 
Edn1-ENSMUSG00000021367-
ENSMUST00000021796 TTGACTACAGAGCTCCCCCA TAGACCAATATGGCCTGCCC 
253 
Hacd4-ENSMUSG00000028497-
ENSMUST00000151280 AACGTGTGAGGTAGCCTGTC GTGACAGTCACAGGACCCAG 
254 
Agtr1a-ENSMUSG00000049115-
ENSMUST00000066412 GGTTCAAAGCTTGCTGGCAA 
GCCAAAACTTCATCAAATGA
CAGC 
255 
Dram1-ENSMUSG00000020057-
ENSMUST00000020249 AAGGTATGTTTCCCTGGAGGA 
TCTCGGGTACAAAGTCCAAG
G 
256 
Calu-ENSMUSG00000029767-
ENSMUST00000031779 TGCAGACAGAGGAACCTACA TGCTCACTGCCTCAGACTTG 
257 
Mertk-ENSMUSG00000014361-
ENSMUST00000014505 AGCTGAGAGGAGGCATGAGA CTCCTTGGCTCTTTCCACCA 
258 
Csrp2-ENSMUSG00000020186-
ENSMUST00000020403 TGAACCCAGTAAGCACGACA TTCACTGGAGGAAGGAACCA 
259 
Gata6-ENSMUSG00000005836-
ENSMUST00000047762 GGTGCTACCAAGAGGCAAGG TGTGGGTTGGTCACGTGGTA 
260 
Itgb1-ENSMUSG00000025809-
ENSMUST00000090006 TCAGGCGGATTTTGCAACAC TCGAGACAGAGCAAGCATGT 
261 
Pdia3-ENSMUSG00000027248-
ENSMUST00000028683 AAGCAACAGCCAAATGCACC GGTTCTTGTTCTTGCCAGCG 
262 
Rpia-ENSMUSG00000053604-
ENSMUST00000066134 TCTAGCCCTGAGAGGAGCAG CAAGGGTCATCGGAGGAACA 
263 
Plac9b-ENSMUSG00000072674-
ENSMUST00000100809 TGACTTCCAGGGATGGTGGA 
CGGAGCTTTTATTTCACACAA
AGG 
264 
Myl12a-ENSMUSG00000024048-
ENSMUST00000148960 AGATGACTGAAGAGCTGCGG ACCTCACTTTCCCAGGCATG 
265 
Prss35-ENSMUSG00000033491-
ENSMUST00000036426 AGGGAAAACTGAAGCGAGCT GCCACACGTTTTGAGGACCA 
266 
Pdia6-ENSMUSG00000020571-
ENSMUST00000057288 GCCTTCCTTGGGCTTTCCT 
TCAGTCCTGAGTCTTTTCTTG
TGT 
267 
Vcl-ENSMUSG00000021823-
ENSMUST00000022369 CCTCGTCAAATCTGGCTGGT TGGTGGACATGTGTCTCCAG 
268 
Lyn-ENSMUSG00000042228-
ENSMUST00000041377 TGGGCATGGAGACTAGCCTA GTAGGGACTGGAGGGCCTTA 
269 
Tpm4-ENSMUSG00000031799-
ENSMUST00000003575 
ACCAGAAGAGTACTGTTTTAAC
ACC 
TGCTCAAAGTTCATCTCCCTG
G 
270 
Klb-ENSMUSG00000029195-
ENSMUST00000031096 
TCAGCTAAACTGCCATTTCTGT
C 
AGAGAAAAAGGATGTGAAG
TCGTG 
271 
Bag3-ENSMUSG00000030847-
ENSMUST00000033136 CTCCCTAGTGTCCCCTGGG 
ACAACATTAAAGCCATTCCAA
CA 
272 
Slc16a9-ENSMUSG00000037762-
ENSMUST00000046807 
TGTTTAGAGGGATATTAAAAG
GCCT TCCCCTGGAGCTGGAGTTAG 
273 
Piezo2-ENSMUSG00000041482-
ENSMUST00000047480 TCACTTAAGACCTGGACTGCA 
AGTCAGTCCTGAACCCAGAG
T 
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274 
9130008F23Rik-
ENSMUSG00000054951-
ENSMUST00000068258 AGTGACACAGCTTATGGGGC TGCTGTATGGCACTACTCCT 
275 
Mvp-ENSMUSG00000030681-
ENSMUST00000165096 ACAAAAGTGACCTGGCGGC 
TCCATTGTCAGTGTAGTCAGT
GT 
276 
Lamb1-ENSMUSG00000002900-
ENSMUST00000169088 ACAGGAAGGGGCTGTAGAGG CCCAGCAACTGAAGGGTTCT 
277 
A730049H05Rik-
ENSMUSG00000048636-
ENSMUST00000057977 GGTTTGCAAAGGCCAAGGAC CCAACACTGTGGGAACAGAA 
278 
Lrp2-ENSMUSG00000027070-
ENSMUST00000080953 GCCTTGCCAACTCTCTAGGG TCCAGCAGCATCATTTCCAGT 
279 
Cat-ENSMUSG00000027187-
ENSMUST00000028610 CCTGTAACTCCGGTGCTCAG CAGACACCATGGAGGCTCTG 
280 
Kcnq5-ENSMUSG00000028033-
ENSMUST00000115300 ATGCATGTTTAGGGGTGGCA AGCTTGAAATGGGTGTGCTA 
281 
Man1a2-ENSMUSG00000008763-
ENSMUST00000008907 CACAGTGGAGCAGCTCTCAA AGCGAATTTGAGGCCAGTGA 
282 
Fndc3b-ENSMUSG00000039286-
ENSMUST00000046157 TAAATCCAGCAGGCCAGTGG 
AGCCTGGAATGTATGTCCAA
CA 
283 
Cd28-ENSMUSG00000026012-
ENSMUST00000027165 TGACAGGGACCCCTATCCAG GGCACTGGGGATACAGCAAT 
284 
Lamb2-ENSMUSG00000052911-
ENSMUST00000065014 GACCACTCCCTAGGGCCTAG 
GGAGGTTCACACAGGTTTAT
TGA 
285 
Heatr5a-ENSMUSG00000035181-
ENSMUST00000040583 CTCTCCTAGCACACTGAGCG CACCACGTGCTCTTGGTCTA 
286 
Ctgf-ENSMUSG00000019997-
ENSMUST00000020171 GCCAGGAAGTAAGGGACACG CCCACCCCAAACCAGTCATA 
287 
Zc3hav1-ENSMUSG00000029826-
ENSMUST00000114900 
GGATGTATACCATGCTGAAACC
A AAACTGGGGGCTTGAGAGTC 
288 
Ptger3-ENSMUSG00000040016-
ENSMUST00000173533 
AGATGATGAACAACCTGAAGT
GGA CCCCCTTTTTATTGTGCTGCC 
289 
Actn1-ENSMUSG00000015143-
ENSMUST00000021554 GACCTCTAACCCGCCCCT ACAGTCTGTGCCAAGCAACA 
290 
Papss2-ENSMUSG00000024899-
ENSMUST00000025833 CTGGCTCTGGCTTCTTCCTC TACCAGCGGGACACTGAAAC 
291 
Lama1-ENSMUSG00000032796-
ENSMUST00000035471 TGAGCCCTAAACTGTCGCC 
TAATAGAGGTATCTGTTGTCC
GTGT 
292 
Slc16a1-ENSMUSG00000032902-
ENSMUST00000046212 CTGACCTGTGAAGCCTGGAG 
TGGACACGTTCCTGATCAGT
G 
293 
Fam114a1-
ENSMUSG00000029185-
ENSMUST00000031080 GCAGGCCACATCTCTTCACT 
GGTTGTTTCAGGAGACATAC
AGC 
294 
Mme-ENSMUSG00000027820-
ENSMUST00000029400 AGATACTGAACATCCACGGCA 
AGCAGAAGGACAAGGAAGG
C 
295 
Ror1-ENSMUSG00000035305-
ENSMUST00000039630 GGAAAGACACCAGCCAGGAA 
GCTTGTAGTTGGAATGCCCA
C 
296 
Car8-ENSMUSG00000041261-
ENSMUST00000066674 GAGAGACCGGGAACAAACCC GGCCAGTCTGGTCTACACAG 
297 
Eogt-ENSMUSG00000035245-
ENSMUST00000054344 ATCCTCTTGCCTGAGCCAAC 
TCCAAAGCTACACCCAAAAT
GT 
298 
Naalad2-ENSMUSG00000043943-
ENSMUST00000172171 GGCTTCTGTCGAGTAGCTTCA GTCCCACCTTCAGAGCTGAC 
299 
Birc7-ENSMUSG00000038840-
ENSMUST00000108875 CCAGGAACTACACTGCAGAGT 
AGGGTGAGAACTTCTGCTTT
AT 
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300 
Rhox2h-ENSMUSG00000079627-
ENSMUST00000115162 TCAGAGGTCCTCTTCCTGCA 
TCAGCTCTTTATTGCAAATAC
AAGT 
301 
Atp10d-ENSMUSG00000046808-
ENSMUST00000126664 GCTAAACATGCAGGACACCC 
AGGCAGCTTCGTTTAGACAC
A 
302 
Fam3c-ENSMUSG00000029672-
ENSMUST00000163963 CAAGACTGACGGGAAGGAGC 
TCTGGATTTCTTTGGAAGGTC
AA 
303 
Blvrb-ENSMUSG00000040466-
ENSMUST00000037399 CACTCTGACCTAGGTGGGGA AGCAGTAGAGCGCCTGTCTA 
304 
Slc38a4-ENSMUSG00000022464-
ENSMUST00000023101 CACCACTAATCCCGGGGAGA GGCCACACAAATGATCGGTG 
305 
Itga1-ENSMUSG00000042284-
ENSMUST00000061673 GTGACCCAGAAAGGCTACCC CCAAACGGCTCTTCCTCTCC 
306 
Pcgf5-ENSMUSG00000024805-
ENSMUST00000062389 CCCAGGCTGAGCTGAATGAA 
TAGGTCAGTGGCTCAGAAAC
C 
307 
Dnajc10-ENSMUSG00000027006-
ENSMUST00000028392 
TGAGCTTTGATGGTGTTGAAG
A TTTTGGAGTTGCAGCAGGGA 
308 
Srgn-ENSMUSG00000020077-
ENSMUST00000160987 CTCTGTCTCCCCACCTCCAT GTTCCAGATGACATCTCCCCC 
309 
Enpep-ENSMUSG00000028024-
ENSMUST00000029658 AGGACGGACAGTGAAAACACG AGCTTTGCTGGAGGACAACC 
310 
Nid1-ENSMUSG00000005397-
ENSMUST00000005532 TCCTTGTTCCCTCTCCAAGT 
TGTACAGCTGTAAACTTGAG
GA 
311 
Ikbip-ENSMUSG00000019975-
ENSMUST00000020149 ACTGCACACCTTCTGATGGG 
TTGAAACGCAGGAGCAGGA
A 
312 
Adamts9-ENSMUSG00000030022-
ENSMUST00000113438 GGCTCTGAAGAGGAAGCCAT CAAACACCAAGTGCTCTGGC 
313 
Myof-ENSMUSG00000048612-
ENSMUST00000172095 TAGTGAAAGCAGCGCCTTCA TACTGGACCCACGGGATCAT 
314 
Prkaa2-ENSMUSG00000028518-
ENSMUST00000030243 GGTAGGGGTGGTTCAATGGG TAGGGGCTTTGAAACGGCTT 
315 
Erp44-ENSMUSG00000028343-
ENSMUST00000030028 ATACTGCAAGCCTTTCCACA 
TGGCACATGTCAATCTTTTAA
GCT 
316 
Ppic-ENSMUSG00000024538-
ENSMUST00000025419 TGGTGACAGAAATGGCGGAA ATCCAAGCCCCAGAATGCTC 
317 
Hhip-ENSMUSG00000064325-
ENSMUST00000079038 CTGCATACACACGCACAACC GCTCTTTTGCCTCCAACGTG 
318 
Cpox-ENSMUSG00000022742-
ENSMUST00000060077 GCATCAGACAGAGCCTTGCT 
GGCAAACACAATCACATACA
TCCA 
319 
Tek-ENSMUSG00000006386-
ENSMUST00000102798 ACTCTTCATGTACAACGGCCA AGAGGAACCATTGCAGCAGG 
320 
Anxa5-ENSMUSG00000027712-
ENSMUST00000029266 GATGACTGAGAGCCGCCTG 
TGGAGGGAAGGGAATGTTTT
T 
321 
Pdlim5-ENSMUSG00000028273-
ENSMUST00000029941 TCAGTGGTTCCAGGAAAGAGA TTGTGTGAGTTGCCTCTGCT 
322 
Nxf7-ENSMUSG00000031410-
ENSMUST00000113163 
TGACATAAAAACACACGGCTG
G 
TCTCAAGAGAAATACACAGA
GCA 
323 
Col8a1-ENSMUSG00000068196-
ENSMUST00000089332 TGTTTAGTCCTGTGCACAGCA 
ACTCAAGCAAGTTACCGGTC
T 
324 
Flrt2-ENSMUSG00000047414-
ENSMUST00000057324 AGCCTAGAGGTCCAGCGTTA AGAATCTTCCAGCCCCTTGC 
325 
Otud4-ENSMUSG00000036990-
ENSMUST00000173078 TGGACATGAATTCAAGGGGCA AGCATCACACCATGTAGGGC 
326 
Colec12-ENSMUSG00000036103-
ENSMUST00000040069 CTGATGCCTCTGAAAGCCGA 
AGTACCGCTATTATTATCTTT
GGCT 
327 
Manf-ENSMUSG00000032575-
ENSMUST00000159620 TGAACCGCAACCATAAGCCT 
TGAGGAAGCTGTGGATATGG
AC 
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328 
Dab2-ENSMUSG00000022150-
ENSMUST00000080880 TTGCCTAGCTTCTGAAGTTGT 
ACAAAACAGTTGTGTGGCTG
A 
329 
Cald1-ENSMUSG00000029761-
ENSMUST00000115027 CGGAGAAAGAACCCAACTGC AGTCAGCTTGCAGTTTCCTCT 
330 
Nog-ENSMUSG00000048616-
ENSMUST00000061728 TTCCTGCTAGAACTCGGGGG TCCTGTTCTGCACTTCTTCCT 
331 
Pawr-ENSMUSG00000035873-
ENSMUST00000095313 ACAAGGTAGAAGCTGCACGG 
AGCTTTCCTTTGAATGATTAC
TGCT 
332 
Nid2-ENSMUSG00000021806-
ENSMUST00000022340 ACGAAGGCAAAGACAGTGGA GAACTGCTGCATCTTTGGTGT 
333 
Anln-ENSMUSG00000036777-
ENSMUST00000040912 GAAGCCTTAAGCCGAGGAGC 
TGGCAAGTGATAGACTTAGT
GTTT 
334 
Rras2-ENSMUSG00000055723-
ENSMUST00000069449 AGAGTCCCTTGAGGTTTAGCT TCAGGAGCGCACTTCGAATT 
335 
Snx9-ENSMUSG00000002365-
ENSMUST00000002436 ACAAGAGAACTCCGAAGTGCT 
TCTGACATTGGGTAAGAACT
GGA 
336 
Phldb2-ENSMUSG00000033149-
ENSMUST00000076333 TTTGGCCATGGTCCACTTCA ACGGTCATGATCTCGGTCCT 
337 
Tmem45a-ENSMUSG00000022754-
ENSMUST00000023435 
AGTCTTTCTTGATAAGCCTTCTC
C 
TCTGAGAACTCCCTGGGTTG
A 
338 
Atp13a3-ENSMUSG00000022533-
ENSMUST00000100013 AAGGCTGCTCTCTGTGCTAG CCACGGTCTCAGGGAATTCA 
339 
Acta2-ENSMUSG00000035783-
ENSMUST00000039631 CCCCCTGCTCTGCCTCTA 
AGTCACGCATGCATATCCAT
G 
340 
Adgrl4-ENSMUSG00000039167-
ENSMUST00000046977 
AGAAGTCATGATAATTACAGCT
GC CAGCATGCTGACTTCCCTCA 
341 
Fut8-ENSMUSG00000021065-
ENSMUST00000062804 CTTCAGACCATCTCGGCCAA 
AGCTTTATAGACAAGAGCAA
GCAC 
342 
F3-ENSMUSG00000028128-
ENSMUST00000029771 CTGAAGCCGCTAACGCTCA 
TGTCTCAATTCCCAATCACCT
T 
343 
Gm5082-ENSMUSG00000054258-
ENSMUST00000067176 ACGTAGTTCTTGTGGCTTTGC AAAAGAGCCAGTAGCCGCC 
344 
Itgav-ENSMUSG00000027087-
ENSMUST00000028499 CAGACAGCACTGAGTCAGCA GGCACCACACGTTCAAGTTT 
345 
Chn2-ENSMUSG00000004633-
ENSMUST00000046856 CACCAGGGAAGTGAGCTGAT CCATAACCAACGCACTGCAT 
346 
Hebp1-ENSMUSG00000042770-
ENSMUST00000045855 TGAACTGAGAACGTCCTGGA 
ACTGCATACGTCAAAGATTT
GTAT 
347 
Anxa3-ENSMUSG00000029484-
ENSMUST00000031447 TGATTGAAGAAGATGGCTCCC GCACCAGGCAACATACAGTA 
348 
Bmper-ENSMUSG00000031963-
ENSMUST00000071982 TCAGCGATGACCTTTGTTCT ACATCAGTGAGTTGGGGGTG 
349 
Plod2-ENSMUSG00000032374-
ENSMUST00000160359 ACGTAACTCAAACTGAATGGCT TGGCACCGTGAATAAAGACT 
350 
Col1a2-ENSMUSG00000029661-
ENSMUST00000031668 TCTCTTTGCCGTTTCCTCCT 
TCTTTTGGAAAACCAAAAAT
GCTTT 
351 
Fibin-ENSMUSG00000074971-
ENSMUST00000099626 
GGCTAATATTTCCATTGTAACT
GCT 
GGACCTTTGTCACACATTTCC
A 
352 
Actc1-ENSMUSG00000068614-
ENSMUST00000090269 
GTGCTTCTGAGATGTCTCTCTC
T AGGTTGCAAGTCCTGGTCTG 
353 
Gm6880-ENSMUSG00000079536-
ENSMUST00000114125 
ACCAGATACAAGAAAACTCAG
AGC TTTGTCCTGACCAGTGGAGC 
354 
Matn3-ENSMUSG00000020583-
ENSMUST00000020899 ACTCTCGCCTGGAAATGTGG AATGTCACAGTGAGGGGCTG 
355 
Isyna1-ENSMUSG00000019139-
ENSMUST00000019283 
CACTGCTTAAATCAAGTGACCG
G 
GCTTGAGACTTGCTTTATTGT
CT 
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356 
Msl3-ENSMUSG00000031358-
ENSMUST00000033725 
TGATGGTTCTGTAAAAACAACT
GCA 
TCAAACAAAACTGGCAAAGC
T 
357 
Igsf1-ENSMUSG00000031111-
ENSMUST00000033442 
AATTACCCTCTCCTTTATAAGA
GCT 
TTTTAACAGAATTGCATGCAC
CA 
358 
Sox17-ENSMUSG00000025902-
ENSMUST00000027035 TTGCCGACCCGACCTGAG 
GCAAATTTTGTGGGAAGTGG
GA 
359 
Ptgs2-ENSMUSG00000032487-
ENSMUST00000035065 
TGAGCTGTAAAAGTCTACTGAC
CA CCCAGGTTCAATCAGCAGGT 
360 
Lmo7-ENSMUSG00000033060-
ENSMUST00000100337 CATTCGAAAGCGCTGTTGCA AGCGGAACAGAAGAGCTCAC 
361 
Sec24d-ENSMUSG00000039234-
ENSMUST00000047923 CCTCGGCTCTCCCTCTGAG 
ACCATCAAAATTGTACAAAG
AACCA 
362 
Krt23-ENSMUSG00000006777-
ENSMUST00000006969 AGCCAAGGAGTTTCTGCCTG 
GAGAGCAGGAGAGTAGAGC
T 
363 
Nov-ENSMUSG00000037362-
ENSMUST00000050027 TAACAGGTGCTCAGGGAAGC GGCTGAAGACGATGGTCCAA 
364 
Slc6a15-ENSMUSG00000019894-
ENSMUST00000074204 TAGCTGAACGAAAGCAGGGG 
TGCCATACAGTTTTAACAATC
ACT 
365 
Dse-ENSMUSG00000039497-
ENSMUST00000048010 TCAGTGCTAACGCCAAGGC 
TCACACCAAAACTTTAGTTCC
ATGT 
366 
Mbnl2-ENSMUSG00000022139-
ENSMUST00000088419 CCTGAGACCAGCTGTGATGT 
TGGTTGTACATTGGGTGAGT
GA 
367 
Fst-ENSMUSG00000021765-
ENSMUST00000022287 ACTCTCCACCAATGTTCAGTGT 
ACATTGCACATTTACATGGTA
GAA 
368 
Ngf-ENSMUSG00000027859-
ENSMUST00000106925 CTGACTTGCCTGCAGCCC 
TCGGTATACAGGATGCTTTG
AAAA 
369 
Vnn1-ENSMUSG00000037440-
ENSMUST00000041416 
CTTGTGCTGATGGAATTTTTAC
ATT AGGTTTGCGTTCTCCTGAGG 
370 
Clcn5-ENSMUSG00000004317-
ENSMUST00000115746 GAATCATGGGCTTGTTGTGGA 
ACCGTAGCCATCTTGTTTACT
CT 
371 
Filip1l-ENSMUSG00000043336-
ENSMUST00000159816 TAACTGACCACCCTCACCCT 
ACTTCTGATAGTTCTCTTTTG
AGCA 
372 
Gm10110-ENSMUSG00000062093-
ENSMUST00000081204 GCCAAATAACCCCTCATGGC 
AAGTCTTGGGTACATCAAAA
CCA 
373 
Igfbp7-ENSMUSG00000036256-
ENSMUST00000163898 AACCTGCGAATCCATGAGCC 
TTGTTTTGTTTAAAGCTACAT
GTGC 
374 
Serpinb6a-
ENSMUSG00000060147-
ENSMUST00000076532 CTTTGACCCTCTCTCCATGGT CTGAAGGTGGGGTGCCATAA 
375 
Serpinb6a-
ENSMUSG00000060147-
ENSMUST00000167163 CTTTGACCCTCTCTCCATGGT CTGAAGGTGGGGTGCCATAA 
376 
Col3a1-ENSMUSG00000026043-
ENSMUST00000087883 ACTCTCTGAAACCCCAGCAA 
AAGATCAACAACTACATACA
AGCTT 
377 
Nppb-ENSMUSG00000029019-
ENSMUST00000103231 GAAGACCTCCTGGCTGCAG 
CCTTTTCAAAAGCAGGAAAT
ACGC 
378 
St3gal6-ENSMUSG00000022747-
ENSMUST00000114357 
TGACCCTATGGATCCAAAAGAT
GA CCAGTCACATGCCCATGAGT 
379 
Hs3st1-ENSMUSG00000051022-
ENSMUST00000117944 GCACTGATTTGCCGTCTCCT 
AGATTTGACAAGGAGGTGAA
AACA 
380 
Trpc6-ENSMUSG00000031997-
ENSMUST00000050433 TAGAGCAGAGCCCCTCAGAA 
CAGCAATTGTTAGCCTCAGC
A 
381 
Plscr2-ENSMUSG00000032372-
ENSMUST00000034932 ACAGAAATCCGACCTGCAGT 
AGAATTTCCCAGGCAATAGT
ATCT 
382 
Cct6b-ENSMUSG00000020698-
ENSMUST00000100722 
TGAATTCCAAATCAATTCATCT
GGA 
AGACCAAAAGACATGCACTA
CCT 
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383 
Icam4-ENSMUSG00000001014-
ENSMUST00000001040 
TATAGATCTGTTTTCGATGCCT
GAC 
CTGAGGAGGAAGACTTTATT
GTTTC 
384 
Gsta2-ENSMUSG00000057933-
ENSMUST00000034902 CAAGTTTTAGTGTGGCTGCAT 
ATTATTGCACAATAGCCAGA
ATCA 
385 
Arc-ENSMUSG00000022602-
ENSMUST00000110009 AGCCTGAATAGAGGGGCCA GGGCCTACCTACACACCCTA 
386 
Arpc2-ENSMUSG00000006304-
ENSMUST00000113820 CCCGCTAACTCTTGGGAACT TGACCCCAACCGTATTTCTTT 
387 
Arpc4-ENSMUSG00000079426-
ENSMUST00000156898 ATCTAGCTGGATCTCGCAGC ACCTCTCCTGTAAGCCCCAT 
388 
Camk2a-ENSMUSG00000024617-
ENSMUST00000025519 CATTGAAGGACCAGGCCAGG AGACAGGAGATCCCCGTGAA 
389 
Cdipt-ENSMUSG00000030682-
ENSMUST00000032920 TGATCCTCTCCCATCCCCAG 
AGGACAGGAGAGAGGAGCT
G 
390 
Dlg4-ENSMUSG00000020886-
ENSMUST00000108589 GACTCTGATTCCTGCCCTGG CATTTCCTGTCCTCCCCTGG 
391 
Dlgap4-ENSMUSG00000061689-
ENSMUST00000169464 GCTCTAAGGCCGTGAAGGAG GGCACACAGAGGTCAAGTGA 
392 
Eif3a-ENSMUSG00000024991-
ENSMUST00000025955 
ACGACGTTAAGTCCCAAGATG
A CACAGCAGCAAATTCCGTGT 
393 
Eif3f-ENSMUSG00000031029-
ENSMUST00000033342 ACCTGTGAATGAGCCCCAAG AGTTAGAAACAGCCTGCCCA 
394 
Eif4a3-ENSMUSG00000025580-
ENSMUST00000026667 ACCTCATCTGAAGCTGGTGC 
TGTCCACGTTTAATGTAAAAG
GTT 
395 
Eif4e2-ENSMUSG00000026254-
ENSMUST00000113235 GGCTCAGGCAGTTCTTCTGT TAAATCTGCCAGTGCTGCCA 
396 
Eif4ebp1-ENSMUSG00000031490-
ENSMUST00000033880 ACATTTAAGGGACCAGCCGT 
CCAGGCTCAGAGGAAAGGT
G 
397 
Eif4g1-ENSMUSG00000045983-
ENSMUST00000044783 ATCACAACTGATGGCGGGTG CCCCTTTCCCCTGCCCAG 
398 
Eif4h-ENSMUSG00000040731-
ENSMUST00000036125 TGAGCTTAGGTTGGGAGGGA GCCTGTCTTTTCCGCATTGG 
399 
Eif5a-ENSMUSG00000078812-
ENSMUST00000043419 AATAACCGGCTTCCAGGGTG 
GAGAGAGCCCACAGGAAAG
G 
400 
Epha2-ENSMUSG00000006445-
ENSMUST00000006614 CTATCTGAGTCCATTGGGGCC 
TCAGTTTGAACCATCTGCAAC
T 
401 
Fxr2-ENSMUSG00000018765-
ENSMUST00000018909 AAAACCTCCGGTCCACATCC TACGCCTTCTCATCCACCAG 
402 
Gabrd-ENSMUSG00000029054-
ENSMUST00000030925 AGTGTGTGCACCAGGTGATG TCATGCTGGGACCAAAGAGG 
403 
Gria1-ENSMUSG00000020524-
ENSMUST00000036315 AGCAGACAGGAAACCCTTGG GCCCAGGTACCAAAGAGCAA 
404 
Htr2c-ENSMUSG00000041380-
ENSMUST00000096299 GTGTAAGCAATAGCAGCGCA TAAGGCAGTCTGTTGCACGT 
405 
Htr5b-ENSMUSG00000050534-
ENSMUST00000055884 AGAAGGGCTGGGGAGAGAAA TTGAAGACACCTGCGTGGAA 
406 
Inpp5d-ENSMUSG00000026288-
ENSMUST00000072999 CTCCCCAAAGCCCAAGAGG 
CAGACTGGGAAACACAGGG
G 
407 
Kcng1-ENSMUSG00000074575-
ENSMUST00000109191 GTCCTCCCTCTAAGCCCAGA GGCTCTATCGCTTCTGGTCC 
408 
Kcnk12-ENSMUSG00000050138-
ENSMUST00000055221 CCTCCAGGTAGAGCGGCC AAGAAAGCGCCATCTCGGAG 
409 
Kcnk5-ENSMUSG00000023243-
ENSMUST00000024011 GCTCCCCACTTGCTTTCCA ACATCTGCCTTCACCATCGG 
410 
Kcnq5-ENSMUSG00000028033-
ENSMUST00000115300 ATGCATGTTTAGGGGTGGCA AGCTTGAAATGGGTGTGCTA 
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411 
Map2k3-ENSMUSG00000018932-
ENSMUST00000019076 AGGATTCATAGGGACTGGCC ACAGCAATAGGTTCCTGCCC 
412 
Map3k1-ENSMUSG00000021754-
ENSMUST00000109267 
TGTTCAGATCAGCTCTAATGGA
GA GCCCTTAAGCCCTGGAAGTC 
413 
Mtap-ENSMUSG00000062937-
ENSMUST00000058030 TGGCTGACACAAGAAGACGT CCCACACGTCCATCAACACA 
414 
Pip4k2c-ENSMUSG00000025417-
ENSMUST00000013970 CTGACTCCAGGGTGATTGCG AAGGTTGCTTGAGGGATGGG 
415 
Pip5k1b-ENSMUSG00000024867-
ENSMUST00000025800 ATAAGTGAAAGCGGCAGCCA 
AGGCCTTTTATAAATAGCTTT
GCTT 
416 
Ppm1m-ENSMUSG00000020253-
ENSMUST00000140761 CCACTGAGGGCTCACATACTG 
TAAGCAAATGTGAGACTGCC
CA 
417 
Ppm1n-ENSMUSG00000030402-
ENSMUST00000032560 AGGAGTGGTGAGATGGGGC TCACGTCTATCACCACCTCCT 
418 
Ppp1ca-ENSMUSG00000040385-
ENSMUST00000046094 AATAGCCTCCATGTGCTGCC 
CCTTTATTCAAGAGACCAGAT
GGG 
419 
Ppp1r16b-ENSMUSG00000037754-
ENSMUST00000052927 GAACTGGAGGAGAGAGCTGC CTAGGTATGCAGAGCCAGGC 
420 
Psd4-ENSMUSG00000026979-
ENSMUST00000102942 TTTGTCCCCCATGCACTCTC AGCTTGGTGGAAGACTGCTC 
421 
Ryr2-ENSMUSG00000021313-
ENSMUST00000021750 
ACCTTGATTGTCTCTGAAAACC
A TTCGCAGAATGACCTCGCTT 
422 
Shank1-ENSMUSG00000038738-
ENSMUST00000107938 GAAGAAGGAGGGAAAGGCCG CAGGTCCTATGCTGAAGGGC 
423 
Sipa1l1-ENSMUSG00000042700-
ENSMUST00000166429 CACCTGCGGGAGGACAAC AATAGCTTGCCCCAAGTCCC 
424 
Slc17a5-ENSMUSG00000049624-
ENSMUST00000052441 
ACAGAAACTGAAGACAACAAA
CA 
AAGAAATGTCACATGGCAAC
TT 
425 
Slc17a7-ENSMUSG00000070570-
ENSMUST00000085374 GACTACTGACCACGGGCCTC AGCGTTTATTGGGAGTGGGG 
426 
Slc17a9-ENSMUSG00000023393-
ENSMUST00000094218 CTGACGATCCAGTCACCCAG AAGGCTCTGGCAAGACTCAC 
427 
Slc30a2-ENSMUSG00000028836-
ENSMUST00000105874 GAATGACTCCCCAGCCAGAC TTACTGTGCCAGGACAGAGC 
428 
Slc30a4-ENSMUSG00000005802-
ENSMUST00000005952 AGAATGAGCTGTCACCCTGC ACTTGGTTTTTGGAGGGGCA 
429 
Slc30a5-ENSMUSG00000021629-
ENSMUST00000067246 GCATGAACAGTGAACAGCGG 
TCAGTGGTTGTAATTTCTCCT
GA 
430 
Slc30a7-ENSMUSG00000054414-
ENSMUST00000067485 CTGACTGCTGAGGGTTCTGG 
AGGGAAGTGAAGTGCTGAG
C 
431 
Slc4a10-ENSMUSG00000026904-
ENSMUST00000112480 AGAAGCTGATTCCCCAAAGCA 
TGACCAGGAATCTGAAATTA
GGAGT 
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RESA barcoding oligos 
name sequence 
FW1 CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC 
FW2 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC 
FW3 CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC 
FW4 CAAGCAGAAGACGGCATACGAGATCTGATCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC 
FW5 CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC 
REV AATGATACGGCGACCACCGAGATC 
 
4.1.6. Plasmids 
piggyBAC transfer vector 
piggyBAC transposon vector 
4.2. Methods 
4.2.1. Cell culture 
4.2.1.1. Culture and differentiation of N1E-115 
N1E-115 cells were obtained from ATCC. Cells are cultured in Dulbecco’s Modified Eagle 
Medium (DMEM), supplemented with 10% Fetal Bovine Serum (FBS) and 2mM L-Glutamine 
at 37°C and 5% CO2 on untreated cell culture plastic. Cells are splitted a least twice per week, 
one to five, and maximally cultured to a passage number of 30. For splitting, the growth 
medium is deprived and the attached cells are washed once with prewarmed PBS solution. 
They are then treated for 5min with 1ml/25cm² PUCK’s saline solution at 37°C and 5% CO2, 
which leads to detachment. The detached cells are washed off the dish with 3ml/25cm² 
prewarmed growth medium and singularized by pipetting against the wall of the dish. 
Afterwards they are spun down for 5min at 800g and the supernatant is disposed of. The cells 
are resuspended via pipetting in 10ml of prewarmed growth medium and 1/5 of this suspension 
is transferred to a new culture vessel, containing already warm growth medium. For storage 
purposes the cells are frozen in growth medium, supplemented with 10% DMSO at -160°C. To 
do so the cells are washed with prewarmed PBS, detached using PUCK’s saline solution, spun 
down in growth medium and resuspended in freezing medium. Freezing cultures are prepared 
with a cell density of 2*106 cells/ml in 1ml. For thawing frozen cultures, the cell vial is quickly 
heated to 37°C in a water bath. After thawing, the cells are spun down for 5min at 800g to 
remove the DMSO. Afterwards the cells are resuspended in prewarmed growth medium. 
For differentiation, the 50% to 70% confluent attached cell culture is deprived of growth 
medium and washed with prewarmed PBS. Then the cells are cultured in differentiation 
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medium (neurobasal medium with 2mM glutamine and no FBS) for 2 days to reach the final 
differentiation state.  
4.2.1.2. Culture and differentiation of Ascl1-mESC 
Ascl1-mESC were created in the lab by Alessandra Zappulo, following the protocol of Iacovino 
et al. [283]. The cells are cultured in a mixture of 20% mESC and 80% 2i medium (20/80). 
Cells are split one to three every day or one to five every other day to a maximum passage 
number of 25. If the cells are not split, the medium has to be changed every day. Cell culture 
plastic has to be coated with a 0.1% gelatin solution using a treatment of 5min with 3ml of 
coating solution for 25cm² of surface. For sub culturing, the cells are deprived from medium 
and washed with prewarmed PBS. Afterwards they are treated with 1ml/25cm² cold TripLE 
for maximum 3min at room temperature or until they detach from the plastic. Detached cells 
are collected in 3ml/25cm² prewarmed Feeder’s medium and centrifuged for 5min at 160g. The 
supernatant is disposed of, and the remaining cells are resuspended via pipetting in prewarmed 
growth medium. An appropriate fraction of the cell suspension is transferred to a freshly coated 
culture vessel containing prewarmed growth medium. For storage, the cells are frozen at -
160°C in 50% ES-FBS, 40% growth medium and 10% DMSO in a concentration of at least 
2*106 cells per ml. To obtain uniform differentiation, the cells are detached from the cell culture 
plastic using TripLE, washed, singularized and centrifuged in Feeder’s medium and cultured 
for two days in AK medium in uncoated cell culture plastic. The concentration of cells should 
be around 1*106 cells in 10ml for a 10cm petri dish. These cultures are suspension cultures and 
the cells will aggregate to form embryoid bodies after few hours. After two days of pre-
differentiation, the embryoid bodies are collected via 3min centrifugation at 140g and split 
carefully into two 10cm petri dishes, each containing 10ml of AK supplemented 3µg/ml 
doxycycline. This second step of differentiation also lasts two days, after which the cells are 
collected once more via centrifugation and plated for the final step of differentiation on a Poly-
L-Ornithine coated surface in monolayer medium, supplemented with 3µg/ml doxycycline. 
The coating is critical for the attachment of the cells and is done using a final concentration of 
0.1mg/ml Poly-L-Ornithine in water for 3h at room temperature, after which the plates are 
washed twice with sterile water and dried completely. To obtain single cells for microscopy 
the embryoid bodies are split into single cells using TripLE. After collecting the cell 
aggregates, they are washed in prewarmed PBS and treated for 3min with cold TripLE. Now 
the cells can be singularized via pipetting using Feeder’s medium. Before plating, the cells 
have to be spun down and washed again with PBS. A density of 100.000 cells per cm² is optimal 
for microscopy purposes. After three days of culturing in monolayer medium with doxycycline, 
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the cells are fully differentiated. Depending on the number of cells, the medium must be 
refreshed every two to three days or if it turns yellow. 
4.2.1.3. RNA transfection 
RNA transfection experiments were performed using Lipofectamine messengerMAX, 
following the manufacturer’s instructions. For filter experiments, 1 million cells were 
transfected with 5µg of A-tailed RNA reporter using 7.5µl Lipofectamine reagent in 250µl 
OptiMEM. One master mix was produced for multiple transfections and used for all reactions. 
4.2.1.4. DNA transfection 
DNA transfections were performed using JetPrime reagent following the manufacturer’s 
instructions. One million cells were transfected in a 10cm cell culture dish with 10ml of growth 
medium using 10µg of plasmid DNA and 30µl of JetPrime reagent. One master mix was 
produced for multiple transfections and used for all reactions. 
4.2.1.5. Generation of stable cell lines using the piggyback transposon system 
Cells were transfected with a donor plasmid (piggyback donor) and a transposase plasmid 
(piggyback transposase) in a ratio of 5:1. After one day, the cells were treated with an 
appropriate antibiotic (200µg/ml hygromycin or 4µg/ml blasticidine) for five days or until the 
relative number of positive cells reached 100%. The percentage of positive cells was validated 
throughout the experiment using fluorescent reporter proteins (e.g. GFP) encoded on the donor 
plasmid. 
4.2.1.6. Separation of subcellular compartments of N1E-115 
For the starting culture, cells were growing 10cm cell culture dishes until they reach 50% to 
70% confluency. After washing the cells with warm PBS, the medium was replaced by 
differentiation medium for one day. Meanwhile the 6-well cell culture inserts were coated from 
the outside using 10µg/ml laminin solution in PBS. For that, the filters are placed upside down 
on the lid of a 6-well dish and 500µl of coating solution is placed on top. After closing the 6-
well-dish it was stored for 24h in the fridge. Before plating the cells, the coating solution was 
aspirated, the filters were washed in sterile water and placed in a 6-well cell culture dish with 
2ml of differentiation medium. After one day of pre-differentiation the cells were carefully 
detached using PUCK’s saline solution, washed once with warm PBS and placed inside the 
insert in another 2ml of differentiation medium. After 24h the cells built long protrusions 
through the filter, which attached to the outside. 
For separating the compartments, the filters were placed in ice-cold PBS for 10s. Afterwards 
one of the two compartments was removed mechanically using a cotton swab dipped in ice-
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cold PBS. Each filter has to be checked under the microscope to ensure efficient cleaning of 
the unwanted compartment. The remaining structures on the filter were extracted using either 
TriFast for RNA extraction or Tris buffered 8M Urea (protein extraction buffer). To gain 
efficient protein extraction, the filters were sonicated using a Bioruptor (15s ON, 45s OFF, 
high, 4 cycles) and the cell debris was subsequently sedimented via centrifugation 
(14.000g/3min/4°C), after which the supernatant was used for further analysis. The 
approximate yield per membrane is 15µg of RNA and 400µg of protein for the soma fraction 
and 400ng of RNA and 15µg of protein for the protrusion fraction. 
4.2.1.7. Separation of subcellular compartments of Ascl1-iNs 
One million cells were placed in 10ml of AK medium for pre-differentiation. After two days 
the formed embryoid bodies are washed with warm PBS and the cells are split into two 10cm 
dishes, each containing 10ml of AK medium supplemented with 3µg/ml doxycycline for two 
more days. Millicell cell culture inserts are coated for three hours at 37°C from the outside with 
Matrigel solution (1/30 in KnockOut DMEM medium). To do this, the inserts are placed upside 
down on the lid of a 6-well-dish, 500µl of Matrigel solution is placed on top of the filter and 
the 6-well-dish is closed again. Before plating the cells, the filters were washed with warm 
PBS to remove remaining coating solution and 2ml of Monolayer medium were placed below 
the filter into the 6-well dish. All embryoid bodies from one 10cm dish were placed into one 
6-well-insert in 2ml of monolayer medium for differentiation. After three days of final 
differentiation the filters were processed to extract either soma or neurite fractions. 
The differentiated cells on the membrane were cooled in ice-cold PBS prior to separation. The 
soma can now be torn from the neurites via pipetting vigorously with 1ml of ice-cold PBS. The 
soma is then collected via centrifugation (1000g/5min/4°C) and, meanwhile, the neurite sample 
is extracted. For this, the leftover soma fragments on the filter are cleaned using a cotton swab 
dipped in ice-cold PBS. To ensure a high purity of the sample, each filter has to be controlled 
using the light microscope for efficient removal of the soma. For RNA extraction the filters 
and the spun down soma fractions were put in TriFast. For protein extraction the filters and the 
spun down soma fractions were put in protein extraction buffer and sonicated using a Bioruptor 
(15s ON, 45s OFF, high, 4 cycles). The approximate yield of one filter is 2µg of RNA and 
200µg of protein for each soma sample, and 200ng of RNA and 20µg of protein for each neurite 
sample. 
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4.2.2. Biochemical assays 
4.2.2.1.  Cloning 
Cloning of the reporter plasmids was performed following the Gibson Assembly protocol. 
10µg of the initial vector was restricted in a volume of 50µl, using 5U of two non-compatible 
restriction enzymes from NEB at a temperature of 37°C overnight. 2.5U of alkaline 
phosphatase was added for two more hours. The restricted vector was purified from a 1% 
agarose gel using GeneJet gel extraction kit (K0692) and the construct was eluted in 30µl. The 
inserts were PCR amplified using primers with compatible overhangs and also purified agarose 
gel. The final reaction was assembled in a 1:5 molar ratio of vector to insert and mixed 1:1 
with homemade Gibson assembly mix. Gibson assembly reactions were performed at 50°C for 
100min. For each reaction a negative control containing no insert was run. The assembled 
vector was transformed into chemical competent Mach1 E. coli strains or, if very high 
transformation rates were needed, it was dialyzed against ultrapure water and transformed into 
electro competent Endura cells (60242-1). Homemade chemical competent cells were thawed 
on ice for 20min prior to use. 2µl of the Gibson assembly mix was mixed with 50µl of bacterial 
suspension and incubated on ice for 10min. The bacterial suspension was then heat shocked at 
42°C for 60s and cooled down on ice again immediately. Cultures were recovered in 1ml LB 
medium for 45min prior to striking out on solid LB plates supplemented with the appropriate 
antibiotic. Electro transformations were performed using the Gene Pulser II electroporator 
(Bio-Rad 165-2105) and Lucigen Endura electrocompetent cells following manufacturers 
instructions. 1mm cuvettes were used with a pulse of 10µF, 600Ohms and 1,800V. The 
efficiency of each clone was calculated by comparing the positive reaction with the negative 
control reaction lacking the insert. Positive clones were either grown in 5ml of LB medium 
supplemented with an appropriate antibiotic for a test culture or immediately mixed after 
recovery and grown in 500ml of LB medium with appropriate antibiotic for a plasmid library. 
Isothermal Start Mix 
1.5 g PEG8000  
3 ml 1 M Tris-‐HCl, pH 8.0  
150 μl 2 M MgCl2   
Total: 3150 µl 
 
2X Gibson Assembly Master Mix 
405 μl Isothermal Start Mix (RT) 
25 μl 1 M DTT (4°C) 
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50 μl 10 mM dNTPs (-20°C) 
50 μl NAD+ (NEB # B9007S) (-80°C) 
1 μl T5 exonuclease (NEB # M0363S – 10 U/μl) (-20°C) 
31.25 μl Phusion High Fidelity DNA Polymerase (NEB # M0530S – 2 U/μl) (-20°C) 
250 μl Taq Ligase (NEB Cat. # M0208S – 40 U/μl) (-20°C) 
437.75 μl H2O   
Total: 1250 µl 
 
4.2.2.2. Preparation of samples for liquid chromatography tandem mass 
spectrometry (LS MS/MS) 
All samples for LS MS/MS were prepared in protein extraction buffer (0.1M Tris pH:8, 8M 
Urea). Total cells were disrupted using the Bioruptor with the settings 15s ON, 45s OFF, high, 
4 cycles. Afterwards the cell debris was spun down for 10min at 14,000g and 4°C. The 
supernatant was then transferred to a fresh tube and stored at -80°C until digestion. 
4.2.2.3. Stable isotope labelling by amino acids (SILAC) 
To gain more quantitative results from mass spectrometry it is necessary to label the proteins 
beforehand. Here we labelled cells with amino acids, which differ from each other in weight 
due to different incorporated isotopes. We used L-lysine monohydrochloride and L-arginine 
monohydrochloride incorporation for light labelling and “Lys 8” (L-lysine-13C6 15N2 
monohydrochloride) and “Arg 10” (L-arginine-13C6 15N4 monohydrochloride) incorporation 
for heavy labelling. Cell culture medium deprived from natural lysine and arginine is 
supplemented with these amino acids and used for growing the cultures. Cells were grown for 
at least five passages in labelled medium to avoid all residues of natural amino acids, which 
would have interfered with the quantification. Prior to the experiment the labeling efficiency 
was tested via MS. For differentiation testing, two different cultures of cells were prepared and 
differentiated in either heavy or light labelled medium. After protein purification via sonication 
(as described above) and concentration measurement via Qubit protein assay, equal amounts 
were mixed and tested in pairs, as heavy labelled non-differentiated protein extracts mixed with 
light labelled differentiated protein extracts and vice versa. The label swap experiment is 
crucial to exclude a bias of the labelled media on the results and, for further analysis, only 
proteins which showed a significant enrichment in both experiments were taken. For 
localization experiments the labelled cells were differentiated in SILAC labelled monolayer 
medium and compartment separation was performed. Protein samples from light labelled soma 
fractions were pooled with the same amounts of proteins coming from heavy labeled neurite 
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fractions and vice versa. All protein extracts were prepared using protein extraction buffer and 
digested and analyzed by MS/MS. 
4.2.2.4. Pulsed stable isotope labelling by amino acids (pSILAC) 
For pSILAC experiments, non-labelled cells (light) were cultured for a certain time in either 
heavy or medium labelled medium. The incorporation of heavy and medium labelled amino 
acids is taken as a measure for protein production in the labelling timeframe. Medium pSILAC 
medium was supplemented with “Lys 4” (4,4,5,5,-D4-L-lysine monohydrochloride) and “Arg 
6” (L-arginine-13C6 monohydrochloride), while heavy labelled pSILAC medium was 
supplemented with “Lys 8” (L-lysine-13C6 15N2 monohydrochloride) and “Arg 10” (L-arginine-
13C6 
15N4 monohydrochloride). The pulse length was set for two hours. Prior to pulse labelling, 
the cells were washed twice with warm PBS to remove any residual non-labelled medium. 
Protein samples from separated subcellular compartments were prepared in protein extraction 
buffer via sonication, mixed in equal amounts and submitted to digestion and MS. 
Fig. 4 pSILAC. Schematic presentation of the pSILAC experiments. 
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4.2.2.5. Quantitative bio-orthogonal noncanonical amino acid tagging with stable-
isotope labelling by amino acids (QuaNCAT) 
In QuaNCAT experiments the pulse labelling with amino acids is combined with bio-
orthogonal amino acid tagging and L-azidohomoalanine. This nontoxic alanine orthologue can 
be used to create covalent bindings via Click-iT ® chemistry. This click chemistry is used in 
the assay to enrich newly synthesized proteins via bead purification and therefore reduces the 
pulse length dramatically. Medium QuaNCAT medium was supplemented with “Lys 4” 
(4,4,5,5,-D4-L-lysine monohydrochloride),“Arg 6” (L-arginine-13C6 monohydrochloride) and 
AHA (L-azidohomoalanine), while heavy labelled pSILAC medium was supplemented with 
“Lys 8” (L-lysine-13C6 15N2 monohydrochloride), “Arg 10” (L-arginine-13C6 15N4 
monohydrochloride) and AHA (L-azidohomoalanine). The pulse length of this experiment was 
set for 30min. TheClick-iT protein purification kit (Thermo Fisher Scientific C10416) was used 
for Click-iT protein purification following the manufacturer’s protocol. Since the amount of 
proteins coming from neurite samples is always limiting, 21 filters were pooled per neurite 
sample. To extract those in the required 400µl of lysis buffer, batches of 7 membranes were 
sonicated and the supernatant buffer containing the proteins was transferred to a new tube 
containing the next 7 filters and so on. After preparing protein samples the protein extracts 
were mixed again in complementary pairs (heavy soma with light neurites and vice versa) and 
Click-iT enrichment for newly synthesized proteins was performed following the 
manufacturer’s protocol. Afterwards protein pools were submitted to digestion and MS 
analysis. 
Fig. 5 QuaNCAT. Schematic presentation of the QuaNCAT experiments. 
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4.2.2.6. SDS-PAGE 
SDS-PAGE was performed using the Bio-Rad Trans-Blot Turbo device (Bio-Rad 1704155). 
At first the separating gel was assembled and poured into the gel-holding device. To ensure a 
linear border to the stacking gel and no air bubble inclusions it was topped up with water until 
it solidified (30min). Afterwards the stacking gel was poured on top and the device was closed 
with the comb for another 30min. Once ready, the gel was mounted into the running device 
and SDS running buffer was filled into the outer and inner part of the assembly. Protein samples 
were mixed 1:5 with Laemmli loading buffer and heated for 5minto 95°C to ensure protein 
denaturation. Before loading the gel, all wells were flushed with a syringe. 25μl of protein 
solution was loaded into each well and the gel was run at 80V until the bromophenol blue 
border reached the separation gel and then at 120V until the bromophenol blue border exited 
the gel on the bottom. After disassembling the running device, the gel was either used for a 
Coomassie Brilliant Blue staining or subsequently for western blotting. 
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SDS loading buffer 5X (aliquots in freezer 5) 
component 
final 
concentrat
ion 
units 
concentrat
ion in 
stock 
units 
uni
ts 
added amount units 
Tris-HCl (pH 
6.8) 300.0 mM 1500 mM ml 8.0 ml 
glycerol 50.0 % 100 % ml 20.0 ml 
SDS 10.0 % 100 % g 4.0 g 
14.3 M β-2-
mercapto-
ethanol 5.0 % 100 % ml 2.0 ml 
bromphenol 
blue 0.1 % mg 40.0 mg 
H2O add to 40.0 ml 
final volume ml 40.0 ml 
SDS-PAGE running buffer (Tris-Glycine/SDS buffer pH 8.3) – shared stock 
1X  10X 
component 
final 
concentratio
n 
units 
final 
concent
ration 
units 
added amount 
for 10X  
units 
M (molar 
mass), 
g/mol 
Tris-
base/Trizma 0.025 M 0.13 M 30.3 g 121.14 
Glycine 0.190 M 0.95 M 144.1 g 75.06 
SDS 0.1 % 1.00 % 10.0 g 
H2O 0.95 L 
final volume 1.00 L 
1x mini gel 2x mini gels 3x mini gels 4x mini gels 
7.5% separating gel: 6 ml 12 ml 18 ml 24 ml 
H2O 2.9 ml 5.8 ml 8.7 ml 11.6 ml 
Acrylamide:Bis 30% 37.5:1 1.5 ml 3 ml 4.5 ml 6 ml 
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1.5 M Tris pH 8.8 1.5 ml 3 ml 4.5 ml 6 ml 
20% SDS 0.03 ml 0.06 ml 0.09 ml 0.12 ml 
10% APS 0.06 ml 0.12 ml 0.18 ml 0.24 ml 
TEMED 0.005 ml 0.010 ml 0.015 ml 0.020 ml 
                 
10% separating gel: 6 ml 12 ml 18 ml 24 ml 
H2O 2.4 ml 4.8 ml 7.2 ml 9.6 ml 
Acrylamide:Bis 30% 37.5:1  2 ml 4 ml 6 ml 8 ml 
1.5 M Tris pH 8.8 1.5 ml 3 ml 4.5 ml 6 ml 
20% SDS 0.03 ml 0.06 ml 0.09 ml 0.12 ml 
10% APS 0.06 ml 0.12 ml 0.18 ml 0.24 ml 
TEMED 0.005 ml 0.010 ml 0.015 ml 0.020 ml 
                 
12.5% separating gel: 6 ml 12 ml 18 ml 24 ml 
H2O 1.9 ml 3.8 ml 5.7 ml 7.6 ml 
Acrylamide:Bis 30% 37.5:1  2.5 ml 5 ml 7.5 ml 10 ml 
1.5 M Tris pH 8.8 1.5 ml 3 ml 4.5 ml 6 ml 
20% SDS 0.03 ml 0.06 ml 0.09 ml 0.12 ml 
10% APS 0.06 ml 0.12 ml 0.18 ml 0.24 ml 
TEMED 0.005 ml 0.010 ml 0.015 ml 0.020 ml 
                 
15% separating gel: 6 ml 12 ml 18 ml 24 ml 
H2O 1.4 ml 2.8 ml 4.2 ml 5.6 ml 
Acrylamide:Bis 30% 37.5:1  3 ml 6 ml 9 ml 12 ml 
1.5 M Tris pH 8.8 1.5 ml 3 ml 4.5 ml 6 ml 
20% SDS 0.03 ml 0.06 ml 0.09 ml 0.12 ml 
10% APS 0.06 ml 0.12 ml 0.18 ml 0.24 ml 
TEMED 0.005 ml 0.010 ml 0.015 ml 0.020 ml 
                 
5% stacking gel: 3 ml 6 ml 9 ml 12 ml 
H2O 2.2 ml 4.4 ml 6.6 ml 8.8 ml 
Acrylamide:Bis 30% 37.5:1  0.5 ml 1 ml 1.5 ml 2 ml 
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1.5 M Tris pH 6.8 0.25 ml 0.51 ml 0.76 ml 1.02 ml 
20% SDS 0.015 ml 0.03 ml 0.045 ml 0.06 ml 
10% APS 0.03 ml 0.06 ml 0.09 ml 0.12 ml 
TEMED 0.003 ml 0.006 ml 0.009 ml 0.012 ml 
 
4.2.2.7. Western blotting 
All western blots were performed using the semi dry transfer method. SDS-PAGE were 
assembled and run on the Bio-Rad Transblot Turbo station. The Gel was equilibrated in transfer 
buffer for 10min. The PVDF membrane was activated in pure methanol for 15s and also 
equilibrated in transfer buffer for 10min. For each blot two stacks of 7 Bio-Rad filter pads each 
were soaked in transfer buffer as buffer reservoirs. The transfer sandwich was assembled by 
layering onto the bottom of the transfer cassette (anode) one stack of buffer-soaked filter pads, 
the PVDF membrane, the equilibrated gel and, on top, another stack of buffer-soaked filter 
pads. All remaining air bubbles in this stack were removed and the transfer cassette was closed. 
The transfer was performed using 25V and 1A for 30min. The efficiency of the transfer was 
monitored via a prestained protein marker (Thermo Fisher Scientific   26619) and also via 
Coomassie staining the remaining gel. Prior to immunostaining, the membrane was blocked in 
blocking buffer (3% skim milk powder solution in TBS) for 30min of shaking. Primary 
antibody incubation was performed overnight at 4°C in blocking buffer with an appropriate 
antibody concentration. After the primary incubation, the membrane was washed three times 
with TBS-T for 15min each. Then the secondary antibody, coupled to horseradish peroxidase, 
was incubated on the membrane for one hour, shaking at room temperature. The secondary 
antibody was washed away with TBS-T three times, for 15min each wash, and pictures were 
made on the ImageQuant LAS4000 using homemade enhanced chemiluminescence (ECL) 
reagents. 
Combine: 
-    10 ml Tris pH 8.5  
- 2,6 μl H2O2  
- 25 μl coumaric acid  
- 50 μl luminol  
 
4.2.2.8. RNA extraction  
RNA extractions were performed with TriFast following the manufacturer’s protocol. All 
concentrations were measured using the Qubit RNA high sensitivity kit following the 
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manufacturer’s protocol. All quality control measurements were performed using either the 
Bioanalyzer RNA nano or RNA pico kit, following the manufacturer’s protocol and 
spectrophotometer measurements for phenol, protein or salt contaminations. RNA was always 
stored in appropriate aliquots in DEPC treated sterile water at -80°C. 
4.2.2.9. cDNA synthesis and quantitative real time PCR (qRT-PCR) 
Prior to cDNA synthesis, high quality RNA was treated with DNaseI following the 
manufacturer’s protocol. cDNA synthesis was performed using the Maxima cDNA synthesis 
kit following the manufacturer’s protocol. All qRT-PCR reactions were performed using the 
Bioline SensiFast Sybr NoRox kit following the manufacturer’s protocol. Reactions were 
assembled in 20μl volume and technical triplicates as well as biological duplicates. For each 
primer pair a no template control was run in triplicates and for each primer-cDNA combination 
a no reverse transcription control was performed to validate the DNase treatment. Each reaction 
was performed using 2ng of diluted cDNA. Reactions were run on a BioRad CFX 96 touch 
qRT-PCR device and results were analyzed using the Bio-Rad CFX Manager version 3.1. For 
new primer pairs the amplicons were validated with a melting gradient and via agarose gel 
electrophoresis once, and the amplification efficiency was validated via cDNA dilution 
gradient. Fold change differences were calculated using the ΔΔCT method using appropriate 
control genes. All error bars in qRT-PCR plots represent the standard deviation of biological 
replicates. 
4.2.2.10. NanoString 
NanoString experiments were conducted following the manufacturer’s protocol. All 
Experiments were performed in duplicates using 500ng total RNA as input material. Results 
were analyzed using the nSolver software using internal controls for normalization.  
4.2.2.11. Total RiboZero RNA sequencing 
Total RiboZero RNA libraries were produced following the Illumina TruSeq stranded total 
RNA library protocol. Prior to the library production, all RNA samples were quality controlled 
for degradation with the Bioanalyzer and for contamination with the spectrophotometer. 
Concentrations throughout and prior to the protocol were measured via Qubit RNA high 
sensitivity assay. ERCC RNA mixes were spiked into all total RiboZero libraries. Ribosomal 
depletion was tested immediately after it was performed via Bioanalyzer and prior to 
sequencing using qRT-PCR. The amplification cycle number in the library generation was 
chosen by diagnostic qRT-PCR with a 1/10 fraction of the sample and set for the CT + 2. 
Libraries were run on a NextSeq500 or HiSeq4000 following the manufacturer’s protocol. All 
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libraries were quality controlled for size and concentration via Qubit DNA high sensitivity kit 
and Bioanalyzer DNA1000 chip. 
4.2.2.12. Small RNA sequencing 
Small RNA libraries were produced following the Illumina TruSeq Small RNA Library Prep 
Kit guide. Prior to the library production, all RNA samples were quality controlled for 
degradation with the Bioanalyzer and for contamination with the spectrophotometer. 
Concentrations throughout and prior to the protocol were measured via Qubit RNA high 
sensitivity assay. Small RNA libraries were all purified from TBE gels and all libraries were 
quality controlled for size and concentration via Qubit DNA high sensitivity kit and 
Bioanalyzer DNA1000 chip . 
4.2.2.13. In vitro transcription and A-tailing 
Fragments coming from a mixture of RNA-seq libraries were PCR amplified for 10 cycles 
using oligos, which add a T7 RNA polymerase promotor sequence. In vitro transcription was 
performed with mMESSAGE mMACHINE T7 in vitro transcription kit following the 
manufacturer’s protocol. RNA was purified using RNeasy column purification following the 
manufacturer’s protocol and A-tailed with Poly(A) Tailing Kit following the manufacturer’s 
protocol. Prior to usage the RNA was column purified again using RNeasy columns. 
4.2.2.14. Modified RNA element selection assay (RESA) 
The RNA element selection assay (RESA), published by Yartseva et al. [284], is a method to 
identify regulatory RNA elements out of a fragmented reporter library. It is based on the 
introduction of a pool of fragmented RNA elements into a test system and analyzing the re-
purified reporter library via next generation sequencing after a period of time. Changes in 
abundancy of specific sequences can be used to identify regulatory sequences that stabilize or 
destabilize the reporter in this system and timeframe. In order to use the theory in our test 
system several things were changed in the experimental setup; the reporter library was 
incorporated stably into the genome of our cell line and instead of a temporal effect on 
stabilization, the effect on localization of the transcript was analyzed. 
384 transcripts that show significant RNA or protein enrichment in our dataset were chosen as 
reporter candidates. Additionally, 48 transcripts that show enrichment in Cajigas et al. [246] 
were chosen as control elements. Primers to amplify the 3’ UTRs of these transcripts were 
designed using primer3 software (see material and methods - oligos). PCR amplification of 3’ 
regions was performed with Phusion high fidelity polymerase in a 20µl volume and 96-well 
format using a temperature gradient from the highest to the lowest Tm of the primers on the 
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plate. 5µl off each reaction was used to validate the product by size via electrophoresis on a 
1% agarose gel. PCR reactions that did not work were one repeated using the GC-buffer. PCR 
reactions that gave multiple amplicons were run on a gel and the correct band was excised and 
gel purified. The amount of amplicon was estimated based on the thickness of the band and 
either 5µl, 10µl or 15µl of the reactions were pooled to create the reporter library. The pool of 
fragments was batch purified using AmpureXP beads and eluted in water. 10µg of the reporter 
pool was used for random fragmentation via sonication using a Bioruptor with the settings 30s 
ON, 30s OFF, high, 40 cycles. After fragmentation the fragments were blunt ended using the 
Klenow fragment, adding 6µl of T4 ligase buffer, 1µl of dNTPs and 3µl of Klenow fragment 
for one hour at 37°C. The fragmented and blunt ended material was run on a Mini-PROTEAN 
gel and fragments with a size between 100 and 150nt were excised from the gel.  
Fig. 6 Fragmentation and gel purification of RESA fragments 
The gel slice was crushed and diluted with 50µl of DEPC treated water and rotated overnight 
at 4°C for elution. Afterwards the gel residues were spun down and the dsDNA fragments from 
the supernatant were purified using AmpureXP beads and eluted in 17.5µl of water. 2.5µl of 
resuspension buffer and 12.5µl of A-tailing mix, both from the Illumina TruSeq stranded total 
RNA-seq kit, were added and the tubes were put on the thermal cycler running the A-tailing 
program from the kit (preheat lid to 100°C, 37°C/30min, 70°C/5min, 4°C/hold). Following the 
adapter ligation procedure from the Illumina TruSeq stranded total RNA-seq protocol 2.5µl of 
resuspension buffer, 2.5µl of ligation mix and 2.5µl of barcoded adapter were added and the 
whole sample was mixed intensively via pipetting and incubated on a thermal cycler for 10min 
at 30°C. 5µl of stop ligation buffer was added and the adapter ligated fragments were purified 
twice with AmpureXP beads in a ratio of 1:1 (sample : beads). The last elution step was 
performed in 32.5µl of resuspension buffer. A diagnostic qRT-PCR was run to estimate the 
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amount of adapter ligated library and the final PCR amplification was performed using the 
Phusion high fidelity polymerase with HF buffer in a 50µlvolume and primers 2425 and 2426 
with Ct+2 cycles to add overhangs for Gibson assembly into the AgeI restricted piggyBAC 
transfer vector. All steps were validated using the Bioanalyzer DNA1000 chip. 
 
Fig. 7 Cloning of RESA fragments 
The vector backbone for cloning was prepared via AgeI digestion of 10µg of piggyBAC 
transfer vector overnight at 37°C. The linearized product was treated with FastAP for three 
hours at 37°C to prevent re-ligation and purified via gel electrophoresis on a 1% agarose gel 
and eluted in 30µl of water. 10µl of this linearized vector was mixed with either 15µl of insert 
or water for the negative control and 25µl of 2x homemade Gibson mix and incubated for 2h 
at 50°C. The complete Gibson assembly reaction was dialyzed against water and transformed 
in 10 reactions into electro competent Endura cells (Lucigen 60242-1). After recovery of the 
cells for a maximum of 30min in supplemented recovery medium, a serial dilution of the mix 
starting from 10µl of undiluted bacterial suspension was plated on LB ampicillin plates to 
estimate the number of c.f.u. in the experiment. The number of c.f.u. is taken as a proxy for the 
number of single ligation events and therefore can be used to calculate the estimated 
complexity of the final library. The rest of the bacterial suspension is used to inoculate 500ml 
of LB supplemented with ampicillin. This culture is used to prepare the plasmid library via 
plasmid DNA isolation using the Nucleobond Xtra Midi Plus kit (Macherey Nagel 
MN/00740412/000050).  
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To prepare a reporter cell line, 160µg of the piggyBAC transfer vector carrying the library was 
mixed with 40µg of piggyBAC transposon vector and transfected into 20 million Ascl1-mESC 
using JetPrime transfection, following the protocol outlined above. Cells were treated with 
200µg/ml of hygromycin for three days until the fraction of GFP positive cells was >90%. 
After one day of recovery from antibiotic selection the cells were differentiated using the 
protocol outlined above and distributed onto 54 filters coated with Matrigel. Filter separation 
was performed as stated above and the neurites and soma of 18 filters are always pooled as one 
replicate. RNA was purified as stated previously and was tested for integrity, purity and 
quantity via Bioanalyzer, spectrophotometer and Qubit RNA high sensitivity assay. 50ng of 
each RNA sample was taken as input for cDNA synthesis using the Maxima cDNA synthesis 
kit and qRT-PCR analysis using primers for the library, rRNA and Tagln to estimate the 
amount of library and the efficiency of separation. 1.8ug of extracted RNA is RQ1-DNase 
treated and, after AmpureXP bead purification, suspended in 13.1µl of water was taken as input 
for targeted cDNA synthesis using the TGI-RT. 1µl of 10µM primer 2317 solution was added 
and the mixture was heated to 70°C for 10min and cooled on ice immediately. 4µl of TGI-RT 
buffer was added together with 80U of the TGI-RT enzyme. The reaction was left for 30min 
at room temperature for priming. 2.5µl of dNTPs was added and the reverse transcription 
reaction was performed for two hours at 60°C. To terminate the reaction and separate the TGI-
RT from the constructs it was necessary to treat the mixture with 1µl of 5N NaOH for 3min at 
95°C, after which  it was neutralized with 1µl of 5N HCl on ice. cDNA was bead purified using 
the AmpureXP beads and eluted in 30µl of water. 2µl of this mixture was taken as input for 
another diagnostic qRT-PCR to estimate the correct cycle number for the final amplification. 
The final amplification of the library for sequencing was also used to introduce different 
barcodes to the different samples using primer pairs 1453/2317, 1454/2317, 1455/2317, 
1456/2317, 1457/2317 and 2317/2318 for samples Neurites1, Neurites2, Neurites3, Soma1, 
Soma2 and Soma3, respectively. PCR reaction was performed in 50uL volume with Phusion 
high fidelity polymerase in HF buffer and diagnostic PCR CT+2 as cycle number. Once ready, 
the libraries were purified with AmpureXP beads and mixed in equimolar amounts for 
sequencing. 
4.2.3. Microscopy 
4.2.3.1. Immunohistochemistry 
For immunostainings of single neurons, cells were differentiated on coated cover slides. The 
coating for N1E-115 cells was 1ug/ml laminin solution in PBS for three hours at room 
temperature. The laminin solution was washed away shortly before seeding the cells. The 
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coating of glass cover slides for Ascl1-mESC was performed for 3h at room temperature with 
a 0.1mg/ml Poly-L-Ornithine solution in water. The coating solution was washed away with 
water and the glass slides were dried. N1E-115 cells were seeded undifferentiated on the 
laminin coated glass slides and differentiated attached to the slide. Ascl1-mESC embryoid 
bodies were prepared as described above. After two days of culturing in AK supplemented with 
3µg/ml doxycycline, embryoid bodies from one 10cm dish were washed gently with warm PBS 
and incubated in 1ml TripLE for 3min at room temperature. Cells were separated via pipetting 
using 4ml of Feeders medium. The cell suspension was spun down at 1,500g for 5min and the 
cells were suspended in monolayer medium. Cell concentration was counted using the Luna 
cell counter (Logos Biosystems CTM0011) and plated in a density of 150,000 cells per cm² in 
monolayer medium. The medium was changed once on the third day of differentiation on the 
slide. Cells were processed on the fourth day of culturing them in monolayer. N1E-115 cells 
were processed on the third day of differentiation on the cover slide. The staining was 
performed as followed: 
- Cells washed gently three times with cold PBS 
- Fixation for 10min at room temperature in 4%PFA in PBS 
- Cells washed gently three times with cold PBS for 5min each 
- Permeabilization at room temperature with PBS supplemented with 0.2% Triton X-100 
- At this step cells were stored in the fridge for up to one month in PBS or 70% EtOH 
- Blocking with PBS supplemented with 0.05% TWEEN and 20% Roche reagent 
- First antibody incubation at 4°C overnight in blocking solution with recommended 
antibody concentration 
- Cells washed three times with PBS for 5min each 
- Second antibody incubation at room temperature in the dark in blocking solution with 
recommended concentration 
- Cells washed three times with PBS supplemented with 0.05% TWEEN for 5min each 
- Mount cells with ProLong Gold on a glass slide holder 
- Dry samples for one day at room temperature in the dark 
Cells grown on the filter were treated as described above until the mounting step. One drop of 
mounting medium was placed on the glass slide holder and the filter was excised from the 
plastic holder and placed on the mounting medium. Another drop of mounting medium was 
placed on top of the filter and the coverslip was placed on top of the sandwich. Filter samples 
were also dried for one day at room temperature in the dark. Pictures were taken using a Laica 
SP8 confocal microscope. 
  
108 
 
 
  
  
109 
 
5. Results 
5.1. Characterization and differentiation of the cell line N1E-115  
N1E-115 neuroblastoma cells were differentiated by serum starvation following the protocol 
from Pertz et al [282]. The neuronal phenotype was validated via immunofluorescence (Fig. 
8a). These cells were used as neuronal model systems in diverse studies [285]–[289]. To 
confirm the neuronal phenotype on the transcriptome level a RiboZero total RNA sequencing 
experiment was performed with RNA extracted on d0 and d3 of the differentiation. Using 
DeSeq2, 20,606 genes were identified in total with more than two reads per condition, of which 
1,175 transcripts showed an upregulation of twofold or more with a p-val below 0.05, while 
219 transcripts were downregulated twofold or more with a p-val below 0.05 (Fig 8b). Gene 
ontology (GO) term enrichment of the upregulated genes (differentiated N1E-
115/undifferentiated N1E-115 > 4) was analyzed using the Panther software [290] (Figure 1). 
A gene ontology overrepresentation test for biological processes showed a clear enrichment 
for neuronal associated terms, such as: regulation of axonogenesis, neurogenesis, synaptic 
vesicle formation and synaptic plasticity as well as several terms related to intracellular protein 
and organelle localization (Fig 8c).  
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Fig. 8 Characterization of the Neuroblastoma cell line N1E-115 
A Immunofluorescence of two days differentiated N1E-115 cells. Differentiation was induced via serum 
starvation. DAPI (blue), Actin (red) and Tubulin (green). B Batch RiboZero RNA-seq of undifferentiated and 
differentiated cells. RNA samples were prepared after two days of treatment. Primary analysis of the data was 
performed by Vedran Franke. C Statistical enrichment of gene ontologies during differentiation reveals a 
statistical overrepresentation of terms related to neuronal development. Shown are the top 20 results of the 
statistical overrepresentation test. 
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5.2. Characterization and differentiation of Ascl-mESC into Ascl1-iNs 
Ascl1-iNs were used as a second test system throughout this study. These cells were 
differentiated into neurons from mESCs, expressing the neurogenic transcription factor Ascl1 
under the doxycycline-inducible promotor (Ascl1-mESC). Ascl1 is expressed endogenously 
early during neuronal differentiation. It is a pioneer proneural transcription factor that drives 
differentiation towards induced neurons (Ascl1-iNs) that are post-mitotic and express neuronal 
markers. 
It has been shown that Ascl1 alone is sufficient to generate functional neurons from mouse and 
human ESCs and astroglia [291], [292].  Homogeneity of the neuronal cell population is the 
critical precondition for performing neuronal localization experiments. Since the Ascl1-iN 
cells showed high homogeneity they were chosen for further experimental manipulation.  
I confirmed the neuronal identity of these cells by SILAC (stable isotope labeling by amino 
acids in cell culture), comparing uninduced Ascl1-mESC and Ascl1-iNeurons (Fig. 9a). In 
these experiments differences in protein abundance between samples are detected using 
isotopic non-radioactive labelling [293]. As expected, GO term overrepresentation analysis 
[290] showed that genes upregulated upon differentiation (iNeurons/mESC > 4) are associated 
with neuronal functions. Additionally, immunofluorescence using markers for neurofilament 
and tubulin showed a clear neuronal phenotype. (Fig. 9c). 
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Fig. 9 Characterization of Ascl1-iNs 
A Immunofluorescence pictured five days after Ascl1 induction. Neurofilament (green), Tubulin (red), DAPI 
(blue). B Stable Isotope Labelling by amino acids followed by MS/MS. Upregulated proteins during 
differentiation are highlighted in red, downregulated proteins are highlighted in blue. Primary analysis of the data 
was performed by Koshi Imami. C Upregulated proteins are associated with neuron related gene ontologies. 
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5.3. The local transcriptome and proteome of neuronal cells revealed by spatial 
omics 
To identify proteins and mRNAs that are asymmetrically localized between the neurites and 
soma of neuronal cells, a modified Boyden chamber assay that allows the separation of distinct 
cellular compartments was employed.  
To isolate neurite outgrowths and soma for biochemical applications, ASCL1-iNeurons and 
N1E-115 neuroblastoma cells were differentiated and maintained on a porous membrane in 
such a way that cell bodies stayed on the upper side of the membrane. The coating agent on the 
lower side of the membrane provided cues for neurites to grow through the pores and attach 
onto the other side of the membrane [282], [294].  
Indeed, neurofilament and tubulin-rich neurites were found primarily on the lower side of the 
membrane, while soma, visualized with DAPI, were only present on the top on the membrane 
(Fig. 11&12). Neurites and soma were mechanically isolated from either side of the membrane 
for proteomic and transcriptomic analyses. As neurites are far smaller than soma and contain 
much less RNA and protein, it would be uninformative to compare the proteomes of neurite 
and soma fractions from the same number of cells. Instead, following recent approaches [81], 
[282], [295], in assumption of uniform total protein and RNA concentrations over the cell body 
the numbers were normalized according to the total protein and RNA content in the sample. 
All protein or RNA measurements in this study are therefore relative differences in the 
subcellular proteome or transcriptome. 
 
 
Fig. 10 Schematic presentation of the separation of subcellular compartments. 
Separation approaches are always performed starting with 1M cells on a 6-well-insert with 4ml of medium in total. 
Mean yield of the soma fraction is about 15µg of RNA and 400µg of protein for N1E-115 cells and 1µg of RNA 
and 100µg of protein per filter for Ascl1 cells. Mean yield for the protrusion fraction is about 100ng of RNA and 
15µg of protein per filter for N1E-115 cells and 200ng of RNA and 20µg of protein per filter from Ascl1 cells. 
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5.3.1. Local -omics analysis of the neuroblastoma cell line N1E-115 
Staining differentiated cells on the membrane using markers for tubulin and DAPI confirmed 
a clean separation of cellular outgrowths and soma compartments (Fig. 11a). The average yield 
of protein extraction from one filter was 15µg per neurite sample and 400µg per soma sample. 
Coomassie staining already showed the difference in protein composition between the samples 
(Fig. 11). Subsequent label-free protein quantification via mass spectrometry revealed a diverse 
proteome of the subcellular compartments. GO analysis of proteins enriched in the outgrowth 
showed a clear enrichment for membrane, cell-junction and receptor associated proteins (Fig. 
11f). Marker proteins as histones (e.g. Histone 2A, Histone 2B) and components of the nuclear 
envelope (e.g. Lamin B1 and several nucleoporins) are found either exclusively or highly 
enriched in the somatic fraction. On the other hand, marker proteins associated with neurite 
growth cones (e.g. Netrin receptors, Slit2, Sema6d) and membrane protrusions (e.g. Actn4, 
Fmnl1) were found highly enriched in the neurite fraction. For validation we compared our 
dataset with a published proteomic dataset from Pertz et al. [282].  
The extracted RNA was depleted from ribosomal RNA using RiboZero bead purification and 
used for total strand specific RNA-seq sequencing. In total, 19,998 genes could be identified 
by at least two readings in either of the compartments. Eight transcripts could be validated as 
upregulated more than twofold with a p-val of below 0.05, whereas 287 transcripts could be 
identified as being significantly enriched in the soma fraction  more than twofold, with a p-val 
of below 0.05. Furthermore, qRT-PCR analysis confirmed that the dataset is statistically weak 
but holds true for these cells (Fig. 11e). Problems in the depletion of ribosomal RNA in one 
neurite sample resulted in a very shallow dataset for this replicate. This is the reason for the 
low number of enriched found transcripts and low statistical validity of the experiment. 
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Fig. 11 Subcellular compartment separation of the neuroblastoma cell line N1E-115 
A Immunofluorescence picture of differentiated cell on the membrane. Tubulin (green), DAPI (blue). Outgrowths 
below the filter are difficult to see because of autofluorescence signal coming from the PET-membrane. B Label-
free MS of subcellular compartments of N1E-115 cells. Highlighted are protein that are exclusively found in the 
outgrowths (dark red), outgrowth enriched proteins (red), soma enriched proteins (blue) and proteins that are 
exclusively found in the soma fraction (dark blue). Primary analysis of the data was performed by Guido 
Mastrobuoni. C Coomassie staining of subcellular compartments from N1E-115 cells. The different patterns of 
protein compositions are clearly visible. D RiboZero total RNA-seq of RNA coming from subcellular 
compartments. Highlighted are transcripts enriched in the outgrowth (red) and transcripts that are enriched in the 
soma fraction (blue) with a p-val below 0.05. Primary analysis of the data was performed by Vedran Franke. E 
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qRT-PCR validation of some known localized transcripts. F GO analysis for the neurite enriched proteins and 
mRNAs. 
 
5.3.2. Local –omics analysis of Ascl1 induced neurons derived from mouse embryonic 
stem cells 
The clean separation of neurite and somatic subcellular compartments was validated via 
immunofluorescence imaging using markers for tubulin and neurofilament (Fig. 12a). The 
yield of protein extraction from subcellular compartments was 20µg per neurite fraction and 
200µg per soma fraction. 
The contamination of proteins coming from the coating reagent was prohibited using a SILAC 
approach. Unfortunately, the correlation of forward and reverse experiment was not sufficient 
for further analysis (Fig. 12b). Plotting the results of the label swap experiments against each 
other revealed a clear correlation but also a very shallow forward dataset. Since this might 
indicate a contamination of the forward neurite sample with soma material, the experiment was 
validated using a third dataset produced by lab colleague Alessandra Zappulo. As expected, 
the reverse experiment showed a clear correlation with the label-free quantification and is 
therefore used throughout the study (Fig. 12c&d). In total 4,317 proteins where identifiedby at 
least two unique peptides in the soma and the neurite sample. Since relative quantification by 
SILAC relies on a ratio of peptides, proteins identified exclusively in one compartment are not 
included in this analysis. 234 proteins could be identified as enriched more than twofold in the 
neurite fraction, while 179 proteins could be identified as enriched more than twofold in the 
soma sample. Western blot analysis of different marker proteins chosen on functionality and 
antibody availability confirmed this data. GO analysis revealed a clear enrichment for 
molecular transport and cytoskeleton in the neurites of Ascl1-iNs (Fig. 12e). Several genes 
known to regulate neurite outgrowth, cell protrusion and growth cones such as Tnc  [296], Fgf3 
[297] or Ptgs2 [298] showed a clear enrichment in the neurite sample. On the other hand, 
marker proteins for DNA metabolism, chromatin structure and the nuclear envelope are found 
highly enriched in the somatic fraction. All together this proves the clean separation and 
validates the SILAC experiment. 
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Fig. 12 Subcellular compartment separation followed by proteome analysis of Ascl-iNs 
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A Immunofluorescence of Ascl1-iNs on the filter. Pictures were taken five days after Ascl1 induction. 
Neurofilament (green) and DAPI (blue). The autofluorescence from the PET-membrane covers slightly the 
neuritic signal. B Subcellular SILAC of Ascl1-iNs. Differently labelled compartments are always compared. 
Label-swap replicates are not conclusive. Primary analysis was performed by Koshi Imami. C&D Validation of 
label swap replicated via label free quantification (done by Alessandra Zappulo). In C the forward replicate of the 
SILAC experiment is plotted against the label-free data. The correlation is not conclusive. In D the reverse 
experiment is plotted against the label-free data. The correlation is sufficient. Highlighted are neuritic enriched 
proteins (red) and somatic enriched proteins (blue). E Gene ontology analysis of enriched proteins. 
 
The average yield for RNA extraction from Ascl1-iNs was 200ng per neurite fraction and 2µg 
per soma fraction. 
After extraction and quality control the RNA was depleted of ribosomal RNA using RiboZero 
and submitted to a total stranded RNA-seq experiment. More than 18,000 protein coding genes 
in neurites and more than 19,000 protein coding genes in the somatic fraction were quantified 
with a threshold of one or more RPKM (reads per kilobase of transcript per million mapped 
reads). 
In total 1,292 genes were identified as enriched in the neurites more than twofold with a p-val 
of below 0.05 and 3,614 genes were identified as enriched more than twofold in the soma 
fraction with a p-val of below 0.05 (Fig. 13a). The performed RNA-seq experiment was 
validated via nanoString and additionally 21 genes were validated by qRT-PCR (Fig. 13b & 
c). GO enrichment analysis revealed a clear overrepresentation of terms associated with 
neuronal functions, cytoskeleton, neuronal protrusions and growth cones in the neurites of 
Ascl1-iNs (Fig. 13d).  
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Fig. 13 Transcriptome analysis of subcellular compartments of Ascl1-iNs  
120 
A RiboZero total RNA-seq of subcellular compartments. Highlighted are neuritic enriched transcripts (red) and 
somatic enriched transcripts (blue) with a p-val below 0.05. Primary analysis was performed by Vedran Franke. 
B Validation of Transcript localization via nanoString. C Validation of RNA-seq via qRT-PCR. 21 representative 
genes were taken for a detailed validation of the RNA-seq results via qRT-PCR.  
5.3.3. The local transcriptome and the local proteome is cell line specific 
Previously published datasets showed that the spatial transcriptome and proteome are highly 
cell type specific [81], [109], [246], [249]. Comparison of the spatial enrichment of transcripts 
in neurite outgrowths of N1E-115 to neurites of Ascl1-iN resulted in very little overlap. A 
significant correlation between the relative enrichment measured in these experiments could 
not be observed (Pearson’s r=0.07). No transcript shows enrichment in both cell lines by more 
than twofold and a p-val of below 0.05 and 16 transcripts show a somatic enrichment in both 
cell lines by more than 2-fold and a p-val of below 0.05. On the proteome level 61 proteins 
show a relative enrichment in both cell lines of more than twofold and 69 proteins show a 
relative somatic enrichment of more than 2-fold in both cell lines. However, no correlation 
between the measured relative enrichment in these cell lines could be observed for the 
proteome either (Pearson’s r=-0,04).  
Fig. 14 Comparison of the neuronal model systems N1E-115 and Ascl1-iNs. 
A Comparison of RNA localization between the two model cell lines. 34,256 transcripts could be identified by at 
least two reads in all compartments of both cell lines. Pearson’s r=-0.05. B Comparison of protein localization 
between the two model systems. 3,269 transcripts could be identified with at least two peptides in all 
compartments of both cell lines. Pearson’s r=0.075. 
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5.3.4. Identification of differential isoform localization, lncRNAs and circRNA 
localization 
Differential splicing can be an effector of spatial RNA regulation and RNA localization [299] 
and previous studies highlighted the differential localization of isoforms for example in the tips 
of migrating fibroblasts and also in neuronal projections [81]. Regulatory sequences can be 
spliced differentially, and the stability of transcripts can be altered tremendously by alternative 
splicing. The identification of differentially spliced isoforms in total RNA sequencing data is 
not trivial due to complex splicing patterns. Employing MISO [111], 39 triplets of exons with 
a slightly different localization were identified (Fig. 15a). Alternatively, spliced exons are 
identified in this network by comparing the relative enrichment of one exon compared to its 
neighboring up and downstream exon. None of the identified exon specific localizations are 
higher than twofold. Specific experiments targeting alternative splicing or A-tailing of 
transcripts have been performed to analyze the impact of alternative splicing on spatial 
localization in more detail. Interestingly, most of the differentially enriched exons are part of 
circular spliced isoforms. Circular mRNAs are a special form of alternatively spliced mRNAs. 
They can inherit exons and introns of canonical transcripts and are defined by a head-to-tail 
splice junction, leading to a circular molecule. It was shown that circRNAs are abundant in 
neuronal cells and particularly in the synapse [300], [301]. Due to their circular nature they 
possess specific attributes such as resistance to exonucleases, lack of a cap and an A-tail 
structure and overlapping and sometimes even indefinite open reading frames. It was shown 
that they can be translated in vivo [302] or act as sponges for trans acting factors such as miRs 
[303], [304]. 362 genes with circular isoforms were identified in Ascl1-iNs with more than one 
RPKM spanning the circular splice junction in either compartments. Out of the 362 circRNAs, 
32 showed two or more-fold enrichment in the neurite compartment while 64 showed two or 
more-fold enrichment in the somatic compartment. Moreover, for 90 circRNAs the circular 
isoform shows a significantly higher neurite localization than the linear form (Fig. 15b). 
Approximately half of these circular mRNAs show a neurite localization, while the linear 
isoform is not localized. This points towards an isoform specific mechanism of localization. 
To give an example, the circular transcript of Ephrin type-b receptor 2 (Ephb2), a receptor 
tyrosine kinase that functions in axon guidance [305], is more than ten times more abundant in 
neurites of Ascl1-iNs than its linear isoform. Whereas in the soma this ratio is reversed. Linear 
Ephb2 is seven times more abundant in the soma than its circular isoform.  
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Different affinities to localization machinery may mediate the differential localization of linear 
and circular transcripts. We also cannot exclude the possibility of local splicing, especially as 
we find a number of splicing factors enriched in neurites.  
Non-coding RNAs comprise a heterogenous and important group of genes with various roles 
in gene expression. Forty percent of lncRNAs show brain-specific expression patterns [306]; 
thus, lncRNA expression in the neurites and soma of iNeurons were analyzed. 550 annotated 
lncRNAs (> 10 RPKM) were detected. Since most lncRNAs are nuclear, it is not surprising 
that most lncRNAs show a somatic enrichment, although 12 lncRNAs of unknown function 
exhibited over twofold enrichment in neurites (P-values < 0.05). This result suggests they could 
contribute to neuronal polarity, spatial translation or act on or with local proteins. 
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Fig. 15 Alternative splicing and localization.  
A Differential exon localization in Ascl1-iNs. Primary analysis was performed by Vedran Franke. B Differential 
circRNA localization in Ascl1-iNs. Primary analysis was performed by Andrei Filipchyk. C Differential 
lncRNA localization in Ascl1-iNs. Primary analysis was performed by Andrei Filipchyk. 
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5.3.5. RNA localization correlates with protein localization in Ascl1 derived neurons 
The impact of local protein synthesis on the spatial proteome has, despite its unquestionable 
importance, never been shown on a global scale. This phenomenon would imply a correlation 
of transcript and corresponding protein localization. To highlight the relation between 
transcript and protein product localization the datasets of subcellular protein and RNA 
localization were compared. While in N1E-115 cells the localization of transcripts and their 
corresponding protein products is not correlating (Pearson’s r=-0.04) in Ascl1-iNs a clear and 
positive correlation is found (Pearson’s r=0.55) (Fig. 16a&c).  
This result might indicate that mRNA localization is important for a substantial fraction of the 
neurite-localized proteome.  
Interestingly, the top enriched fraction of proteins in our dataset is also found spatially enriched 
as transcripts. This suggests that high amounts of local proteins require mRNA localization.  
The average localization for transcripts for either neuritic or somatic enriched proteins does not 
differ in N1E-115 cells, while there is a significant difference in Ascl1-iNs (p<0.005; Fig. 
16b&d). For further analysis the pool of genes was divided into six major groups: (1) genes for 
which the RNA and the protein were found enriched in the neurites; (2) genes for which the 
RNA and the protein product were found enriched in the somatic fraction; (3) genes for which 
the RNA was enriched in the neurites and the protein product was not; (4) genes for which the 
protein was found enriched in the neurites but the transcript was not; (5) genes for which the 
RNA was somatic enriched but the protein was not; and (6) genes for which the protein was 
somatic enriched but the RNA transcript was not. GO analysis revealed a clear enrichment for 
neurite and receptor associated genes within groups 1, 3 and 4 (Fig. 16e). 
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Fig. 16 Comparison of transcript localization and corresponding protein products in neuronal model systems 
A Correlation of RNA-transcripts and protein products in the neuroblastoma cell line N1E-115 . Highlighted are 
genes for which transcript and protein are neurite localized (red) and genes for which transcript and protein are 
somatic localized (blue). B Violin plot for RNA localization of neuritic and somatic proteins. C Correlation of 
transcript and protein localization in Ascl1-iNs. Highlighted are proteins for which the transcript and the protein 
is neuritic localized (red) and genes for which the transcript and the protein product are somatically localized 
(blue). RNA and protein localization show a positive correlation (Pearson’s r=0.55). D Violin plot for the 
transcript localization of either somatic or neuritic proteins. E Gene ontology analysis for enriched genes. 
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5.3.6. Overlay with spatial ribosome profiling data reveals the impact of local 
translation on the spatial proteome 
To rule out the possibility of independent localization of proteins and their transcripts the 
spatial translatome was examined. The impact of local protein synthesis on protein localization 
can be visualized by correlating datasets for spatial proteome, transcriptome and translatome. 
For translatome, a dataset from spatial ribosome profiling (RiboSeq) experiments performed 
by Camilla Cioli Mattioli was used [307]. In these experiments just those mRNAs were 
sequenced which were in the moment of fixation covered by a ribosome. Assuming that the 
elongation state is predominant, this can be used as a proxy for ribosome activity and therefore 
translation. We used the ratio of RiboSeq reads in neurites versus soma to assess the relative 
translation amount in the spatial compartments (Fig. 17a). The ratio of RiboSeq reads per kb 
of transcript can therefore be taken as a measurement of translational efficiency of a specific 
transcript. The spatial RiboSeq data correlates with both protein (Pearson’s r=0.41) and RNA 
localization (Pearson’s r=0.33). Comparing the relative RiboSeq signals for the different 
subgroups shows a significant difference between somatic and neuritic enriched transcripts 
(Fig. 17b). 
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Fig. 17 Local translation in neurites of Ascl1-iNs 
A Local translation identified via subcellular RiboSeq correlates well with RNA and protein localization. Plotted 
is RNA vs. protein localization color coded for local translation. RiboSeq data was generated by Camilla Cioli 
Mattioli. Primary analysis was performed by Lorenzo Calviello. .B Boxplot for relative RiboSeq signal for 
different gene subgroups.  
 
For validation of these experiments spatial pSILAC and QuaNCAT experiments were 
performed. These experiments quantify de novo protein synthesis using pulse labelling of 
newly synthesized proteins via stable isotope labelled amino acids, followed by mass 
spectrometry. During a defined pulse, cells were treated with either heavy or medium labelled 
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amino acids that are subsequently incorporated into newly synthesized proteins. The pulse 
length is critical to distinguish between spatially synthesized and transported proteins. Due to 
the relatively low translational activity in post mitotic cells a pulse length of two hours was 
used in the pSILAC assay, knowing that protein transport in this time might bias the data. 
Ascl1-iNs cultured on a porous membrane were incubated for the pulse length in either heavy 
(H) or medium (M) isotope-labelled medium and subsequently used for subcellular 
fractionation of soma and neurites. Subsequently, the differentially labelled lysates were 
pooled (H neurites + M soma in forward (FW) and M neurites + H soma in reverse (REV) 
experiment, Fig. 18a). The FW and REV experiments represent “label swap” biological 
replicates to eliminate biases introduced by the labeling procedure (Fig. 18b). The ratios of 
peak intensities, H /M in FW experiment and M/ H in REV experiment, quantifies the relative 
translation rates in neurites versus soma. Thus, the translation rates of 242 proteins were 
measured in the two compartments (Fig. 18c, the relatively low coverage is expected after a 
short two hour labeling pulse). Importantly, we observed a strong correlation between relative 
translation rates measured by RiboSeq and pSILAC (Fig. 18c).  
To shorten the pulse length even more a QuaNCAT experiment was performed to quantify 
relative translation rates in neurites and soma. These experiments combine isotope labelling of 
de novo synthesized peptides with azidohomoalanine (AHA; Fig. 18e) labelling. 
Azidohomoalanine enables covalent linking of newly synthesized proteins to alkyne agarose 
beads using “click chemistry”, and their separation from the protein pool. Proteins are digested 
“on bead” and treated using the pSILAC workflow (Fig. 18e&f). The purification step 
employed in QuaNCAT substantially reduces the background of pre-existing proteins, which 
enabled reproducible measuring of relative protein abundance of 380 newly synthesized 
proteins after a short pulse of AHA (30 min). Relative translation rates measured by QuaNCAT 
and pSILAC supported the spatial omics analysis (pSILAC Pearson’s r=0.53, QuaNCAT 
Pearson’s r=0.71) and correlate positively to the RiboSeq dataset (Pearson’s r=0.8), indicating 
that the pulse length and therefore protein transport is in this case not interfering with results. 
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Fig. 18 Validation of local translation 
A Scheme of pSILAC experiments. Cells were cultured in light medium for five passages prior to the experiment. 
B Label-swap replicates show a sufficient correlation. Outliers were excluded from further analysis. Primary 
analysis was performed by Koshi Imami. C Correlation of pSILAC and RNA-seq results. D Correlation of 
pSILAC and SILAC results. E Scheme of QuaNCAT experiments. Cells were cultured in light medium for five 
passages prior to use. F Label-swap replicates show a sufficient correlation. Outliers were excluded from further 
analysis. Primary analysis was performed by Erik McShane. G QuaNCAT results plotted against local RNA-seq 
results. H QuaNCAT results potted against SILAC results. 
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5.3.7. Pools of localized RBPs and miRs as potential players of RNA localization and 
regulators of local translation 
Local translation in neurites is very likely to be controlled as in any other part of the cell. Major 
players of posttranscriptional regulation are miRNAs and RBPs. In addition to that, RBPs and 
miRNAs bare the potential to play a role in the process of localization itself. To assess the 
number of miRNAs in the spatial transcriptome, small RNA sequencing experiments were 
performed. Hereby, small cDNAs were enriched through gel purification prior to sequencing. 
500ng input material coming from either outgrowth or soma of N1E-115 or Ascl1-iNs was 
used as input material. In total 933 miRNAs in N1E-115 cells were identified, of which 20 are 
more than twofold enriched in the outgrowth and 14 are more than twofold enriched in the 
soma fraction (Fig. 19a). Among the outgrowth enriched miRNAs are miR-140-5p, which has 
a postulated neuroprotective function [308] and miR-5115, which is known to be localized to 
the synapse [309].  
In Ascl1-iNs 1,648 miRNAs could be identified, of which 191 were more than twofold 
enriched in the neurites and 151 more than twofold enriched in the soma (Fig. 19b). Among 
the top neurite enriched miRNAs there are several for which neuronal functions were already 
shown,such as miR-214-3p and -5p [310], miR-483-3p and -5p [308] and members of the let-
7 family [311], [312]. No correlation in miRNA localization between the cell lines could be 
detected (Pearson’s r=-0.01). Components of the RISC were found in the neurite compartments 
of both cell lines but were not enriched in either of them. 
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Fig. 19 Spatial miRs in the neuronal model systems N1E-115 and Ascl1-iNs 
A Spatial small RNA-seq reveals local miRNAs in N1E-115 cell. 933 miRs were identified of which 20 are 
enriched in the outgrowth (red) and 14 miRs are enriched in the soma (blue) fraction are. B Spatial small RNA-
seq reveals local miRNAs in Ascl1-iNs. 1,648 miRs were identified of which 191 miRs enriched in the neurites 
(red) and 151 miRs enriched in the soma (blue) are. Primary data analysis performed by Vedran Franke. C 
Correlation of miR localization between the used cell types.  
Targets of identified miRNAs were chosen using a dataset published by Chou et al. 2017 [313]. 
Only experimentally validated miRNA-mRNA interactions were used for the analysis. As 
parameters for validated miRNA-target interactions were chosen pairs of miRNA-mRNAs 
identified by qRT-PCR, RNA-Seq, microarray, luciferase reporter system and western blot 
respectively. Localization of miRNAs does not correlate with their validated targets, in N1E-
115 not in Ascl1-iNs (Fig. 20a&b). Also, there is no observable correlation between miRNA 
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localization and differential spatial translation efficiency of the target mRNA in Ascl1-iNs 
(Fig. 20b).  
 
 
Fig. 20 Targetome of either neuritic or somatic enriched miRs in Ascl1-iNs 
A Localization of miRs and their targets does not correlate in Ascl1-iNs. Targets of neurite enriched miRs 
highlighted in red, targets of somatically enriched miRs highlighted in blue.  B Boxplot of spatial relative 
translation efficiency of validated miR targets. There is no significant difference of the spatial relative translation 
efficiency of targets of neuritic enriched miRNAs or somatically enriched miRNAs.  
 
Recent studies identified mRNA-bound RBPs in diverse cells using an mRNA interactome 
capture approach and created a census of 1,542 RBPs [314]. Overlaying spatial proteome data 
from the label-free quantification approach in N1E-115 cells and the SILAC based experiment 
in Ascl1-iNs with said RBP dataset generated by Tuschl et al. reveals the distribution of RBPs 
in N1E-115 and in Ascl1-iNs (Fig. 21a & b). In total, 730 RBPs could be identified in N1E-
115 cells by two or more peptides, of which 12 were found more than twofold enriched and six 
exclusively in the outgrowth. On the other hand, 476 were found more than twofold enriched 
in the soma and 119 exclusively in the soma. In Ascl1-iNs 806 RBPs were identified as being 
highly expressed, of which 26 were found more than twofold enriched in the neurites and 52 
were more than wofold enriched in the soma. Neurite enriched RBPs fall into diverse 
categories: ribosomal proteins (Rpl26, Rpb27, Rpl31) and rRNA modulators (Urb2, Tfb1m), 
translational regulators (Lsm14b, Rrbp1), proteins involved in tRNA metabolism (Wars, 
Rpp14) but also transcription factors, and proteins involved in DNA binding (Peg10, Ttf2, 
Pura, Gtf2f1), nucleases (Hrsp12, Rexo2), RBPs that are known to play a role in the localization 
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machinery (Mvp, Rrbp1, Elavl2, Lsg1, Nxf7) and a group of proteins with general RNA 
binding properties (Mov10, Calr, Rbms2, Ppan, Hdlbp, Fam120a, Rnaseh2c). Interestingly the 
average distribution of RBPs in the two examined cell lines is significantly different. Whereas 
RBPs in general are evenly distributed in Ascl1-iNs, in N1E-115 cells they are clearly 
somatically enriched (Fig. 21c). 
 
 
Fig. 21 RBP localization in the used model systems 
A Overlay of the RBP dataset published by Tuschl et al. [314] and protein localization in N1E-115. Highlighted 
are RBPs enriched in the outgrowth (red) and other RBPs (blue). B Overlay of the RBP dataset with protein 
localization in Ascl1-iNs. Highlighted are RBPs enriched in the neurites (red) and not enriched RBPs (blue). C 
Violin plot for relative enrichment of RBPs in the used cell lines. 
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5.4. Going postal: Towards a zip-code directory for neuronal cells 
5.4.1. Motive enrichment analysis of neurite enriched RNAs  
There are various ways in which RBPs can target mRNAs: based on linear motifs, secondary 
structures, unstructured regions, or even unspecific targeting the ribose backbone. Most of 
these interactions occur in the untranslated regions of the mRNA, thus either the 3’ or 5’ UTR. 
In order to identify de novo sequence motifs for mRNA localization the MEME [315] Suite 
toolbox and MAST [316] were employed to identify motifs enriched in the UTR of localized 
transcripts. As a background pool, somatically enriched or equally distributed mRNAs were 
used. We found several motifs as significantly enriched in the neurites of Ascl1-iNs compared 
to the soma (Fig. 22). Some of them are known to be targeted by RBPs or other mechanisms. 
For example, 21% of all mRNAs that are neurite localized and also spatially translated showed 
a reminiscent GC-motif that is associated with m1A methylation sites in the 5’ UTR region of 
mRNAs and that is reported to promote translation [317]. Overall, reported m1A sites from 
mouse liver, mouse fibroblasts, mESC and brain [318] showed a significant overlap with the 
neurite transcriptome. Some of the other de novo found motifs match to known RBP binding 
motifs, such as the hnRNP E/poly(rC)-binding protein Pcbp2, which is broadly involved in 
RNA metabolism. It was shown that Pcbp2 regulates splicing for Mapt/Tau exon 10, which is 
critical for neuronal survival and function [319]. 
 
 
Fig. 22 Motive enrichment analysis of localized Transcripts. 
A Enriched motifs in neurites of Ascl1-iNs identified by MAST and MEME. Primary data analysis performed by 
Esteban Peguero Sanchez. 
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5.4.2. Using an RNA reporter library to identify zip-codes in Ascl1 iNs 
The high throughput identification of regulatory RNA sequences is a wide and fast-growing 
field in molecular biology. Several techniques are known and widely used to identify the 
interactions of specific RBPs with RNAs (such as RIP [320] or CLIP [321]) or to find 
regulatory elements inside restricted sequences. Here a technique is proposed to identify RNA-
elements de novo that are targeted by the localization machinery. Although the method can 
discern sequence elements which are necessary for localization, it can discriminate between 
the different mechanisms of localization. The theory behind these experiments is to generate 
an RNA-reporter library containing a pool of overlapping RNA constructs, deliver this pool 
into neuronal cells and recover the reporter pool from subcellular compartments after a period 
of incubation. Differences between the pools recovered from neurites and soma can be used to 
identify (1) sequences that are actively localized to one of the compartments and (2) sequences 
that vary in stability between the compartments (Fig. 23). To ensure highest sensitivity in 
reporter readout, next generation sequencing methods were used to validate the input and 
output of the experiments.  
 
Fig. 23 Schematic presentation of high throughput identification of zip codes in Ascl1-iNs.  
Reporter libraries are delivered into Ascl1-ins and the localization of these reporters is analyzed using NGS 
techniques. Experiments are always performed as batch experiments to guarantee reproducible results.  
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The input reporter pool of transcripts has to fulfill several criteria in order to be useful for the 
identification of zip-codes in neurons: (1) regulatory sequences have to be in the pool but the 
background should be non-regulatory; (2) sequences have to be long enough to contain full 
sequences yet short enough to enable specific discrimination of the sequence motif; (3) the 
sequences have to be partially overlapping and redundant, to ensure tiling and therefore precise 
mapping of regulatory elements; (4) the reporter pool should be as diverse as possible; (5) the 
reporter has to mimic a nascent RNA; and (6) the reporter has to be easily and clearly 
distinguishable from native RNAs. To fulfil all of these criteria the input sequences for the first 
experiments were taken from a RiboZero total RNA Sequencing library coming from the 
neurites of Ascl1-iNs. These fragments fulfill most of the above-mentioned criteria: (1) they 
contain endogenous sequences; (2) the average size of the endogenous fragments is 180bp; (3) 
sequences are redundant and overlapping due to the nature of RNA-seq library preparation; (4) 
it contains, in theory, all possible sequences coming from the neurite compartment; (5) after in 
vitro transcription and A-tailing the sequences mimic endogenous RNAs; and (6) due to 
adapter sequences that are added during library preparation, the reporter pool can be easily 
separated from endogenous RNAs. 
The RNA-seq library was amplified by PCR using primer overhangs that added a T7 promotor 
sequence and subsequently reverse transcribed them using a T7 in vitro transcription kit. To 
increase stability of the reporter pool the fragments were A-tailed to the degree of a nascent 
transcript (Fig. 24a). This RNA pool was introduced via RNA transfection into fully 
differentiated Ascl1-iNs cultured on porous membranes. After one day of incubation total RNA 
was extracted from the subcellular compartments and the reporter pool coming from the 
different compartments was isolated, making use of the sequencing adapters (Fig. 24a). The 
pool was sequenced on the NextSeq500, running one sample per flow cell with a read length 
of 150bp. Libraries were sequenced and mapped to the mm9-genome. 75,519,699 reads could 
be uniquely mapped to the genome in the neurite sample and 82,845,155 reads could be 
uniquely mapped to the genome in the soma sample. The average read distribution over mRNA 
molecules showed no overall bias towards any part of the mRNA. Amplification bias during 
the preparation of the library resulted in an extreme inhomogeneity of the signal, making the 
use of conventional peak calling or differential expression analysis uninformative. 
A 10-mer “counting” approach was used to identify short linear motifs that are either enriched 
or depleted in one of the compartments. The distribution of all possible (410 = 1,048,576) 
polynucleotides 10 bases long was calculated within the spatial compartments. Out of the 
1,048,576 10-mers, 994 showed at least a twofold enrichment in the neurite sample. 
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Additionally, just those 10-mers with more than 100 reads were filtered out leaving a pool of 
43 10-mers for the neurite sample and 83 10-mers more than twofold enriched in the soma 
sample. Plotting the neurite-enriched 10-mers to the genome shows a random distribution (Fig. 
24b). 
The top 10 enriched 10-mers for both soma and neurites were cloned in a row into the context 
of an artificial 3’UTR of a GFP reporter construct. This construct was stably integrated into the 
genome of Ascl1-mESC and localization was analyzed after differentiation and compartment 
separation via qRT-PCR (Fig. 24c). The soma reporter showed around fourfold somatic 
localization, while the neurite reporter showed just a slight somatic localization. 
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Fig. 24 Employing a total and transfected RNA reporter library in Ascl1-iNs. 
A Experimental setup. Batch transfection of the highly diverse reporter library was performed using 300µg of 
RNA reporter library into 3,000,000 cells. All steps of the protocol were controlled using agarose gel 
electrophoresis. B Localization of in silico generated 10-mers in our data. Primary data analysis performed by 
Vedran Franke. C Validation of the 10-mer experiment by qRT-PCR 
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5.4.3. Using a transgenic reporter cell line to identify zip-codes in Ascl1-Ins 
To increase the efficiency of reporter delivery into Ascl1-iNs and nascent RNA mimicry, the 
input library was cloned into the context of an artificial 3’UTR of a GFP reporter gene. This 
library pool was used to generate a transgenic cell line employing the piggyBac transposase 
system (Fig. 25a). Subcellular compartments of the reporter cell line were separated and RNA 
from these compartments was purified. All steps of cell line generation and reporter library 
extraction were controlled for complexity compliance. After adapter-specific purification of 
the reporters the libraries were PCR-amplified and the NextSeq workflow was followed using 
a read length of 150bp and one flowcell per compartment. Unfortunately, the extreme size and 
variety of sequences combined with multiple PCR steps, which were required due to low output 
of the assay, still resulted in inhomogeneity of the signal and therefore a low signal to noise 
ratio. The outcome was an extremely clustered sequence coverage (Fig. 25b). Therefore, peak 
calling algorithms could not be applied. Assuming the pool of sequences mimics a conventional 
differential expression experiment, using DeSeq2 for the analysis of the pools identified 69 
transcripts as more than twofold enriched with a p-val below 0.05 in the neurite compartment 
thus being potential candidates to inherit localization signals.  
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Fig. 25 Employing a polyclonal reporter cell line to identify zip codes in Ascl1-iNs. 
A Experimental setup. The plasmid-based reporter library pool was generated via Gibson assembly. The cloning 
efficiency was validated by counting transformants throughout the cloning strategy. The final plasmid prep was 
performed using a pool of approximately 10 million transformants. 30 million Ascl1-mESC cells were transfected 
with 300µg of reporter plasmid. The selection was performed for four days on high dose to ensure purity of the 
polyclonal reporter cell line. 30 million GFP positive cells were plated on 30 membranes and total RNA was 
collected from subcellular compartments. The reporter library was extracted using RT-PCR and analyzed using 
conventional NGS techniques. B representative tracks of highly and lowly expressed genes. Primary data analysis 
performed by Esteban Peguero Sanchez. 
 
To identify motifs that might drive the localization of these 69 mRNAs, MEME Suite database 
[315] and MAST [316] were used. Motive analysis of the enriched sequences revealed the 
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enrichment of an A-rich motive in the neurite pool when compared to the total pool or the soma 
enriched pool as a background model (Fig. 26a). The motif was found in 13 of the 69 neurite 
enriched mRNAs with an E-value below 0.1 and not at all in the soma pool (Fig. 26b). The 
motive was cloned into the 3’UTR context of the GFP reporter and used to generate a new 
reporter cell line. Analysis via qRT-PCR of the reporter construct did not show significant 
neurite enrichment (data not shown). 
 
Fig. 26 Motive enrichment analysis of localized sequences.  
A Identified motif from the neurite enriched reporter pool. Motifs were identified by MAST and MEME. Primary 
analysis was performed by Esteban Peguero Sanchez. B List of genes that inherit the found motif. C Mapping the 
genes in our initial spatial RNA-seq data. Eight out of 13 potential candidates inheriting the motive are also present 
in our initial dataset. Six of them show a positive neuritic enrichment, whereas two show a somatic enrichment in 
our initial RNA-seq data. There is no known RBP binding this motive.  
 
5.4.4. The RNA element selection assay (RESA) provides the tools for precise mapping 
of cis-regulatory elements of RNA localization 
The RNA element selection assay (RESA) was published by Yartseva et al. in 2017. Authors 
showed that it is suitable to identify regulatory RNA sequences inside a reporter pool during 
maternal-zygotic transition of a zebrafish egg in a qualitative and quantitative way. The limited 
size of the reporter pool is thereby crucial to gain the required tiling and precise mapping of 
regulatory sequences [284]. In theory this experiment can also work in identification of zip-
codes in our test system. Since the delivery of a reporter to our cells was optimized using the 
PiggyBac transposon system, a RESA-suitable reporter library was cloned into the transfer 
vector. 
Regulatory sequences of RNA localization (e.g. zip codes) were assumed to be in the 3’UTRs 
of localized transcripts. Therefore, the oligos for PCR amplification of the input library were 
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designed with the Primer3 [322], [323] software to span the 3’UTRs of 384 transcripts from 
the most neurite enriched mRNAs, in neurites of the initial spatial RNA-seq experiment and 
the 3’UTRs of proteins that showed more than twofold neurite enrichment even though the 
corresponding transcript was not enriched (see materials and methods - oligos). As an internal 
control and subsequent comparison to published data, the 3’ UTRs of the top 48 enriched 
mRNAs from the Cajigas et al. [249] were also PCR-amplified and introduced to the reporter 
pool. 
All PCR reactions that gave a product of expected size were pooled corresponding to the 
amount of amplicon and batch purified via AmpureXP bead purification (Fig. 27b). In total 
364 fragments from our dataset and 41 fragments from the Cajigas et al. neuropil dataset could 
be amplified (see materials and methods - oligos). The resulting cDNA library was fragmented 
via sonication. Fragments were treated with the Klenow Large Fragment (NEB 0210) for 
30min at 12°C and ligated sequencing adapters following the Illumina TruSeq stranded LT 
sequencing kit (steps A-tailing and adapter ligation). This fragment library mix was cloned into 
the 3’UTR context of a GFP reporter plasmid via Gibson assembly (Fig. 27a).  
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Fig. 27 Customizing the RESA protocol to identify zip-codes in neurons. 
A Experimental setup. To ensure sufficient coverage of the reporter library it is important to monitor the number 
of fragments cloned into the plasmid-based RESA library, as well as the amount of incorporation events in the 
generated cell line. To reduce PCR bias, for each PCR step, the minimal amount of cycles was detected using 
qRT-PCR. C Oligo design for the generation of the RESA library. 405 candidate genes were amplified. Candidates 
were chosen from our identified neuritic enriched transcripts and from a validation dataset (Cajigas et al.). B 
RESA library generation. 1. Example of PCR reactions. PCRs were all performed in 96-well format using NEB 
Phusion high fidelity polymerase. The annealing gradient for each plate was determined by the highest and the 
lowest annealing temperature. The amplification time for each plate was chosen based on the longest transcript. 
Amplicons were pooled in comparable amounts based on agarose gel electrophoresis. Amplicons with many 
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unspecific products were cut from the gel, pooled as gel slices and batch purified using conventional gel 
purification techniques. All amplicons were pooled and purified using AmpureXP beads. 2.-4. All steps were 
monitored using a bioanalyzer with DNA1000 chip to ensure correct size of the fragments. To prevent PCR bias 
for all PCR steps a diagnostic qRT-PCR was performed in advance.  3. Size selection was achieved through gel 
purification excision and purification. 
 
5.4.5. Generation of a plasmid-based RESA library 
The plasmid library was used to generate a polyclonal transgenic reporter cell line. 30 million 
cells were transfected with 250µg GFP-reporter-transfer vector and 50µg of PiggyBac 
transposase expressing vector. Transfected cells were recovered for one day under normal 
growth conditions and were then selected for positive integration via hygromycin selection. To 
recover the cell numbers in the transgenic cell line, the cells were cultured under normal growth 
conditions for two more days prior to differentiation. To ensure high complexity of the library, 
the cell population was kept at a minimum of 30 million cells throughout the whole experiment. 
After separation of subcellular compartments and subsequent RNA extraction the reporter 
transcripts were isolated from endogenous RNAs via targeted RT and PCR amplification. 
These libraries were used to proceed with a standard sequencing protocol. Three replicates per 
compartment were sequenced. 276,249,538 reads for the neurite sample and 154,890,476 reads 
for the soma sample could be mapped uniquely to the genome. The overall distribution of reads 
showed a strong bias towards the 3’ UTR, which is of course not surprising due to the selection 
of input fragments (Fig. 28b). Principle component analysis of the replicates shows a clear 
difference between the compartments (Fig. 28c). To identify peaks, e.g. sequences that are 
enriched or depleted in the neurite compartment, we used the MACS2 package [324], which 
identified 105,627 regions. Using DESeq2 [325] to obtain differentially localized sequences 
and filtering for those sequences with at least 60 reads in three replicates, considering only 
those sequences that we initially put in the library, revealed 139 regions being enriched in the 
neurite samples and 41 regions being enriched in the soma sample. 
Mapping the sequences to the genome revealed a strong bias towards the 3’ ends of the input 
sequences (Fig. 28d). This indicates a problem in the end repair and adapter ligation, during 
the initial library preparation. 
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Fig. 28 Diagnostics of the plasmid-based RESA experiment. 
A Cumulative distribution of reads over the genome. For all libraries about 75% of the reads map to 400 genes. 
Primary analysis was performed by Esteban Peguero Sanchez. B Cumulative distribution of reads over the gene 
body. The vast majority of reads maps to the 3’ end of the transcripts. C Hierarchical clustering of the samples. 
There is a clear difference between neurite and soma samples but the sample “Soma 2” also overlaps with the 
neurite samples. D Representative tracks of two cloned fragments. A clear pileup of reads at the 3’ ends of each 
construct is visible. The coverage between those “peaks” is very low. 
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6. Discussion 
6.1. The neuronal model systems N1E-115 and Ascl1-iNs 
Many approaches have been made recently towards identification of the dendritic/axonal 
transcriptome. Before 2016 most of these were either microarray-based approaches, yielding a 
maximum of 285 enriched mRNAs [241], [242], synaptosome analysis with all known 
impurities, or massive high-throughput in situ hybridization screens [239], identifying 68 
mRNAs in the synaptic neuropil. Overlaps between those studies, however, yield a surprisingly 
small number of mRNAs discovered in more than one study. This might suggest that either 
identification is far from being saturated or the local transcriptome is extremely variable. 
Including studies from Taliaferro, Ainsley, Cajigas and Shigeoka enlarges the pool of potential 
synaptic mRNAs by far, although the overlap stays quite low (Fig. 29). Possible glia 
contaminations in samples from in vivo mouse brains might further bias these studies. It seems 
obvious that different cell types require different spatial transcriptomes due to the distinct 
molecular functions they must fulfil. In addition, Shigeoka et al. [109] showed that the local 
translatome changes significantly during embryogenesis and Ainsley et al. [151] showed that 
even in mature neurons the synaptic translatome is variable upon stimulation. Although both 
studies focus just on the ribosome bound mRNAs, these changes might as well be reflected in 
overall localization of the transcripts. 
 
Using cell culture-based systems circumvents at least some of these variations. The used model 
systems here differ dramatically from each other. While N1E-115 cells are known to 
differentiate into active neuroblastoma cells [282], [285], [286], Ascl-mESC are known to 
build a homogenous population of post-mitotic Ascl-iNs [326]. Since no neuronal stimulatory 
supplement was used throughout this study it cannot be ruled out that the local transcriptome, 
translatome and proteome is as variable in our cell lines. It has been shown previously that 
cultured neuronal cells undergo spontaneous activation [327] and, therefore, our cell 
population might consist of a mixture of activity states. This might be a disadvantage for the 
investigation of specific mechanisms of neural plasticity, though it does not intervene with 
identification of the stable “steady-state” of the spatial molecular environment. 
The local transcriptome and translatome of neuronal cells also seem extremely variable and 
highly cell type specific in the data of this study. Comparing the spatial transcriptome data of 
N1E-115 and Ascl1-iNs as well as other published datasets of cortical neurons, CAD neurons, 
N2A neurons to an in vivo mixture of CA1 neurons, there is a marginal overlap (Fig. 29). It is 
clear that different cell types with different cellular functions require specific subcellular 
environments.  
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The missing correlation between RNA and protein localization in N1E-115 might be an 
outcome of technical difficulties during the experiment. 
 
 
Fig. 29 N1E-115 and Ascl1-iNs data in correlation to other publications. The correlation of diverse spatial 
RNA-seq experiments is very weak. The usage of different cell types, different developmental stages and 
different sequencing conditions might be the reason for this phenomenon. 
6.2. The role of RNA localization and local translation in establishing local 
protein pools in neurons 
The existence of spatial protein production in neurites and the role of mRNA localization has 
been a hotly debated topic in neuronal cell biology. It has been shown that local translation is 
crucial for neuronal plasticity [72], [152], [328], neuronal survival [329], synaptic 
differentiation [330], as well as for differentiation [331] cell migration [332], the cell cycle 
[333] and cellular polarity [39], [45], [331], [334]. Despite the implication of spatial translation 
in specific pathways, the global distribution has never been shown. An in vitro subcellular 
neuronal fractionation system was employed for this study, in combination with mass 
spectrometry and RNA-seq to quantify the transcriptome-wide patterns of mRNA localization, 
the impact of mRNA localization on local translation in Ascl1-iNs. Additionally, a translatome 
dataset [307] of the same cell line was used to highlight the impact of spatial translation. Using 
a minimal cutoff of twofold enrichment in the neurite datasets the analysis revealed that 
neurite-targeted mRNAs encode for approximately 63% of the spatial proteome (protein 
log2FC neurite/soma > 1; 148 out of 234 proteins; RNA log2FC neurite/soma > 1, P-values < 
0.05). Using RiboSeq, pSILAC and QuaNCAT it can be confirmed that most of the localized 
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mRNAs are locally translated. Consistently with neurite localization, GO term enrichment 
analysis showed that these genes are associated with molecular functions “actin cytoskeleton”, 
“calcium ion binding”, “extracellular matrix,” and “growth factor binding”. Furthermore, a 
substantial group of the localized proteins are encoded by mRNAs, which are moderately 
enriched in neurites (79 out of 234 proteins; 0 < RNA-seq log2FC < 1). These proteins may 
represent an intermediate group localized via multiple mechanisms, involving both mRNA and 
protein transport and differential translation efficiencies. Calculating these translation 
efficiencies (diff_trans log2FC= RiboSeq log2FC / RNA-seq log2FC) reveals that more than 
85% (197 out of 234) of the local proteome can be explained by local protein synthesis, leaving 
a very small part of the local proteome that cannot be explained by mRNA localization or 
neurite localized translation (4 out of 234 proteins; diff_trans log2FC and RNA-seq log2FC < 
0; Fig.30). Mechanisms of protein transport may underlie those cases as well as temporal 
regulated translational regulation. Due to technical limitations those mechanisms could not be 
analyzed in this study. 
Local protein synthesis has been implicated in several neuronal diseases, neurodevelopmental 
disorders, and psychiatric and degenerative diseases [148]. In fact, it was found that 
approximately 40% of the localized genes are implicated in neuronal diseases such as the 
DiGeorge syndrome, autism spectrum related disorders, fragile X syndrome, Alzheimer’s 
disease and Parkinson’s disease. Localization of these mRNAs suggests that dysregulation of 
either localization or local translation of these mRNAs may give rise to some of the mentioned 
disorders. 
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Fig. 30 Spatial translation is the main regulator of the local proteome. 63% of the neuritic enriched proteins 
are also enriched as mRNAs (SILAC REV loc2FC > 1; RNA-seq log2FC > 1 & p-val < 0.05). 34% of the spatial 
proteome is at least slightly enriched as mRNAs (SILAC REV loc2FC > 1; 0 < RNA-seq log2FC < 1 & p-val < 
0.05). 3% of the local proteome correspond to somatic enriched mRNAs (SILAC REV loc2FC > 1; RNA-seq 
log2FC < - 1 & p-val < 0.05). Three of those proteins do have a positive differential translation efficiency, 
indicating a more efficient spatial translation in the neurite. 
Correct subcellular localization of proteins is crucial for neuronal functions. It can be achieved 
(1) by transporting proteins with molecular motors as parts of RNPs or vesicular organelles, 
(2) through mRNA localization and local translation, or (3) via preferential local translation of 
equally distributed mRNAs, i.e., due to localization-dependent translational regulation. 
Specific examples for each mechanism have been described in the literature, but it is unclear 
to what extent each mechanism contributes to the overall protein distribution asymmetry. One 
reason for this is that most genome-wide studies focused on one particular layer of gene 
expression - transcriptome, proteome, or translatome, or a single cellular compartment (e.g., 
axon profiling without comparison with the somatic compartment). For example, Taliaferro et 
al. [81] applied RNA-seq to neurites and the soma of neuronal cell lines and mouse cortical 
neurons to study the differential localization of RNA isoforms. Shigeoka et al. [109] used the 
Ribotag approach to identify ribosome-bound mRNAs in mouse retinal axons.  
Due to differential sensitivity of high throughput mass spectrometry and sequencing methods, 
the proteome and translatome data vary in the number of detected transcripts. Because of this 
differential detection threshold, there is a pool of mRNAs that is enriched in the neurite 
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compartment but not translated, or is translated but is not identified on the protein base by the 
experiments in this study (low abundance, no specific peptides). This pool also contains RNAs 
that stay translationally repressed and might be released upon a specific stimulus. As it was 
shown by Ainsley et al., a big part of the neurite ribosome associated transcriptome changes 
upon intensive neuronal stimulation [151]. To understand the function of axonal translation 
and mRNA localization it is important to carry out comprehensive and unbiased global studies 
in various homogenous, synchronized neuronal populations. 
Of course, this raises the question of how the local translatome is controlled by upstream inter- 
and intra-cellular signaling. It was postulated that mTorc1 regulates axonal translation [335]. 
mTorc1 is important for axon organization [336] and also peaks in actively wiring axons [109]. 
Its targets show a steep increase at P0.5 and many of them are also found in the neurite dataset. 
In contrast to this, the activity of Fmrp was predicted to peak later in development since target 
mRNAs show a coordinate decrease in ribosome association in mature axons. The translational 
break mediated by Fmrp is also utilized more in the mature CNS [337], [338]. 
However, the translational regulator APC, which is known to regulate microtubule assembly, 
axonal growth and plays a critical role in local translation in various systems of axis formation 
and neurogenesis, seems to be most important in immature axons at stage E17.5 [109]. 
A recent study on mRNA and protein localization in MDA-MB231 breast cancer cells did not 
find any correlation between mRNA and protein localization [295]. This suggests that mRNA 
localization and spatial translation is more critical in highly polarized cells with long 
protrusions such as neurons. It was also shown that cancerogenous cells can suffer from 
significant abrogation in mechanisms of mRNA transport and spatial translation. Cancer cell 
lines are therefore an imprecise model for the exploration of in vivo mechanism of spatial 
localization. The lack of spatial translatome data in these migrating cells makes a comparison 
to our system impossible. It might be that outgrowth of migrating cells holds completely 
different localization machineries than steady state differentiated neurons. The establishment 
of the spatial translational machinery including ribosomes, translation factors, regulatory 
elements and posttranslational modifiers might not be energetically rewarding for a cell that is 
continuously changing its shape, although it is advantageous for the long distances and 
established immotile compartments of terminally differentiated neurons. This hypothesis is 
consistent with the observation of no correlation between protein and RNA localization in 
N1E-115 cells. 
Emerging data indicates that local protein synthesis is crucial for synaptic development and 
plasticity [117], [339], [340], although protein production in the cell bodies is undoubtedly 
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important. The data suggests local protein synthesis is the major player of building the local 
proteome of cultured iNeurons. It is of undoubted importance to gain comparable datasets from 
other model systems including ex vivo primary neurons and in vivo experiments to validate 
these results in the mammal brain. 
The revealed translatome includes several neurotransmitters, receptors, adhesion molecules, 
signaling molecules and regulators of protein synthesis, but also several transcription factors 
and other proteins associated with nuclear functions. The phenomenon of axonal translation 
and retrograde trafficking was already examined for diverse transcription factors like Creb 
[259], Smad1, 5 and 8 [341] and Stat3 [342]. As already suggested by others there are at least 
two explanations for this phenomenon: (1) though previously associated with nuclear 
functions, many proteins might have additional functions; and (2) the distal translation and 
retrograde trafficking of transcription factors and DNA modifiers implies one additional layer 
of intracellular signaling. As post-translational modifications are often achieved co-
translationally they rely heavily on the molecular environment. These modifications further 
alter the function of a nuclear protein as it is trafficked into the nucleus, depending on its NLS. 
Through this mechanism intercellular signaling is translated rapidly into transcriptional 
regulation. 
Despite genes associated with synaptic functions, we can find several axon-related proteins 
with clear spatial localization in our dataset. Although we cannot distinguish in our data 
between axonal and dendritic localization and translation, this is another hint towards axonal 
protein synthesis in mature neurons. This phenomenon was long doubted and could only be 
measured in developing axons [343], [344]. Other recent publications have also discovered a 
wide range of spatially translated proteins in mature axons [109], [246]. These studies suggest 
that axonal mRNA translation continues in the mature brain and may regulate presynaptic 
functions changing during synaptic excitation and over the lifetime of the neuron. 
The presence of mRNAs for diverse membrane proteins and their translation including several 
receptors and ion channels is not surprising. Many of those channels are known to be expressed 
in gradients from the soma towards the dendrites supporting excitatory potential of the 
dendrites and local control of signaling [345], [346]. The local synthesis of voltage gated 
channels and its regulation via neuronal excitation implies another layer of neuronal signaling. 
It was shown by Raab-Graham et al [347] that Kv1.1 translation is suppressed by synaptic 
excitation in pyramidal neurons, resulting in enhanced excitability [347]. Similar feedback 
loops are at least possible, if not probable. Multiple omics datasets from ground state and 
excited neurons would be of undoubtful interest to solve this puzzle. The fact that membrane 
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associated proteins are observed as being translated in the distal cellular compartments 
naturally requires the presence of the co- and posttranslational processing machinery of these 
proteins. Although it was known before that also distal parts of neurons contain components of 
the ER and Golgi [348]–[351], it remained a matter of debate whether the whole secretory 
pathway, the glycosylation pathway, and also key enzymes that influence ER export are 
present. Components of all of those machineries were identified in the neurite dataset of this 
study. Although most of them do not seem to be enriched in the neurite compartment, they are 
clearly present in the neurite. The glycosylation of membrane proteins is especially crucial for 
their correct folding and function.  
This study provides first global insights into the molecular architecture of outgrowing neurites 
on the proteome, transcriptome and translatome level. It is a valuable resource for future 
analysis of neuronal functions. Of course, mRNA localization and local translation is not only 
crucial for neuronal functions; many mechanisms of localization are also pivotal for cell 
migration, the establishment of cellular symmetry, cell cycle functions, cellular differentiation, 
especially in the context of inequal cell divisions. Also intercellular communications, including 
cell-cell contacts, cell-ECM contacts and mechanisms of RNA localization as well as spatial 
translation will not be exclusive to neurons. 
6.3. Spatial translational regulation in outgrowing neurites 
The directed outgrowth of axons is triggered by various extracellular cues inducing elongation 
or collapse of the growth cone. It was shown that inhibition of translation prevents sensitivity 
to most of these external signal [335], [352]. While attractive factors like netrin-1 or nerve 
growth factor (Ngf) stimulate spatial protein synthesis of cytoskeleton associated genes in the 
axon growth cone [353]–[355], repulsive factors like Sema3A or Slit2 stimulate the spatial 
disassembly of the cytoskeleton [161], [356]. The external signal gradient induces filopodia 
and lamellipodia formation and withdrawal and, thereby, axon architecture and navigation 
[353], [354]. Additionally, it was shown that various components of intracellular signaling 
pathways, guidance receptors and cell adhesion molecules are translated in neurites under 
vigorous control [109], [357]. 
After reaching their terminal target through the molecular guidance gradient, axons initiate 
branching to connect via synapses with their post-synaptic partners [358]. It was shown that 
branching points are points of protein synthesis in vitro [336], [359], [360] and destinations of 
mRNP transport [361]. Inhibition of translation inhibits both initiation and stabilization of new 
branching points [361], suggesting that regulation of spatial protein production is crucial for 
this mechanism. Finally synaptogenesis requires local translation in the presynaptic 
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compartment [362]. Spatial synthesis of Snap25 and β-catenin is crucial for presynaptic vesicle 
release and, therefore, neuronal functionality [362]–[364]. It was shown that GABA release in 
established synapses and, therefore, long-term synaptic plasticity underlies controlled local 
protein synthesis. The question of how thousands of different mRNAs are spatiotemporally 
controlled in translation is of high impact for the field of neuroscience, since it bears answers 
to fundamental questions of neuronal functions. Many axon guidance cues and neurotrophins 
are known to stimulate kinases that further induce phosphorylation of specific RBPs. Through 
this mechanism target mRNAs can be released, degraded, modified or bound and translational 
patterns can be changed [365]–[368]. A prominent example of this is the mTORC1 pathway 
that selectively promotes cap-dependent translation of target mRNAs. The fine-tuning of 
multiple pathways like these could bear the potential of defining spatiotemporal control of 
protein synthesis.  
As RBPs are crucial for RNA metabolism and translational regulation in every direction, I 
focused also on neurite enriched RBPs. It is obvious that neurite enriched RBPs bear the 
potential to mediate mRNA localization as well as regulate spatial translation and spatial 
mRNA turnover. 
The Elav like protein 2 (Elavl2), for example, was identified as a neurite enriched RBP. It was 
shown that this protein is implicated in mRNA localization in the Xenopus egg cell during 
oogenesis [369]. Additionally, it was shown to be important during neuronal differentiation 
and its dysregulation is linked to severe neuronal diseases like autism [370]. Also, the nuclear 
export factor 7 (Nxf7) which was shown to be additionally involved in RNP granule formation 
in neurons and is therefore linked to neuronal RNA localization [371], was found enriched in 
the data. 
RBPs with known roles in mRNA decay and translational regulation such as Mov10 and 
Lsm14b were also found, which could regulate the levels of neurite targeted transcripts and 
their translation efficiencies. Several RBPs which are known to play a role in protein transport 
like Mvp or Rrbp1 are, of course, interesting candidates for simultaneous protein and RNA 
localization. 
Peg10 is a neurite enriched RBP that is known to be involved in cell growth promotion and 
interacting with the tissue growth factor beta (Tgf-β) [372]. 
Neurite enriched ribosomal proteins like Rpl26, Rpl27 and Rpl31 support the hypothesis of 
distinct spatial ribosomal subpopulations that could enable the cell to regulate spatial 
translation [373].  In particular, the presence of Urb2, a ribosome biogenesis factor, and Tfb1m, 
a protein implicated in rRNA modification, supports this idea. Spatial pools of “specialized” 
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ribosomes could react differentially to ex- or internal stimuli and could drive differential spatial 
translation. 
Other enriched RBPs are known to be involved in general RNA metabolism and might 
therefore be important for spatial RNA turnover rated regulating spatial translation indirectly. 
Examples for this group are RNaseH2c, Rexo2 or Hrsp12.  
Another interesting group of neurite-enriched RBPs are transcription factors and DNA 
regulators. We found Ttf2, Pura and Gtf2f enriched in the neurite fraction. Both Ttf2 and Pura 
are gene specific transcription factors known to be involved in neurological disorders [374], 
[375], whereas the general transcription factor, 2 subunit 2f (Gtf2f), is a general transcription 
factor promoting transcription initiation. The presence of transcription factors in distal parts of 
the cell like the neuronal growth cone was already observed by Cox et al. in 2008 [259]. It was 
postulated that locally translated transcription factors can be modified depending on the 
molecular environment of their synthesis and that these modifications might resemble a 
feedback loop altering their functions when they are retrograde trafficked to the nucleus. 
The specific functions of these RBPs are under investigation, using knockout studies in 
combination with genome-wide target identification, using RNA immunoprecipitation (RNA-
IP), or crosslinking and immunoprecipitation (CLIP) assays to provide additional insight into 
the mechanisms by which those RBPs establish cell polarity and neuronal functions.  
Locally enriched miRNAs can also be implicated in differential spatial translation as well as 
differential mRNA localization. The miRNAome of neurons and neurites is highly cell type  
and most probably also development specific [376]. Intracellular miRNA gradients of course 
bear the potential of altering spatial protein synthesis rates, as does alternative 3’ UTR – 
localization. The observed trend of longer 3’ UTRs in distal neuritic compartments by 
Taliaferro et al. [81] could hint towards spatial regulation via 3’UTR-binding trans factors like 
RBPs and miRNAs. There are examples known for miRNAs controlling axonal synthesis of 
target mRNAs like miR-338 [199], [279] and also spatially responding to signaling as miR-
182 in growth cones [193]. Localization and local processing of miR precursors was 
demonstrated in dendrites [189] and is still under debate in axons. 
In total 191 miRNAs were identified as preferentially localized to neurites in Ascl1-iNs. Some 
of them are known to exhibit neuronal functions and to be localized to dendrites or axons like 
members of the let-7 family [311], [312] and miR-483 [308]. The overlap with a published 
dataset of axonally enriched miRNAs of sympathetic neurons is rather poor. Three out of 17 
axonally localized miRNAs found by Natera-Naranjo et al. [199] could be identified in our 
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neurite enriched data. Of course, this might be due to the nature of miRNAs that are highly cell 
type specific. 
Using in silico miRNA-target predictions based on experimental data we could not observe 
any global effect on either localization or translation of miRNA targets in our assay, though it 
should be mentioned that these effects are often rather small and difficult to observe in global 
data. A global miRNA-target interaction database for Ascl1-iNs is crucial to identify direct and 
indirect effects of localization and translational regulation in a dataset like this one. In 2014 
Sasaki et al. published a dataset of axon and growth cone enriched miRNAs [200]. This dataset 
was generated using massive qRT-PCR analysis of subcellular fractions from in vitro cultured 
hippocampal neurons. It is postulated that despite their role as fine tuners of gene expression, 
miRNAs are key regulators of neuronal function and development [377]. In total six miRNAs 
were found enriched in their axonal fraction. Obviously, that dataset is not complete due to the 
nature of the experiment and the overlap with the data of this study is therefore very poor.  
In silico examination of miR influence showed that miR-1 targets decrease during axon 
maturation in RGC development [109]. It might be that most miRNAs are (1) activity 
dependent or (2) active during maturation and, thereby, the effects of miRNAs in the test 
system of this study could not be observed. 
Posttranscriptional modifications are another wide field of spatiotemporal translational 
regulation. Axonal Gap43 mRNA is modified, for example, with n6-methyladenosin (m6A) 
[378] and, therefore, a substrate for the demethylase enzyme fat mass and obesity-associated 
protein (Fto). Depending on its methylation state, local translation is either promoted or 
repressed [378]. Unfortunately, no global analysis of spatial mRNA modifications has been 
published yet. The direct coupling of extracellular signaling to ribosome dissociation and 
release for example via Netrin-1 [379] is another attractive potential mechanism for spatial, yet 
unspecific, translational regulation. Since some mRNAs coding for ribosomal proteins are 
enriched in the neuritic fraction, it is possible that local translation of ribosomal proteins can 
repair damaged ribosomes or alter composition of local ribosome populations [109], [366]. 
In contrast to other studies, we could not detect extensive isoform diversity using MISO [111] 
in our datasets. This might be due to the type of sequencing (small read length) and protocol 
of library preparation (not 3’ end specific). Further studies including 3’ end sequencing in 
subcellular compartments of Ascl1-iNs will be of great interest to identify the isoform specific 
localization and local translation. Also, MISO does not de novo detect exon junctions, but only 
uses predefined annotations. It might be that localized isoforms are not annotated and are 
therefore excluded from the analysis. 
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6.4. Spatial circular RNAs bear the potential for unknown functions in 
subcellular compartments of neurons 
The functions of circular RNAs are, except for some specific examples, not known, 
althoughtheir abundance, tissue specificity, transcriptional regulation and conservation clearly 
points towards functional importance [380], [381]. They seem to be especially enriched in 
neuronal tissues [300]. 
In total 376 circular RNA isoforms could be identified in Ascl-iNs, of which 36 showed an 
enrichment in neurites (circular isoform in neurites / circular isoform in soma > 2) and 61 
showed a circ specific enrichment (circular isoform neurites / linear isoform neurites > 2). 
Additionally, seven genes showed an enrichment of the circular isoform, while the linear 
isoform is depleted from the neurites (circular isoform neurites/ circular isoform soma > 2 & 
linear isoform neurites/ linear isoform soma < 2). It is known that neuronal cells are enriched 
for circular spliced isoforms and that circular spliced isoforms are found in synaptosomes and 
axons of terminally differentiated neurons [381]. Here it is shown for the first time that some 
circular isoforms are enriched in the neurons of Ascl1-iNs. This enrichment seems to rely on 
their circular nature since the linear transcript of many of these circRNAs is not enriched. It 
might indicate specific functions of the circular isoforms in the subcellular compartment of 
these cells. There are few circular RNAs for which the function is known. Despite others, one 
reason for this is the complicated validation of circular-specific functions. In vivo most of these 
circular isoforms are very low abundant,although most hypothesis are based on batch 
sequencing experiments, therefore average the found molecules over a large number of cells 
and of course also over the whole cell body. Spatial enrichment of circular isoforms bears the 
potential to alter these hypotheses, since the relative abundance of said circular isoforms in the 
subcellular compartment might exceed the homeopathic concentrations calculated by canonical 
bulk RNA-seq experiments. Interestingly, the top enriched genes, for which the circular 
isoform is specifically enriched, are associated with polarization-related terms. Ptpn14 [382] 
and Mob3b [383] are associated with receptor kinase activities and involved in signal 
transduction. Lama1 [384] and Fndc3a [385] are associated with cell-cell adhesions, while 
Zwilch [386], Spag5 [387] and Ephb2 [305] are associated with cytoskeletal function, protein 
transport and axon guidance, respectively. However, the circular isoform of a gene canonically 
involves just the first 2-4 exons and translation of these circular isoforms was not yet validated 
in the system used in this study. 
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6.5. Identification of cis-regulatory elements and trans acting factors of RNA 
localization in Ascl1 iNs  
The importance of RNA localization for cellular life and especially highly polarized cells such 
as neurons is indisputable. Thus, the dissection of mechanisms of RNA localization is as 
important as it is challenging. Here the combination of a multi reporter based, high throughput 
method for the de novo identification of zip codes in neurons is proposed. Knowledge about 
how and why the message is delivered to a specific compartment bears the potential to design 
target-specific drugs in the form of artificial messengers that work on a subcellular level. For 
molecular biology the knowledge about what goes where is also of crucial importance, since it 
enables the user to make subcellular compartment specific reporters for other mechanisms of 
polynucleotides and proteins. 
The global analysis of mRNA localization is, however, a very broad field and many attempts 
have been made to identify players of mRNA localization. The presented approach focuses 
now for the first time not on the trans acting factors that might be involved, but the cis-acting 
sequence that might inherit the potential to be localized. Most known RBPs that do contribute 
to mRNA localization also fulfil other molecular functions, therefore pinpointing the effect 
only on mRNA localization from RIP or CLIP data is problematic. Furthermore, follow-up 
knockout or knockdown studies of specific RBPs don’t provide clear answers to the question 
of localization, since the secondary effects of these studies might hide localization mechanisms. 
Due to the sophisticated mechanisms that interplay in the orchestra of mRNA localization (e.g. 
splicing, degradation, stabilization, direct transport) the term “zip-code” appears to be system 
specific. An RBP that is involved in overall transcript degradation in cell type A might also be 
involved in spatial degradation and therefore localization of the same transcript in cell type B. 
6.5.1. Problems and solutions of the RESA-approach 
The delivery of the reporter library turned out to be crucial in this system. Yartseva et al. [284] 
used microinjections into the Danio rerio embryo, which is of course not suitable for this model 
system. RNA transfections might be a valid method, although the transfection efficiency of 
post-mitotic neurons is not very high and, therefore, the amounts of recovered reporter mix 
required more PCR steps prior to the sequencing, which resulted in less complexity of the 
output and thus a reduced tiling. 
The second problem of this approach was the extreme size of the input library (whole 
transcriptome), which resulted in a crude tiling. Since the fine and overlapping tiling of the 
reporter library is of crucial importance for bioinformatical analysis, the complexity of the 
input library must be reduced (as it is stated in the original RESA paper). The block-like over-
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amplification of few sequences, which prohibited canonical peak-finding algorithms to work 
on this data could be avoided by reducing the library size as well.  
Reducing the reporter library to selected candidates as it was done in the original paper is 
crucial for the generation of a reasonable signal to noise ratio. Unfortunately in this attempt, 
either the blunt ending reaction or the A-tailing reaction failed, resulting in a strong bias in 
adapter ligation towards the 3’ ends of the constructs. The inequal coverage of the library 
prevented identification of RNA elements that might drive localization. 
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